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Abstract 
 
There is a large inter-subject variability in the capacity to oxidise fat (MFO) during 
exercise and this could have important implications for metabolic health. However, prior 
to this thesis the evidence in support of this statement was limited and inconsistent. 
Accordingly, Chapter 3 of this thesis was designed to explore the relationship between 
MFO with 24-h fat oxidation and insulin sensitivity as surrogate markers of long-term 
metabolic health. This study showed that MFO during exercise is significantly and 
positively associated with both 24-h fat oxidation and insulin sensitivity in young, healthy 
men. Such links highlighted the need for a better appreciation of the factors that 
influence the inter-subject variability in MFO during exercise. Therefore, Chapter 4 
investigated relationships between selected plasma metabolites, hormones and 
overnight-fasted resting fat oxidation rates, with MFO. The results demonstrated the role 
of plasma lipolytic markers, plasma insulin, resting fat oxidation and aerobic capacity as 
important modulators of the inter-subject variability in MFO. Finally, Chapter 5 utilised 
the findings of Chapter 4 from a translational perspective by exploring the influence of 
meal timing (i.e., eating before [Fed exercise] or after [Fasted exercise]) an acute bout of 
aerobic exercise, on substrate utilisation, lipolytic markers and insulin, and intra-
muscular triglyceride (IMTG) use in obesity. This study found that Fasted- as compared 
with Fed-state augments exercise fat oxidation, as well as the circulating concentration 
of plasma glycerol and NEFA during exercise, and suggests IMTG use in obesity. In 
conclusion, this thesis generates new data that contributes to our understanding of the 
	 iv 
links between MFO and metabolic risk, as well as the factors that influence the inter-
subject variability in MFO during exercise. It also provides preliminary evidence of 
exercise-induced IMTG use in obesity, and shows clearly that fasted, as compared with 
fed exercise augments exercise fat oxidation, which could have meaningful implications 
for optimising metabolic health. 
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Thesis Outline 
 
This thesis starts with a General Introduction (Chapter 1). Here, information is provided 
relating to substrate utilisation at rest and during exercise, including an outline of the 
most important regulators of substrate use during exercise. Thereafter, an insight into 
studies that have identified inter-subject differences in fat oxidation during exercise, 
including the Maximal capacity for Fat Oxidation (MFO), is given. This is followed by a 
discussion on the research that has sought to: (i) address the significance of the inter-
subject variation in MFO during exercise in the context of metabolic health; and (ii) 
explain the determinants of this variation. The final part of this chapter explores the role 
of intramuscular triglyceride (IMTG) and associated lipid metabolites in the development 
of insulin resistance in obesity, along with insights into potential nutritional strategies to 
increase IMTG utilisation during exercise, which could help to improve insulin sensitivity 
in this population.  
 
Next, information on the techniques used in the experimental chapters of this thesis is 
provided (Chapter 2). The experiments undertaken during this period of study are shown 
in Chapters 3-5. Presented here are studies further investigating (i) the significance of 
the inter-subject variability in MFO during exercise in the context of metabolic health 
(Chapter 3); (ii) factors which influence the inter-subject variation in MFO during exercise 
(Chapter 4), and; (iii) the influence of pre- or post-exercise food intake on substrate 
utilisation, lipolytic markers and insulin, and IMTG utilisation in obesity (Chapter 5). 
	 xxvi 
Lastly, Chapter 6 summarises the key findings from the experimental chapters and 
discusses how these integrate and build upon the existing body of literature. It also 
discusses the wider implications of the thesis findings and proposes directions for future 
research.
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CHAPTER 1  
 
GENERAL INTRODUCTION 
	 2 
1.1 Introduction 
At rest and during aerobic exercise, energy demands of the body are met primarily by 
the oxidation of the energy substrates carbohydrate and fat. During exercise, the 
absolute and relative contributions of each substrate to energy expenditure are 
influenced by a number of factors including exercise intensity (Romijn et al, 1993, 
Bergman & Brooks, 1999, van Loon et al. 2001), exercise duration (Romijn et al. 1993), 
aerobic capacity/training status (Holloszy & Coyle, 1984), nutritional status (Bergman & 
Brooks, 1999; Coyle et al. 2001) and sex-related differences (Tarnopolsky et al. 1990). 
Interestingly, there is marked inter-subject variation in the capacity to oxidise fat during 
exercise and it has been proposed that this variation could have important implications. 
From the perspective of athletic performance, an increased reliance on fat oxidation 
during exercise could permit an athlete to exercise for longer before becoming 
exhausted due to glycogen depletion, which could confer a performance advantage. 
Emerging evidence also suggests a link between impairments in fat oxidation and the 
development of unfavourable metabolic conditions such as obesity and insulin 
resistance, which is a precursor to type II diabetes (Zurlo et al. 1990; Kelley & Simoneau 
(1994). Whether a reduced fat oxidation is a cause or consequence of these adverse 
health outcomes is yet to be determined. Nevertheless, a better understanding of if, and 
why, fat oxidation during exercise is important, as well as the determinants of the 
apparent inter-subject variability, could help to inform novel interventions to increase fat 
oxidation during exercise and curtail the rise in obesity and its related disorders.  
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1.2 Substrate utilisation at rest and during exercise 
During aerobic exercise, carbohydrate and fat are the principle substrates for oxidative 
phosphorylation and energy (adenosine tri-phosphate; ATP) production (Hargreaves 
2012; Spriet, 2012), whilst the relative contribution of amino acids, particularly the 
branched chain amino acids (isoleucine, leucine and valine) is thought to be low 
(typically less than 5%, maximally 10%; Lemon & Mullin, 1980).  
 
1.2.1 Carbohydrate as a fuel source 
Carbohydrate is stored predominantly in skeletal muscle but also in liver as glycogen, 
with smaller amounts of carbohydrate (~4 g for a person weighing 70 kg; Wasserman, 
2009) circulating freely in the blood stream as blood glucose.  
 
The endogenous carbohydrate pool is small but flexible. For instance, early work that 
employed the liver and muscle biopsy technique demonstrated that dietary manipulation 
exerts a large influence glycogen reserves (Bergstrom et al. 1967; Nilsson & Hultman, 
1973). Liver glycogen concentrations usually vary with the diet (range 1.4 g to 8.0 g/kg 
wet liver tissue in 58 healthy subjects who were studied in the post-absorptive state 
following a period of ad libitum diet; Nilsson, 1973) and can also vary throughout the day 
depending upon patterns of eating and fasting (Hultman & Nilsson 1971). Findings from 
muscle biopsy samples indicate that glycogen concentrations in the vastus lateralis 
muscle range from 60-120 mmol glycosyl residues/kg wet tissue (mean 85 mmol 
glycosyl residues/kg wet tissue; Hultman, 1967). If these values are extrapolated to the 
	 4 
whole body level, it can be estimated that a man weighing 70 kg with ~40% of his mass 
attributed to muscle and a liver weighing 1.8 kg, has a whole body glycogen storage 
capacity of ~500 g. If the highest reported values are extrapolated (Bergstrom et al. 
1967; Nilsson, 1973) then this could increase to 700 g. Nevertheless, 700 g of glycogen 
storage correspond to only 11.7 MJ (2,800 kcal), which highlights the limited energy 
storage capacity of carbohydrate. 
 
1.2.2 Fat as a fuel source 
Fat is predominantly stored as triglyceride in deep visceral and subcutaneous adipose 
tissue, with a lesser amount (~7.8 MJ or 1,850 kcal) stored as lipid droplets inside 
muscle fibers as IMTG (van Loon et al. 2001). There is also some fat circulating in the 
bloodstream as non-esterified free fatty acids (FA), which is bound to a protein carrier 
(albumin). Some FAs are also found as TG incorporated in circulating lipoprotein 
particles (chylomicrons and very-low- (VLDL), low-, intermediate-, and high-density 
lipoproteins). The energy storage capacity of fat is large and markedly exceeds that of 
carbohydrate. For instance, a healthy, lean man of approximate body mass 70 kg can 
store between 9-15 kg of endogenous fat, which equates to a total energy storage of 
350-586 MJ (80,000-140,000 kcal); adequate to fuel a person to walk for ~16,000 km 
(Jeukendrup et al. 1998).  
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1.2.3 Energy production at rest and during exercise 
During resting conditions and after an overnight fast, a combination of carbohydrate, fat 
and protein are oxidised to provide the fuel necessary for basal metabolic processes. 
These substrate sources usually share a reciprocal relationship and the relative 
contribution of each can vary considerably between individuals. The contribution of each 
substrate to energy production at rest can vary despite a reasonably unchanged 
metabolic demand, predominantly arising from alterations in substrate availability.  
 
The shift from rest to exercise induces a substantial rise in metabolic demand for 
energy, which can increase several-fold above that during resting conditions. 
Accordingly, the metabolic pathways that oxidise carbohydrate and fat must be activated 
simultaneously (Hargreaves, 2012), however the pattern of substrate utilisation is 
susceptible to many factors, including (but not exclusive to) cardiorespiratory fitness 
(V̇O2max; Kiens et al. 1993; Klein et al. 1994; Phillips et al. 1996b; Coggan et al. 2000), 
sex (Tarnopolsky et al. 1990; Tarnopolsky et al. 1995; Tarnopolsky et al. 1997; 
Venables et al. 2005; Tarnopolsky et al. 2007), recent (Coyle et al. 1985; Gleeson et al. 
1986; Achten & Jeukendrup, 2003) and habitual (Goedecke et al. 2000) diet, body 
composition (particularly fat-free mass; Venables et al. 2005) and the circulating 
concentration of blood-borne hormones and metabolites (Coggan et al. 2000; Horowitz 
et al, 1997; Horowitz et al. 1999; Achten & Jeukendrup, 2004; Moro et al. 2013). Further 
discussion on the influence of these factors on substrate use during exercise can be 
found in Chapters 3 and 4. 
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1.2.4 General overview of lipid metabolism during exercise 
As described in Section 1.2.2, the energy storage capacity of lipids is large and it is 
therefore not surprising that lipids contribute to a substantial portion of energy 
production, particularly during low and moderate intensity exercise, as well as exercise 
of increasing duration (Krogh & Lindhard, 1920; Christensen & Hansen, 1939b; Romijn 
et al. 1990, van Loon et al. 2001; Figure 1.1). However, lipid metabolism during exercise 
is complex, with numerous possible sites for regulation and multiple steps to oxidation 
(for review see Spriet et al. 2014).  
 
 
	
Figure 1.1 Maximal contribution to energy expenditure derived from glucose and FFA 
taken up from blood and minimal contribution of muscle triglyceride and glycogen stores 
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after 30 min of exercise, expressed as a function of exercise intensity. Total amount of 
kilocalories (kcal) available from plasma does not change in relation to exercise 
intensity. Data redrawn from Romijn et al. (1993).  
(i) Sources of fat as a fuel during exercise (see also Figure 1.1): Following an overnight 
fast, energy demands at rest are met by the oxidation of fatty acids originating 
predominantly from visceral adipose tissue TAGs and to a lesser extent subcutaneous 
adipose tissue (Arner et al. 1990). At rest, FA release from adipose tissue is ~2 times 
greater than FA oxidation (Klein et al. 1989) and therefore a large portion are re-
esterified back into TAGs, usually by the liver. As discussed (Section 1.2.3), the shift 
from rest to low or moderate intensity exercise (25-65% V̇O2max) causes an increase in 
metabolic demand and fat oxidation is elevated ~5-10 fold above resting conditions 
(Krogh & Lindhard, 1920) and lipolysis of adipose tissue TAGs increases ~2-3 fold (Wolf 
et al. 1990; Klein et al. 1994).  
 
In addition to energy supplied from adipose tissue TAGs, there are also FA’s located 
within circulating triglyceride-rich lipoproteins, which can be hydrolysed by lipoprotein 
lipase (LPL) located on the capillary endothelium of skeletal muscle and adipose tissue. 
These FA’s can be taken up by skeletal muscle for oxidation, however their contribution 
to total fat oxidation during exercise is only very small (<10%; Havel et al. 1967).  
 
Studies that have employed electron microscopic analysis of skeletal muscle tissue have 
demonstrated that IMTG droplets are situated in close proximity to the site of oxidation in 
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the muscle mitochondria (Hoppeler et al. 1973) and it has long been recognised that 
IMTG is an important contributor to overall fat oxidation during prolonged exercise 
(Froberg & Mossfeldt, 1971) and exercise of particular intensities (Essen et al. 1977). 
Indeed, plasma FA’s are the predominant contributor to overall fat oxidation during low 
intensity exercise in well-trained men (25% V̇O2max) but as exercise intensity increases 
total fat oxidation far exceeds the rate of plasma FA disappearance, such that during 
fasted moderate intensity exercise (65% V̇O2max) IMTG provides ~50% of the total fat 
oxidation, whilst its contribution declines during high intensity exercise (85% V̇O2max) 
(Figure 1.1). Research also demonstrates that IMTG is an important fuel source during 
prolonged moderate-intensity (60% V̇O2max) cycling exercise in well trained individuals 
(van Loon et al. 2003), and also contributes as a fuel source during resistance type 
exercise (Essen & Gustavsson, 1990). For a comprehensive overview of the influence of 
intensity, diet and training status on IMTG utilisation, the interested reader is directed to 
three excellent reviews (Watt et al. 2002; van Loon, 2003; Shaw et al. 2013).  
 
1.3 Variability in the relative contribution of substrates during exercise  
Although there are a number of factors that can influence substrate metabolism during 
exercise, it is interesting that there also seems to be substantial inter-subject variability 
in the contribution of carbohydrate and fat to energy expenditure during exercise even in 
relatively homogenous groups under standardized conditions. For example, Helge and 
co-workers found RER during overnight-fasted exercise performed at the same relative 
exercise intensity (55% V̇O2max) to range between 0.83 and 0.95 in a group of untrained, 
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healthy men (Helge et al. 1999). Consistent with this, but using a well-trained cohort of 
61 cyclists (V̇O2peak, 56 ± 7 ml/kg/min), another study demonstrated a large degree of 
variation in RER at rest (0.72 – 0.93), that remained throughout exercise at three pre-
determined workloads (41, 63 and 80% of V̇O2peak; Goedecke et al. 2002). Whilst these 
studies offered some initial insight into the apparent inter-subject variability in fat 
oxidation during exercise, it is noteworthy that RER considers only relative fuel utilisation 
and does not inform of the rate of carbohydrate and fat oxidation. Further, substrate use 
in these studies was assessed over only one (Helge et al. 1999) or three (Goedecke et 
al. 2000) pre-determined workloads, and it cannot be excluded that findings might have 
been different at higher or lower exercise intensities. 
 
1.4 Inter-subject variation in absolute rates of fat oxidation during exercise 
The insights obtained by the studies in Section 1.3 stimulated great interest in 
developing a test protocol to assess the absolute rates of carbohydrate and fat oxidation 
over a wide range of exercise intensities; thereby providing the resolution to more clearly 
identify the extent of the apparent inter-subject variation in fat oxidation during exercise. 
Achten and colleagues were the first to do this (Achten et al. 2002). They determined 
MFO and corresponding exercise intensity (Fatmax) systematically over a wide range of 
exercise intensities, using an incremental cycling protocol with 35 W stages of 3-minute 
duration, based on respiratory gaseous exchange and indirect calorimetry (Figure 1.2). 
The test was validated against longer duration stages and in another study its 
reproducibility was assessed (Achten et al. 2003). In recent years, the term Maximal Fat 
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Oxidation (MFO) has been increasingly used to describe an individual’s peak rate of fat 
oxidation and could be regarded as a useful marker of an individual’s capacity to oxidise 
fat during exercise. 
	
Figure 1.2 A typical Fatmax curve obtained during an incremental exercise test over a 
range of exercise intensities. Redrawn from Achten et al. (2002). 
 
Interestingly, the substantial inter-subject variability in the relative contribution of fat to 
energy expenditure during exercise is also apparent in the maximal rates of fat oxidation 
that have been observed during exercise. For example, the study by Achten and co-
workers showed MFO determined during cycle ergometer exercise in endurance-trained 
men was 0.52 ± 0.15 g/min (Mean ± Standard Deviation [SD]) and varied 4-fold between 
individuals (0.23 - 0.91 g/min; Achten et al. 2002). Using a more heterogeneous group of 
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healthy men and women, Venables and co-workers demonstrated similarly large inter-
subject variability in MFO during treadmill exercise (0.46 ± 0.17 g/min; range 0.18 - 1.01 
g/min; Venables et al. 2005). More recently it has been shown that there is considerable 
inter-subject variability in MFO in homogenous groups of overweight men (Rosenkilde et 
al. 2010) and normal-weight, pre-menopausal healthy women (Isacco et al. 2014) 
 
1.5 Significance of fat oxidation in relation to metabolic health  
The prevalence of obesity is rising at an alarming rate (Wang et al. 2011), which is 
undoubtedly a major cause for concern given the attendant inflated risk of chronic 
disease (WHO, 2010). Whilst much of this rise is related to genetic or epigenetic factors, 
as well as the increasing prevalence of sedentary lifestyles (King et al. 2005) and 
greater access to low cost, high energy density foods (Bell et al. 1998; Drewnowski, 
2004; Monteiro et al. 2004), it is also interesting that the propensity to develop these 
conditions may be through disturbances in whole body and skeletal muscle lipid 
metabolism.  
 
1.5.1 Links between fat oxidation and change in body mass and/or composition 
One interesting observation is that an elevated 24-h respiratory quotient (RQ; reflective 
of tissue exchange of CO2 produced and O2 consumed) is commonly used in resting 
and calorimeter studies), which is indicative of a low relative fat to carbohydrate 
oxidation (an RQ of 0.7 denotes total fat oxidation, whilst an RQ of 1.0 denotes total 
carbohydrate oxidation), has been shown to be predictive of long-term alterations in 
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body mass and composition. For instance, a prospective study (Zurlo et al. 1990) 
measured 24-h RQ using a whole-room respiration chamber and indirect calorimetry in 
152 non-diabetic Pima Indians fed a weight-maintenance diet. In 111 subjects for whom 
follow-up data were available (25 +/- 11 months), they found that those with an elevated 
24-h RQ (90th percentile; RQ = 0.88) were predisposed to gain ≥ 5 kg in body mass 
compared to those with a lower 24-h RQ (10th percentile; RQ = 0.82). Importantly, this 
finding remained when adjusted for potential confounding variables such as energy 
expenditure, fat mass and fat-free mass. Moreover, the coefficient of determination of 
this relationship showed that 5% of the variability in body mass gain was associated with 
the variability in RQ, adjusted for energy balance and percent body fat.  
 
An allied observation comes from a longitudinal study by Seidell and colleagues (Siedell 
et al. 1992), who followed 775 men (aged 18-98 years) for a period of approximately ten 
years. They measured fasting RER and resting metabolic rate (RMR) at baseline and 
related this to subsequent change in body mass. Following adjustment for factors such 
as age, body mass index, fat-free mass, and duration of follow-up, they demonstrated 
that RER, but not RMR, was predictive of subsequent body mass gain (P < 0.001). 
Furthermore, major body mass gain (from at least 5 kg to 15 kg) was associated with 
initial RER in non-obese white men (initial BMI < 25 kg/m2). In further analysis, non-
obese white men who displayed a fasting RER of ≥ 0.85 were ~2.5 times more likely to 
gain ≥ 5 kg body mass compared to men with a fasting RER < 0.76. Considered 
collectively, these studies demonstrate that a reduced reliance on fat oxidation to daily 
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or resting energy expenditure may be an important metabolic predictor of body mass 
gain.   
 
1.5.2 Links between fat oxidation and body mass and body fat mass re-gain 
Whilst many diet and exercise interventions can effectively facilitate body mass loss, it is 
apparent that most individuals will re-gain body mass within 3-5 years (Weiss et al. 
2007). Accordingly, a better understanding of the metabolic characteristics that 
predispose individuals to body mass-regain following body mass loss is an important 
public health challenge. It has been suggested that one such mechanism could be 
through impairments in daily fat oxidation, such that a high RQ predisposes individuals 
to re-gain body mass following a period of weight loss. This was demonstrated by 
Froidevaux and co-workers (Froidevaux et al. 1993) who assessed 24-h energy 
expenditure and 24-h RQ in a group of 10 moderately obese women on four occasions: 
1) before body mass loss (body mass = 78 kg), 2) during body mass loss (64 kg), 3) 
after re-alimentation (63 kg), and 4) 6-15 months after the study diet with ad libitum diet 
(68 kg). They reported a significant and positive correlation between basal RQ and body 
mass re-gain following a period of diet-induced body mass loss (R = 0.89, P < 0.01) and 
suggested that following a period of body mass loss, an elevated postabsorptive RQ 
appears an important determinant of the long-term stabilization of body weight in 
previously obese women.  
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This apparent association between RQ and body mass gain has been confirmed by 
some (Hainer et al. 2000; Marra et al. 1998; Weyer et al. 2000; Marra et al. 2004), but 
not all (Weinsier et al. 1995; Weinsier et al. 2002; Weinsier et al. 2003), studies; a 
disparity that could be due to population differences and dietary control in study designs.  
 
It could also be that the period of RQ measurement influences associations between 
daily substrate metabolism and future body mass gain. Indeed, previous studies have 
typically determined relationships between fasting, sleeping and 24-h RQ with 
subsequent alterations in body mass (Weinsier et al. 2003). However, RQ measured 
during fasting or sleeping conditions encompasses a period when reliance on 
endogenous fatty acid oxidation for fuel is high and does not account for an individual’s 
capacity for fat and carbohydrate oxidation across typical post-prandial periods of the 
day. It has been suggested that the relationship becomes stronger when RQ is 
measured during the non-sleeping segment of the day and is associated with changes in 
body mass (Ellis et al. 2010).  
 
1.5.3 Potential mechanisms for the association between fat oxidation and 
alterations in body mass and composition 
Mechanistically, perturbations in fat mass are underpinned by the state of fat balance 
(fat intake [+synthesis] – oxidation; Flatt, 1993). To reduce fat mass a negative fat 
balance must be reached and this can be achieved by manipulating fat intake or 
expenditure to a level whereby fat oxidation is greater than fat intake.  
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It has been suggested that a reduced fat oxidation (and thus elevated carbohydrate 
oxidation) impacts upon long-term body mass or composition through increased ad 
libitum food intake in free-living conditions, which may offer a behavioural explanation 
linking low fat oxidation to unfavourable body or fat mass development. For instance, 
Eckel and colleagues demonstrated in 39 young normal-weight (n = 23), overweight (n = 
8), and obese (n = 8) men and women that those who exhibited a higher carbohydrate 
balance and thus lower fat balance, measured during a 24-h stay in a respiratory 
chamber following a 15 day isocaloric high carbohydrate diet, gained less fat mass (P < 
0.001), percentage body fat (P = 0.006), and body mass (P = 0.024) over a 4-year 
follow-up period (Eckel et al. 2006). It has been proposed that the effects of substrate 
oxidation and balance on food intake mediate these relations (Pannacciulli et al. 2007). 
These authors provided 112 normoglycemic men and women with a 3-day weight-
maintenance diet, following which they measured 24-h energy expenditure and 
substrate utilisation in a respiratory chamber and allowed participants to self-select their 
food intake during a subsequent 3-d period. They showed that 24-h RQ (positive 
association), 24-h carbohydrate oxidation (positive association), and 24-h carbohydrate 
balance (negative association) were significantly associated with ad libitum food intake. 
Considered collectively, these findings offer support to the glycogenostatic model 
devised by Flatt (1987), which proposes that those who rely less on fat oxidation for 
energy production (and more on carbohydrate) are likely to exhibit increased ad libitum 
food intake in an attempt maintain carbohydrate balance and replenish limited glycogen 
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stores, both of which are reduced according to the extent of daily carbohydrate 
oxidation.  
 
As a high fat oxidation whilst physically active could make important contributions to 
daily fat oxidation it is not unreasonable to consider a high capacity to oxidise fat whilst 
physically active as advantageous for the long-term maintenance of body mass and 
body composition. To this author’s knowledge, there is only one study that has 
investigated the link between substrate utilisation during exercise and subsequent ad 
libitum feeding. Almeras and colleagues demonstrated using eleven healthy, sedentary 
to moderately active, young men, that those who had a reduced reliance on fat oxidation 
towards energy expenditure during 90 minutes of exercise at 60% V̇O2max exhibited a 
higher post-exercise ad libitum energy intake relative to the energy cost of exercise 
(when meals were consumed within the laboratory [snacks ingested outside the 
laboratory] and energy intake covertly recorded). Furthermore, exercise RQ was 
positively related with post-exercise energy and lipid balance (Almeras et al. 1994). 
Unfortunately, this study did not associate exercise RQ with changes in body 
composition, but it is tempting to speculate that individuals who derive a greater 
proportion of energy from the oxidation of fat whilst physically active could be at a 
reduced risk of future body mass gain, compared with those who exhibit a lesser 
reliance on fat (and higher reliance on carbohydrate). 
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1.5.4 Links between fat oxidation and insulin sensitivity  
There is evidence that the inter-subject variability in fat oxidation could be significant for 
the development of favourable or unfavourable metabolic phenotypes. For example, 
observational studies have linked impairments in fat oxidation, particularly at the level of 
skeletal muscle, with a reduced metabolic flexibility (defined as the capacity to adapt fuel 
oxidation to fuel availability) and insulin resistance, which is an early sign of the 
development of type II diabetes (Kelley & Simoneau, 1994; Zimmet et al. 2001).  
 
There is also evidence that is suggestive of a link between exercise fat oxidation and 
insulin sensitivity. For example, one study reported a significant and positive correlation 
between fat oxidation during exercise at 55% V̇O2max (mg/kg/min; R = 0.42, P = 0.011) 
and insulin sensitivity index in a group of South Asian and European Men; an 
association that remained when adjusted for potential confounders such as age, BMI, fat 
mass and physical activity (R = 0.36, P = 0.035) (Hall et al. 2010). An allied observation 
was made by Abilgaard and colleagues who demonstrated a positive relationship 
between whole body fat oxidation measured during cycling exercise at 50% V̇O2max and 
insulin sensitivity (derived from an oral glucose tolerance test; R = 0.56, P = 0.05) in a 
group of healthy women (Abilgaard et al. 2013). 
 
In line with the above-mentioned associations between a reduction in fat oxidation at 
rest or during exercise and insulin sensitivity, longitudinal studies show that an 
enhancement in fat oxidation with exercise training is associated with improvements in 
insulin sensitivity (Goodpaster et al. 2003). Furthermore, greater exercise training-
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induced improvements in insulin sensitivity have been observed using exercise training 
strategies that enhance fat oxidation during acute exercise e.g., targeting training 
intensity Fatmax or exercising in the overnight-fasted state (Venables et al. 2008).  
 
From a mechanistic standpoint, the association between an elevated fat oxidation during 
exercise and insulin sensitivity seems plausible (for a more comprehensive overview of 
the etiology of insulin resistance at the potential role of fat oxidation in modulating insulin 
sensitivity please see Section 1.7). Briefly, it has been suggested that incomplete 
metabolism of fatty acids in the β-oxidation pathway induces an accumulation of acyl 
carnitines in the mitochondria and this is associated with insulin resistance (Koves et al. 
2005). Furthermore, the accumulation of lipid metabolites such as ceramide, 
diacylglycerol (DAG) and long-chain fatty acyl-CoA (LCFA-CoA) has also been linked 
with insulin resistance in skeletal muscle (Shaw et al. 2010). Therefore, a higher fat 
oxidation during physical activity could help to alleviate lipotoxic stress in skeletal muscle 
and confer improvements in insulin sensitivity (Venables et al. 2008).  
 
With this in mind, it seems reasonable to suggest that those who exhibit a higher MFO 
during exercise have better insulin sensitivity, compared with those who have a lower 
MFO. However, the evidence to date linking the capacity for fat oxidation during exercise 
to insulin sensitivity is limited and inconsistent. For example, one study observed no 
association between insulin sensitivity and RER at rest and during exercise (Goedecke 
et al. 2001), whereas a more recent study (Chu et al. 2014) showed MFO was positively 
correlated with insulin resistance (estimated from the homeostatic model assessment of 
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insulin resistance) and unrelated to whole-body insulin sensitivity index (determined from 
oral glucose tolerance testing).  
 
This is in contrast to what might be expected given the above-mentioned associations 
between (i) reduced fat oxidation at rest (Kelley & Simoneau, 1994) and during exercise 
(Hall et al. 2010; Abilgaard et al. 2013) and reduced insulin sensitivity; and (ii) increased 
fat oxidation in response to exercise training and improvements in insulin sensitivity 
(Goodpaster et al. 2004; Venables et al. 2008). Of note and as previously mentioned, 
Goedecke and co-workers assessed RER during only three pre-determined exercise 
workloads (41%, 63%, and 80% V̇O2max). Exercise RER considers only relative fuel 
utilization whereas MFO, which incorporates metabolic rate, could better reflect 
metabolic capacity and thus be more likely to correlate with insulin sensitivity. The study 
population was endurance-trained individuals with high levels of insulin sensitivity and 
low inter-subject variation and it is unclear if similar results would be obtained in 
populations exhibiting larger variability in exercise substrate oxidation and insulin 
sensitivity. The study by Chu and colleagues was conducted in a group of normal and 
overweight girls and it could be that the relationship between MFO and insulin sensitivity 
is different in other populations.  
 
1.5.5 Links between Maximal Fat Oxidation during exercise and metabolic health 
To date there are only two studies that have investigated the association between MFO 
and metabolic risk factors (with the exception of insulin sensitivity). Rosenkilde et al. 
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(2010) demonstrated in an otherwise homogenous group of overweight young men that 
those with a lower MFO during exercise (and lower resting fat oxidation) had a higher 
clustering of metabolic syndrome risk factors than those with a higher MFO. When 
separated into two groups according to their MFO, half of the participants (4 out of 8) in 
the low MFO group (mean ± SD, 0.17 ± 0.03 g/min), compared with zero in the high 
MFO group (mean ± SD, 0.33 ± 0.01 g/min), displayed the metabolic syndrome. More 
recently, Isacco and colleagues demonstrated in healthy normal-weight pre-menopausal 
women that those with a lower MFO during exercise exhibited an unfavourable fat mass 
distribution (higher abdominal to lower body fat mass index, associated with metabolic 
disorders such as insulin resistance and dyslipidaemia) than those with a higher MFO 
(Isacco et al. 2013). This type of cross-sectional evidence affords the suggestion that an 
increased capacity to oxidise fat during exercise may convey protection towards 
developing a metabolic unhealthy cardiometabolic phenotype and metabolic syndrome.  
 
Despite previous calls (Kelley et al. 1994; Jeukendrup & Wallis, 2005; Isacco et al. 
2013), our understanding of the links between the capacity to oxidize fat during exercise 
and metabolic health remains uncertain. There is clearly a need for further studies to 
identify the extent to which inter-subject variation in fat oxidation during physical activity 
or exercise contributes to the observed relationships between fat oxidation and 
metabolic disease risk. Further understanding this could provide insights into the role of 
physical activity in the optimisation of metabolic health.  
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1.5.6 Should focus be placed upon oxidising fat or calories?  
 
An emerging message throughout this Chapter is that increasing one’s ability to utilise 
fat as a fuel source could have important implications from the perspective of metabolic 
health and future risk of weight gain, and body fat re-gain after a period of diet-induced 
weight loss. Accordingly, it seems logical that clinicians and practitioners who are 
looking to improve an individual’s metabolic health status might focus the design of their 
nutritional and/or training strategies towards increasing ones capacity to use fat as a 
fuel. However, if the goal is to reduce body fat mass then it is undoubtedly important to 
acknowledge that fat oxidation and fat loss are not synonymous and that the state of 
energy balance is more important than fat oxidation per se. Given that one must be in a 
state of negative energy balance to achieve a reduction in body fat mass (and the 
magnitude of the reduction in fat mass is dependent upon the net energy deficit), the 
first priority should be on the design of an intervention whereby the absolute energy 
expenditure is sufficient to create an exercise-induced energy deficit. This might mean 
prescribing an exercise regime that lies within or outside of one’s optimal ‘fat burning’ or 
Fatmax zone (±10% Fatmax). Indeed, exercising above this zone might be particularly 
appropriate if the individuals MFO occurs at a very low exercise intensity, as only 
prolonged exercise will create an appropriate exercise-induced energy deficit.  
 
At present, there is no conclusive evidence to suggest that one form of exercise is more 
effective than another in aiding weight loss or increasing the capacity for fat oxidation 
during exercise. Indeed, there are many different training protocols that can do this, 
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ranging from prolonged endurance exercise to high intensity interval training. 
Accordingly, the key aim for any practitioner would be to prescribe an intervention that 
takes into account the individuals preferences, such that the exercise regime can be 
adhered to and is sustainable. As a result, regular exercise training will improve one’s 
aerobic capacity, which is significantly and positively associated with the capacity for fat 
oxidation (as described in the section below; Venables et al. 2005). This increased 
capacity for fat oxidation could aid progressive weight loss (Thompson et al. 2012; see 
Figure 8) and lead to improvements in one’s metabolic health status (Rosenkilde et al. 
2010; Isacco et al. 2014).  
 
1.6 Determinants of the inter-subject variation in fat oxidation during exercise 
 As exercise is a primary means to acutely increase fat oxidation and reduced fat 
oxidation has been linked with disorders such as obesity and insulin resistance, further 
understanding the factors that influence the inter-subject variability in the capacity to 
oxidise fat during exercise could provide important insights into strategies to increase fat 
oxidation and optimise metabolic health.  
 
Prior to this thesis, there were only two published cross-sectional studies that 
comprehensively investigated the variability and potential determinants of fat oxidation 
during exercise across a range of exercise intensities. Goedecke and colleagues, who 
assessed substrate use using RER over a select range of exercise intensities in 61 well-
trained cyclists, conducted the first (Goedecke et al. 2000). These authors observed an 
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~4-fold difference in fat oxidation at rest (RER 0.72-0.93) that persisted during exercise 
of increasing intensity. However, the determinants of this variability in fat oxidation 
during exercise were less uniform. Serum concentrations of metabolites (FAs and 
plasma lactate) were the primary drivers of the variation in RER at rest and during low 
intensity exercise (41% V̇O2peak), whereas muscle substrate concentration (glycogen and 
IMTG) and glycolytic enzyme activities were important at 63% V̇O2peak, and during high 
intensity exercise (80% V̇O2peak) plasma lactate concentration contributed significantly to 
the variation in RER. At all exercise intensities there was no significant association 
between the variability in RER and V̇O2max (ml/kg/min), dietary carbohydrate intake (% 
energy), muscle fiber composition (type I or type IIa content %), body fat (%) or gender.  
 
In another attempt to elucidate the determinants of the inter-subject variation in MFO 
during exercise, Venables and colleagues assessed fat oxidation over a wide range of 
exercise intensities using a large heterogeneous cohort (n=300) of trained and 
untrained, healthy men and women (Venables et al. 2005). Several factors previously 
identified to influence exercise substrate oxidation including aerobic fitness (V̇O2max, 
ml/kg/min), self-reported physical activity level (SRPAL), fat-free mass (kg) and sex-
related differences explained part (35%) of the inter-subject variation in MFO (MFO 
range: 0.18 - 1.01 g/min). However, when MFO was scaled relative to FFM, it was 
revealed that gender, physical activity level and V̇O2max accounted for only 12% of the 
observed inter-subject variability in MFO, therefore leaving a large proportion 
unexplained. The influence of other factors such as circulating concentrations of plasma 
hormones and metabolites, habitual and recent diet, and muscle fiber type was not 
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determined by Venables and colleagues, but could be important and remains to be 
comprehensively determined.  
 
1.7 Nutritional strategies to increase fat utilisation during exercise and 
augment insulin sensitivity 
 
1.7.1 Obesity and IMTG accumulation 
Obesity is a condition that is partly characterized by the accumulation of IMTG and lipid 
metabolites such as LCFA-CoA, DAG and ceramide in skeletal muscle. The reason for 
this is likely to be two-fold. It could be due to an increased uptake of FAs into skeletal 
muscle and/or impairment in FA oxidation.  
 
Regarding the former, FA uptake into skeletal muscle appears to be elevated in obese 
individuals with type II diabetes (Bonen et al. 2004) and is purported to occur as a 
consequence of elevated expression of proteins involved in FA uptake into skeletal 
muscle such as FABPpm (Simoneau et al. 1999) and/or permanent translocation of 
FAT/CD36; Bonen et al. 2004). A second means by which IMTG stores are increased in 
obesity could also be through a reduction in skeletal muscle fat oxidation. For example, 
several studies show that obese individuals, compared with lean individuals, display a 
reduced fat oxidation under postabsorptive and/or postprandial conditions (Kelley & 
Simoneau, 1994; Colberg et al. 1995; Kim et al. 2000; Kelley et al. 1999; Hulver et al. 
2003) and this may be a result of reduced suppression in oxidative capacity. For 
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instance, one study demonstrated in sedentary obese individuals that the activity of 
CPT1, CS, and cytochrome c oxidase action (a marker of respiratory chain function) are 
all significantly lower, compared with lean sedentary individuals (Simoneau et al. 1999). 
Others have also shown that a suppression of respiratory chain activity may play a role 
(Kelley et al. 2002; Ritov et al. 2005; Schrauwen-Hinderling et al. 2007), whilst there is 
also evidence that reduced mitochondrial size and content may also be important. For 
instance, Kelley and co-workers observed that obese and type II diabetics had a smaller 
mitochondrial size and a lower NADH:02 oxidoreductase action (a marker of respiratory 
chain activity), compared with their lean counterparts (Kelley et al. 2002). Considered 
collectively these findings suggest that the reduced oxidative capacity observed in 
obesity is likely attributed to not one but multiple factors, including a reduction in 
mitochondrial function, content and size. 
 
1.7.2 Significance of IMTG accumulation in skeletal muscle – implications for 
insulin resistance 
Findings from studies performed over a decade ago proposed that elevations in IMTG 
content are a key feature underpinning the insulin resistance that is frequently observed 
in obesity. For example, one study demonstrated a significant and negative relationship 
between measured IMTG content (determined using magnetic resonance spectroscopy) 
and insulin sensitivity (using the hyperinsulinaemic euglycemic clamp technique) and 
concluded that abnormal deposition of IMTG stores may hallmark a large part of insulin 
resistance, even in normal healthy subjects (Phillips et al. 1996a). Indeed, this 
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observation is consistent with many others who investigated the association between 
IMTG stores and insulin resistance or type II diabetes (Goodpaster et al. 1997; Pan et al. 
1997; Forouhi et al. 1999; Jacob et al. 1999; Krssak et al. 1999). In addition to 
observational studies, interventional studies that have employed strategies associated 
with improved insulin sensitivity such as body mass loss (Dengel et al. 1996; Niskanen 
et al. 1996; Goodpaster et al. 1999) have demonstrated a decline in IMTG content. 
Moreover, it has been shown in rodent models that high fat feeding leads to excessive 
accumulation of IMTG and this reduced their insulin sensitivity (Storlien et al. 1991).  
 
Paradoxically, well-trained athletes exhibit high IMTG concentrations yet have muscles 
with high insulin sensitivity, which suggests that the expansion of the IMTG pool may 
accompany various metabolic purposes (Goodpaster et al. 2001). For instance, a classic 
adaptation of regular exercise training in well-trained individuals is the expansion of the 
IMTG store in an attempt to provide an additional substrate for lipid oxidation, 
particularly during times of increased metabolic demand i.e. during intense and/or 
prolonged exercise. In overweight and obese individuals, the enlargement of the IMTG 
pool occurs because of the abovementioned mismatch between FA supply and flux into 
skeletal muscle and oxidative metabolism, and it has been proposed that IMTG 
accumulation in obesity is an attempt to protect the muscle from excess lipotoxic 
metabolites and therefore insulin resistance i.e., IMTG acts as a sink to buffer excess 
lipid metabolites (Watt, 2009). Considered collectively, there appears to be a clear 
dissociation between IMTG content and insulin sensitivity.  
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A more contemporary viewpoint suggests that IMTG accumulation may act as a 
surrogate marker of insulin sensitivity, but it is the formation and accumulation of lipid 
metabolites such as DAG and LCFA-CoA that are important mediators of the 
diminishment in insulin action and can induce insulin resistance, as opposed to the inert 
IMTG store located within lipid droplets (Yu et al. 2002; Hegarty et al. 2003). 
Mechanistically, the inhibitory influence of the lipid metabolites occurs by activation of 
skeletal muscle pro-inflammatory/stress pathways that are associated with insulin action. 
For example, LCFA-CoA and DAG activate PKC, which inhibits insulin signalling by 
serine phosphorylation of the insulin receptor substrate-1. Ceramide induces 
impairments in insulin signalling by activating protein phosphatase 2A, which 
dephosphorylates and inactivates PKB (for review see Hulver & Dohm, 2004). Well-
trained individuals are able to tolerate the enlarged IMTG pool and maintain high levels 
of insulin sensitivity in the face of high IMTG concentrations because they have a high 
IMTG turnover and muscle fat oxidation. This encourages a constant depletion and 
replenishment of the IMTG pool, which helps to maintain low muscle levels of ceramide, 
DAG and LCFA-CoA and high insulin sensitivity (Moro et al. 2008). In contrast, 
sedentary obese individuals have a low IMTG turnover and thus develop an inert IMTG 
pool encompassing expanded and inflexible lipid droplets and heightened 
concentrations of insulin resistance-inducing lipid metabolites.  
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1.7.3 Strategies to augment IMTG utilisation and improve insulin sensitivity in 
obesity 
The positive relationship between exercise training status and high insulin sensitivity 
affords the suggestion that obese sedentary individuals who are insulin resistant might 
benefit from performing regular physical activity in an attempt to stimulate IMTG turnover 
and reduce the deleterious effects of excess lipid on intracellular insulin signalling 
pathways. To this end, longitudinal studies have reported that 12 weeks of regular 
exercise training does not improve insulin sensitivity in lean, obese and diabetic men, 
despite improvements in cardiorespiratory fitness and controlling for alterations in body 
mass and/or composition that may accompany exercise and impact upon insulin 
sensitivity (Segal et al. 1991). This finding is supported by more recent work from Ross 
and colleagues who demonstrated in middle-aged obese men (Ross et al. 2000) and 
premenopausal obese women (Ross et al. 2004) that body mass loss induced by 
aerobic exercise training (and in the absence of caloric restriction) improves insulin 
sensitivity, but exercise without body mass loss has no beneficial effect, despite 
improvements in cardiorespiratory fitness. Considered collectively, such findings suggest 
that exercise training in the absence of body mass loss does not improve long-term 
whole body glucose uptake and insulin sensitivity.  
 
It could be that the timing of recent nutrition around exercise explains the failure of 
aerobic exercise training to induce favourable effects on peripheral insulin sensitivity in 
longitudinal studies on obese populations. Indeed, it has been demonstrated that a 
single exercise session performed in the overnight-fasted (post-absorptive; PA) state 
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i.e., before breakfast, substantially improves skeletal muscle insulin sensitivity within 48-
h of exercise. This effect has been observed in rodents (Richter et al. 1992) and in 
healthy (Mikines et al. 1988; Richter et al. 1989) and insulin resistant (Devlin et al. 1987) 
humans and occurs through a large increase in insulin-stimulated muscle glycogen 
storage via improvements in insulin-stimulated glucose transport-phosphorylation 
(Perseghin et al. 1996). When exercise is performed in the post-prandial (PP) or fed 
state i.e., after breakfast, exercise appears ineffective at improving glucose homeostasis 
in both insulin resistant and type 2 diabetic individuals (Larsen et al. 1997; Larsen et al. 
1999).  
 
More recent work conducted in healthy, lean individuals has demonstrated that PA 
exercise, as compared with PP exercise, significantly increases IMTG utilisation during 
exercise (De Bock et al. 2005). In this study, participants performed 2-h of constant load 
cycling (~75% V̇O2max) either in the overnight-fasted state or in the fed-state having 
received carbohydrates before (~150 g) and during (1 g/kg BW/h) exercise. In both 
conditions, net muscle glycogen breakdown was similar, however during the subsequent 
4 hours of recovery (when carbohydrate was fed), net muscle glycogen re-synthesis rate 
was 3-fold higher after PA compared with PP exercise. What is more, PA exercise led to 
a significantly higher fat oxidation rate during exercise and induced a substantial 
reduction in type I fibre IMTG content pre- to post-exercise (18 ± 2% to 6 ± 2%, 
respectively; P = 0.007). In contrast, IMTG breakdown was completely prevented in the 
fed-state (P > 0.05).  
 
	 30 
Interestingly, indirect evidence suggests IMTG can be utilised as a substrate source 
during aerobic exercise in obese individuals, at least in the PA state. For instance, 
Goodpaster and co-workers (Goodpaster et al. 2002), demonstrated that obese 
individuals had a greater reliance on fat oxidation towards energy expenditure than their 
lean counterparts when performing steady state exercise (50% V̇O2max) for 60 minutes, 
and the contribution of non-plasma FA oxidation (likely from IMTG) was significantly 
higher (~50%) in obese compared with lean. In this study, the exercise bout was 
performed in the PA state and the influence of PA versus PP exercise on IMTG use 
during exercise in obesity has not yet been studied. Based on the observations made 
from healthy, lean populations (De Bock et al. 2005; abovementioned) it is tempting to 
speculate that PA exercise, as compared with PP exercise, would facilitate a greater 
IMTG breakdown and reduction in lipotoxic stress in the skeletal muscle of obese 
individuals, and this could confer greater improvements in insulin sensitivity as 
compared with exercise performed in the PP state. 
 
It should be noted that not all studies have reported findings that promote PA exercise 
for the prevention of insulin resistance. For instance, Derave and colleagues (Derave et 
al. 2007) used seven sedentary males with metabolic syndrome and found that although 
fat oxidation during exercise was higher during PA exercise, the glycemic response to a 
high-carbohydrate breakfast was lower following PP exercise than PA exercise. 
Furthermore, the timing of nutrition (either before [PA] or after [PP] exercise) did not alter 
glucose and insulin handling during subsequent meals throughout the day. These 
authors suggest that PA exercise might not be more effective than PP exercise at 
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improving insulin sensitivity, however they do highlight caution when extrapolating data 
from acute exercise to chronic exercise and training.  For instance, recent studies have 
demonstrated that PA exercise, but not exercise with carbohydrate ingestion, promotes 
an increase in mRNA expression in muscle of genes involved in FA transport and 
oxidation such as CD36, CPT 1, uncoupling protein 3, and 5’-AMP-activated protein 
kinase-a  (Civitarese et al. 2005). Such alterations in mRNA expression are unlikely to 
have an acute effect in the hours after exercise but could promote altered protein 
expression following chronic PA exercise. A parallel with this, a recent study conducted 
in lean individuals found that during a period of high fat feeding (50% kcal from fat) PA 
exercise was superior to PP exercise at improving glucose tolerance and promoting 
adaptations of muscle oxidative capacity that may confer improvements in insulin 
sensitivity (Van Proeyen et al. 2010). As insulin resistance appears to be caused by the 
excess accumulation of insulin resistance-inducing lipid metabolites in skeletal muscle, 
the emerging question that remains is whether chronic PA exercise, compared with PP 
exercise, is more effective at reducing the accumulation of these metabolites and 
therefore improving insulin sensitivity in obesity. 
 
Considered collectively, it could be that the timing of nutrition in relation to the exercise 
bout is a critical factor in elucidating the failure of aerobic exercise training to induce 
favourable effects on peripheral insulin sensitivity in longitudinal studies on obese 
populations. Recommending obese individuals to exercise in the fasted-state, as oppose 
to the fed-state, could help to optimise metabolic adaptation to training and augment 
insulin sensitivity and a healthy metabolic phenotype. 
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1.8 Summary  
In summary, an elevated 24-h RQ has been shown to be predictive of long-term body 
mass gain and regain of fat mass after diet-induced body mass loss. Furthermore, 
impairments in fat oxidation at the level of skeletal muscle have been associated with a 
reduced metabolic flexibility and insulin resistance. There is a large inter-subject 
variability in the capacity to oxidise fat during exercise and as a high fat oxidation during 
exercise could make important contributions to daily fat oxidation, it is not unreasonable 
to consider a high capacity to oxidise fat during exercise as advantageous for long term 
metabolic health. Whilst studies have begun to address this, there is clearly a need for 
further understanding. Accordingly, Chapter 3 aims to determine whether the capacity 
for fat oxidation during exercise is associated with 24-h fat oxidation and insulin 
sensitivity as markers for long-term metabolic health in young, healthy men. It was 
hypothesised that there is a significant and positive correlation between MFO and 24-h 
fat oxidation and between MFO and insulin sensitivity as markers for long-term 
metabolic health.  
 
If this is important then a more comprehensive understanding of the factors influencing 
the capacity to oxidise fat during exercise is undoubtedly important. Despite appreciable 
efforts to elucidate the determinants of the inter-subject variability in MFO, a large 
proportion of the inter-subject variability remains unexplained. It could be that circulating 
concentrations of plasma metabolites and hormones known to influence fuel selection 
during exercise could be important mediators, whilst there is evidence to suggest that 
resting fat oxidation could also play a role, but this has not yet been investigated. 
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Therefore, Chapter 4 investigates the influence of plasma lipolytic markers, insulin and 
resting fat oxidation on maximal fat oxidation during exercise. It was hypothesised that 
there would be a significant and positive relationship between MFO and plasma glycerol 
and NEFA concentration and a significant and negative relationship between MFO and 
plasma insulin concentration. Further, there would be a significant and positive 
relationship between MFO and resting fat oxidation.  
 
A better insight into the factors that influence the capacity to oxidise fat during exercise 
could help inform of novel strategies to increase fat oxidation during exercise and 
promote metabolic health. An emerging body of evidence demonstrates that the 
accumulation of insulin resistance-inducing lipid metabolites govern the reduction in 
insulin sensitivity seen in obesity. Exercise training could be one means of reducing the 
accretion of these metabolites and improving insulin sensitivity, however longitudinal 
studies indicate aerobic exercise training in obese individuals in the absence of body 
mass loss has minimal impact on insulin resistance. At present it is not known whether 
the timing of recent nutrition with respect to exercise is important in explaining the 
inability of aerobic exercise training per se to improve peripheral insulin sensitivity in 
obese populations. As such, Chapter 5 investigates the influence of meal timing i.e., 
eating before or after an acute exercise bout, on (1) exercise substrate utilisation, (2) the 
plasma hormone and metabolite response during and around exercise, and (3) IMTG 
utilisation in obesity. It was hypothesised that a single bout of aerobic exercise 
performed in the fasted- versus fed-state would (1) induce a greater reliance on fat and 
lesser reliance on carbohydrate towards exercise energy expenditure, (2) enhance the 
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availability of circulating lipolytic makers (namely, plasma glycerol and NEFA) and 
reduce the availability of insulin during exercise, and (3) enhance IMTG degradation. 
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GENERAL METHODS 
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2.1 Introduction (see also Table 2.1) 
Specific methods for each study are provided in the relevant section of each 
experimental chapter and will therefore not be repeated unless necessary. Rather, the 
purpose of this section is to overview the core principles of the major methods employed 
and provide a rationale for their use where appropriate. 
 
Table 2.1 An overview of the methods / techniques used in the experimental chapters of 
this thesis. 
 Components 
of energy 
balance  
(EI & EE) 
Indirect 
calorimetry 
Insulin 
sensitivity 
Biochemical 
analysis 
Body 
composition 
Muscle 
analysis 
Chapter 3 X X X X X  
Chapter 4 X X  X X  
Chapter 5  X X X X X X 
 
 
2.2 Components of energy balance 	
2.2.1 Estimation of habitual energy intake 
In Chapters 3 and 4, the habitual energy intake of all participants was estimated using 
self-reported 4-d weighed food intake. This prospective, quantitative method, alongside 
24-h recalls, diet history, and food frequency questionnaires (FFQ), is common amongst 
experimental and large population studies. A strength of this approach lies in its capacity 
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to capture quantitative information, given that all foods and drinks are weighed and 
recorded prior to consumption. Indeed, the weighed food approach has been employed 
as the reference to which other dietary intake methodologies have been compared 
(Trabulsi & Schoeller, 2001). However, it is also accepted that this approach is subject to 
measurement error i.e., writing and / or processing mistakes (random error) and 
reporting bias such as under-reporting of true intake (systematic error) (Trabulsi & 
Schoeller, 2001). Regarding the latter, reporting bias can occur because the action of 
recording intake can influence the individuals’ food choices and alter their intake during 
the recording period. This bias is not usually found in retrospective methodologies (i.e. 
diet history and FFQs), however these are subject to error including poor recollection of 
past diet and underreporting of true intake. Of note, underreporting has been shown to 
be greater in females compared with males (32% and 13%, respectively; Goran & 
Poehlman, 1992) and appears positively associated with BMI, waist circumference and 
fat mass (Tomoyasu, Toth & Poehlman, 1999). Further, it has been demonstrated that 
the number of inaccuracies reported increases as the number of recording days 
increases (Gersovitz, Madden & Smiciklas-Wright 1978). Accordingly, a number of 
measures were put in place to mitigate any potential error. For instance, the participants 
in Chapters 3 and 4, who were all lean, healthy men, were provided with detailed 
instructions to enable diary completion and the investigatory team answered any 
questions. The chosen recording period was 4-d as any longer could increase the 
number of inaccuracies reported, whereas any less may not reflect the participants’ 
habitual diet. Further, they were given two sets of digital weighing scales; one that was 
portable (for use away from home) and one that was larger in size (for use at home). 
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Finally, each diary was checked meticulously for any cases of misreporting and to clarify 
any uncertainties.  
 
2.2.2 Estimation of daily energy expenditure (EE) 
Daily EE was estimated in Chapters 3 and 4 by multiplying a daily PAL value (obtained 
using physical activity diaries and the factorial approach; further details of this approach 
are provided in the experimental chapters) by an age and sex specific predictive 
equation (WHO, 1985). This method of assessment appears superior to the activity 
recall method (Conway et al. 2002) and has shown to be strongly correlated with the 
doubly labeled water (DLW) technique (Schulz, Westerterp & Bruck, 1989; Bratteby et 
al. 1997), which is considered a gold-standard tool for measuring EE. The advantage of 
using this approach was that it was affordable and practical, particularly in Chapter 4 
when a relatively large number of participants (for physiology studies) were evaluated 
(n=57). However, there are also limitations of this approach such as not accounting for 
inter-individual differences in the energetic cost of performing a movement and there 
can be poor individual compliance and recording error. To mitigate this the investigatory 
team provided all participants with clear and detailed instructions to enable accurate 
completion of the diaries, any questions were answered and any potential cases of 
misreporting or inaccuracies were clarified. Furthermore, participants were encouraged 
to record physical activity instead of recall (i.e., to record activity immediately after it was 
performed), and to make notes on any sport or exercise performed during the 4 days 
such that a specific MET value could be assigned to this activity by the investigatory 
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team. Of note, in Chapter 3 there were no significant differences between the EE 
predicted using the physical activity diaries and predictive equation and that measured 
during the 24-h stay in the whole room calorimeter, which gives this researcher 
confidence that the diary approach provided an accurate estimation of habitual EE over 
the 4-d recording period.  
 
In Chapter 5 daily EE was estimated using resting metabolic rate determined via indirect 
calorimetry (ventilated hood system) and a population specific activity factor of 1.53 
(WHO, 2001). The principle of indirect calorimetry is to measure oxygen consumption 
and carbon dioxide production and convert it to EE using formulae, which in this Chapter 
was that of Weir (1949), which is commonly used in studies of exercise metabolism. 
Indirect calorimetry is non-invasive, very accurate and highly reproducible and is widely 
considered a gold standard tool for measuring EE (Volp et al. 2011). Although the 
procedure can be relatively complex, the use of trained personnel ensured its correct 
use.  
 
2.3 Indirect calorimetry 
 
The respiratory quotient (RQ; as is conventionally used in metabolic chamber studies) 
and respiratory exchange ratio (RER; as is conventionally used in studies of exercise 
metabolism) both indicate relative fuel utilisation and can be calculated by measuring 
the ratio of the V̇CO2 consumed and the V̇O2 produced by gaseous exchange and using 
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indirect calorimetry (RQ or RER = V̇CO2 / V̇O2). Carbohydrate, fat and protein differ in 
their chemical composition and in the amount of carbon dioxide produced and oxygen 
required for oxidation. Therefore by measuring the V̇O2 consumed and V̇CO2 produced 
it is possible to determine energy expenditure, as well as the absolute and relative 
contribution of fuels being oxidised for energy production. It is beyond the scope of this 
thesis to provide a detailed synopsis of indirect calorimetry, calculation of substrate 
oxidation and the respective strength and limitations and readers are directed to a 
pertinent review by Wallis and Jeukendrup (2005) should they seek this. However, a 
brief overview of the methods and equations used to determine energy expenditure and 
substrate oxidation is necessary.  
 
2.3.1 Determination of energy expenditure and substrate oxidation at rest 
Resting energy expenditure plus carbohydrate and fat oxidation (Chapters 3, 4 and 5) 
were calculated during a stable measurement period i.e., a deviation in V̇O2 of <10% of 
the average V̇O2 between minutes 20-30 according to the equations of Frayn (1983) 
assuming urinary nitrogen excretion to be 0.11 mg/kg/min (Flatt, Ravussin, Acheson & 
Jequier, 1985).  
 
2.3.2 Determination of substrate oxidation during exercise  
In Chapters 3 and 4, during the exercise test V̇O2 and V̇CO2 were averaged over the last 
minute of each sub-maximal exercise stage and fat and carbohydrate oxidation were 
calculated according to the equations of Frayn (1983), with the assumption that the 
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urinary nitrogen excretion rate was negligible. The last minute was chosen because 
participants were likely to have reached steady state of respiratory exchanges (Achten, 
Gleeson & Jeukendrup, 2002).  Urinary nitrogen excretion rate was assumed as 
negligible because the quantitative contribution of amino acid oxidation to energy 
expenditure during exercise is usually minimal (<1%). Although it has been shown that 
exercising with low muscle glycogen can increase net protein degradation, the 
contribution to total EE remains small (Lemon & Mullin, 1980). Only when a subject 
partakes in prolonged exercise with no caloric intake does the contribution of amino acid 
oxidation to total EE increase to around 10% (Wagenmakers, 1998). Given that the 
graded exercise test employed in Chapters 3 and 4 was approximately 30 minutes in 
duration, it seems reasonable to assume that amino acid oxidation was negligible.  
 
In Chapter 5 during the exercise test employed in visits 3 and 4, V̇O2 and V̇CO2 were 
measured at two time points (25-30 minutes and 55-60 minutes into exercise) and fat 
and carbohydrate oxidation were calculated according to the equations of Frayn (1983).  
 
Calculation of carbohydrate and fat oxidation (Frayn, 1983) 
CHO oxidation (g/min) = 4.55*V̇CO2 – 3.21* V̇O2 
Fat oxidation (g/min) = 1.67* V̇O2 – 1.67* V̇CO2 
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2.3.3 Determination of Maximal Fat Oxidation (MFO) during exercise 
In Chapters 3 and 4, all participants completed a graded exercise test in order to 
determine their MFO during exercise. The test was originally developed by Achten et al. 
(2002) who systematically undertook a series of studies in trained men to design a test 
that enables the intensity that elicits MFO, and its corresponding exercise intensity 
(Fatmax), to be determined. The test was validated against longer duration stages 
(Achten, Gleeson & Jeukendrup, 2002) and its reproducibility was assessed (Achten & 
Jeukendrup, 2003). Achten and colleagues reported a coefficient of variation for Fatmax 
of 9.6% in a group of 10 well-trained individuals assessed on three separate occasions 
and demonstrated limits of agreement that corresponded to a difference in heart rate of 
9 beats per minute (range 7-14 beats per minute); concluding that the test is reliable. In 
contrast, Meyer and co-workers, using 21 recreationally active men and women who 
completed two exercise tests, reported limits of agreement that corresponded to a heart 
rate difference of 35 bpm, and these authors subsequently concluded that the intra-
individual variability in Fatmax measurements is too large (Meyer, Gassler & Kindermann, 
2007). However, this last study did not control for recent activity or diet, which are both 
potent modulators of substrate utilisation during exercise and therefore the conclusions 
raised are limited to individuals tested under non-standardised conditions. Of note, these 
studies assessed the reliability and validity of MFO during cycling exercise. Despite a 
number of studies having used the treadmill approach to determine MFO during exercise 
(Achten, Venables & Jeukendrup, 2003; Venables et al. 2005), including those 
presented in Chapters 3 and 4 of this thesis (Robinson et al. 2015; Robinson et al. 
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2016), its reliability and validity (specific to treadmill exercise) is yet to be determined. 
Undoubtedly, this is something future research should seek to explore.  
 
MFO during exercise is typically determined by one of four methods: 1) visual inspection 
i.e., the determination of the highest value of fat oxidation obtained during the exercise 
test and the corresponding exercise intensity (Achten, Gleeson & Jeukendrup, 2002; 
Achten & Jeukendrup, 2003a; Achten & Jeukendrup, 2003b; Venables, Achten & 
Jeukendrup, 2005); 2) the construction of a 3rd polynomial fitting curve (P3; Stisen et al. 
2006); 3) the Sine model (SIN; Cheneviere et al. 2009); and 4) the non-protein 
respiratory quotient technique (Perez-Martin et al. 2001). For all participants in Chapters 
3 and 4, MFO during exercise was calculated and reported using visual inspection. To 
ensure the main findings from these chapters were not influenced by the method 
employed for the determination of MFO, MFO was also calculated using the P3 method, 
which demonstrated a strong correlation with the visual method used in both 
experimental chapters (Chapter 3, R=0.98 and Chapter 4, R=0.98).  
 
2.4 Assessment of body composition  
 
Three different techniques were used across the three experimental chapters due to 
reasons of availability and practicality. This researcher conducted all measures of body 
composition performed during the studies conducted in Chapters 3, 4 and 5.  
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2.4.1 Dual-energy X-ray Absorptiometry (DXA) 
DXA provides a quick, non-invasive three-compartment model that divides the body into 
bone mineral, fat mass (FM) and fat-free mass (FFM) to a high level of precision and 
with minimal radiation. It is widely used in osteoporosis screening and bone mineral 
density assessment, and is also increasingly used as a criterion measurement for body 
composition assessment (Pietrobelli et al. 1996).  
 
The principle of using DXA to determine body composition is based on the different 
bone and soft tissue attenuation characteristics at the two-pulsed X-ray wavelengths. 
The DXA scanner in our laboratory sends a very thin, invisible beam of low-dose X-rays 
with two distinct energy peaks through the body to a detector array. These X-rays are 
blocked or attenuated relative to the density of the tissues they are penetrating. Bone, 
fat and lean tissue possess distinctive densities which can be used to calculate the 
relative masses of each of the three components in any given region of the body.   
 
2.4.2 Calliper-measured skinfold thickness 
Calliper-measured skinfold thickness is a two-compartment model of body composition 
assessment i.e., it characterizes body composition by dividing it into fat and fat-free 
components and assumes that the relative amounts of the FFM components (water, 
protein, bone mineral and non-bone mineral) are fixed. This method has been used to 
estimate percent body fat measures for four decades and does so by measuring skinfold 
thickness at specific locations on the body to determine subcutaneous fat.  Results are 
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then inserted into equations that convert these numbers into an estimate of a subject’s 
percentage body fat (%BF), FM and FFM.  
 
There are several different formulas to predict percent body fat from calliper-measured 
skinfold thickness, of which the most widely used are the original Durnin and 
Wormersely (1974) equations. However, these have recently been found to not predict 
percent body fat uniformly in all races or ethnicities when compared with %BF measured 
by DXA as the gold standard. As such, %BF, FM and FFM were calculated in Chapter 4 
using updated sex and race/ethnicity specific equations that incorporated the 
combinations of four skinfold sites (bicep, tricep, subscapular and suprailliac) and body 
height, weight, age and waist circumference (Davidson et al. 2011).  
 
2.4.3 BODPOD  
The BODPOD is an Air Displacement Plethysmograph that was first validated in the mid-
1990’s (Dempster & Aitkens, 1995). It is a two-compartment model that partitions the 
body into two compartments of constant densities (FM = 0.9007 g/cm3 and FFM = 1.100 
g/cm3) and assumes that the relative amounts of the FFM components (water, protein, 
bone mineral and non-bone mineral) are fixed. The physical design and operating 
principles of this system have been described elsewhere (Dempster & Aitkens, 1995). 
This method initially measures body mass using a highly accurate scale (with the 
participant outside of the BODPOD) and volume (with the participant is inside the 
BODPOD) using air displacement, which allows for the determination of body density 
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using Archimedes principle (Density = Mass/Volume). Body volume is assessed based 
on the physical relationship between pressure and volume. During a measurement, 
there are very small volume changes inside the BODPOD, which measures the pressure 
response to these changes. Initially, the volume of the chamber is measured whilst 
empty. The interior volume is then measured with the participant seated inside (IV) the 
chamber and subsequently the individual’s body volume is determined (body volume = 
EV – IV).  Once the overall density of the body is known, the relative percentages of FM 
and FFM were determined using an equation (Siri, 1961).  
 
2.5 Insulin sensitivity 
 
In Chapters 3 and 5, insulin sensitivity was calculated from fasting plasma glucose and 
insulin concentration using the Quantitative Insulin Sensitivity Check Index (QUICKI) 
derived from Katz et al. (2000).  
 
QUICKI = 1 / (log [I0] + log [G0]) 
*I0 = fasting insulin (µIU/mL, G0 = fasting glucose (mmol/L) 
 
QUICKI has been validated as an accurate and reliable surrogate marker of insulin 
sensitivity; shown to have a strong positive correlation (R=0.78) with the gold standard 
hyperinsulinaemic euglycemic clamp technique. The QUICKI method was chosen as it 
provided a convenient measure of insulin sensitivity that was easily implemented in 
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these studies. The gold standard methods of determining insulin sensitivity is the 
euglycemic-hyperinsulinemic clamp technique, however this is a complicated procedure 
and the infusion of insulin or glucose would have affected the metabolic and hormonal 
response to the GET used in Chapter 3, whilst we did not want to burden the 
participants in Chapter 5 with any further invasive procedures. Nevertheless, fasting 
levels of glucose and insulin have been found to contain enough information to precisely 
measure insulin sensitivity in a diverse population.  
 
2.6 Blood sampling and biochemical analysis 
 
This researcher collected all of the blood samples obtained during the conduct of the 
three experimental chapters presented in this thesis. Furthermore, he also carried out all 
biochemical procedures with respect to plasma hormone and metabolite analysis, with 
the exception of plasma insulin in Chapters 3 and 4, which were analysed by 
collaborators at Imperial College London using the radioimmunoassay technique.  
 
During Chapters 3, 4 and 5, each participant had a cannula placed in the forearm vein to 
allow for repeated blood sampling throughout the measurement period. To allow for 
repeated blood collection during the treadmill running exercise performed in Chapter 4 
(without the need for changes in running speed or form), the cannula was connected to 
a 150 cm polyethylene extension line, which was attached to a 3-way stopcock. When a 
blood sample was required during the 24-h measurement period in the respiration 
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chamber, participants passed their arm through an air-tight hatch and a blood sample 
was obtained. On all occasions the cannula was kept patent for the duration of insertion 
by regular flushing of 0.9% sodium chloride.  		
2.6.1 Plasma metabolite analysis 
Unless explicitly stated, all collected samples were analysed using enzymatic 
colorimetric assays for glucose (Glucose Oxidase kit, Instrumentation Laboratories, 
Cheshire, UK), NEFA (NEFA kit, Randox, London, UK), glycerol (GLY kit, Randox, 
London, UK), lactate (LAC kit, Randox, UK) and triglyceride (TG kit, Instrumentation 
Laboratory, Warrington, UK) using an iLAB 650 Clinical Chemistry Analyzer 
(Instrumentation Laboratory, Warrington, UK). This automated blood analyser is used 
frequently in clinical chemistry laboratories to measure plasma metabolites using 
spectrophotometry or turbidity. Enzyme catalysed assays were used whereby 
absorbance values correlate with the concentration of a particular blood metabolite. The 
intra-assay (inter-assay) CV for these methods in our laboratory are as follows: glucose, 
1.48% (5.9%); glycerol, 2.76% (5.9%); NEFA, 3.34% (3.1%), lactate 2.04% (3.9%) and 
TG 1.28% (3.5%) (based on analysis of 20 duplicate plasma samples).  
 
(i) Plasma glucose: In all experimental Chapters, the concentration of plasma glucose 
was quantified using glucose (oxidase) and end point analysis (trinder methodology). 
Here, the elevation in absorbance generated by red quinoneimine is proportional to the 
glucose concentration in the sample.  
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(ii) Plasma glycerol: A direct colorimetric procedure using a glycerol reagent (Randox, 
County Antrium, UK) was used for the quantification of glycerol, which included three 
enzymatic reactions (below). The subsequent intensity of n-(4-antipyryl)-3-chloro-5-
sulphonate-pbenzoquinoneimine (ACSB: red dye) was determined and is proportional to 
the glycerol concentration in the sample. 
                           	
 
 
(iii) Plasma non-esterified fatty acids (NEFA): A direct colorimetric procedure using a 
NEFA reagent (Randox, County Antrium, UK) was used for the quantification of NEFA, 
which included three enzymatic reactions (below). The subsequent intensity of purple 
adduct was determined and is proportional to the NEFA concentration in the sample.					
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(iv) Plasma lactate: A direct colorimetric procedure using a lactate reagent (Randox, 
County Antrium, UK) was used for the quantification of lactate, which included two 
enzymatic reactions (below). The subsequent intensity of purple product was determined 
and is proportional to the lactate concentration in the sample. 																	
																 
 
(v) Plasma triglyceride 1: A direct colorimetric procedure using a triglyceride reagent 
(Randox, County Antrium, UK) was used for the quantification of triglyceride, which 
included four enzymatic reactions (below). The subsequent intensity of red quinoneimine 
was determined and is proportional to the triglyceride concentration in the sample. 
 
																																																								1	TAG data presented in Chapter 5 of this thesis was corrected for free glycerol concentrations.  
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2.6.2 Plasma insulin analysis 
In Chapter 3 and 4, insulin was analysed by radioimmunoassay using commercially 
available kits (HI-14K Human Insulin, Millipore, Billerica, MA). The intra-assay (inter-
assay) CV for this method in the laboratory where analysis was conducted (Nutrition and 
Dietetic Research Group, Imperial College, London, United Kingdom) was 16.9% 
(17.1%) (based on analysis of 10 duplicate plasma samples).  
 
The Millipore Human Insulin assay uses the double antibody/PEG technique (Morgan & 
Lazarow, 1963). Here, a fixed concentration of labeled tracer antigen (125l-labeled 
Human Insulin) is incubated with a constant dilution of antiserum (Human Insulin 
antiserum), which subsequently limits the concentration of antigen binding sites on the 
antibody. Once unlabelled antigen is added, there is competition between the labeled 
tracer and unlabelled antigen for the limited but constant number of binding sites on the 
antibody. Accordingly, the amount of tracer bound to antibody will decrease as the 
concentration of unlabelled antigen increases. This can be measured after separating 
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antibody-bound from free tracer and counting one or the other. A standard curve is 
constructed with increasing concentrations of standard unlabelled antigen and from this 
curve the amount of antigen in unknown samples can be calculated. 
 
In Chapter 5, insulin concentrations were determined using a human insulin Enzyme 
Linked-Immuno-Sorbent Assay (ELISA) kit (Invitrogen, Paisley, UK) and a Biotek 
ELx800 analyser (Biotek Instruments, Vermont, USA). The intra-assay (inter-assay) CV 
for this method our laboratory was 21.0% (17.0%) (based on analysis of 10 duplicate 
plasma samples). 
 
The ELISA method uses monoclonal antibodies (mAb), which are are directed against 
distinct epitopes of insulin. Each sample is added to a small well; following which a 
detector mAB labeled with horseradish peroxidase is added. Following an incubation 
period, the enzyme–labeled antibody is removed and a substrate solution 
(tetramethylbenzidine – H2O2) is added and incubated. The reaction is stopped with HCI 
and the microtiter plate is read spectrophotometrically. The intensity of the colour is 
proportional to the insulin concentration in the sample.  
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2.7 Muscle sampling and analysis 
  
In Chapter 5 Dr Gareth Wallis performed the muscle biopsy procedure and collected 
each of the muscle samples. This researcher was present during each of the biopsies to 
assist with the muscle biopsy collection. Dr Helen Bradley and myself performed the 
muscle sample analysis.  
 
2.7.1 Muscle biopsy procedure 
The study in Chapter 5 involved six muscle biopsies per participant (three during Visit 3 
and three during Visit 4). For each, participants rested in the supine position and a 
muscle biopsy was obtained from the vastus lateralis using the percutaneous needle 
biopsy technique (Bergstrom, 1975), adapted to include suction. Prior to this, antiseptic 
(Videne, Ecolab, UK) was applied to the skin ~20 cm proximal to the patella, following 
which it was anaesthetized using 1% Lidocaine (Braun, Melsungen, Germany). When 
the area was numb to the touch a 4-6 mm incision was made through the skin and 
muscle fascia using a surgical scalpel (Swann-Morton, Sheffield, UK). A 6G biopsy 
needle was then inserted ~2-6 cm into the incision and a piece of muscle guillotined. A 
sample of ~100 mg was collected and freed from any visible non-muscle material, 
following which a portion was mounted in embedding Tissue Tek OCT (Sigma Aldrich, 
Dorset, UK) and frozen in liquid nitrogen-cooled isopentane (Sigma Aldrich, Dorset, UK) 
and transferred to an aluminium cryotube (Caltag Medsystems, PA6003) and transferred 
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to an aluminium cryotube (Caltag Medsystems, PA6003) for later immunofluorescence 
microscopy analysis. All samples were stored at -70oC for later analysis. 
 
2.7.2 Analysis of muscle samples 
(i) Sample Preparation and Staining: Cryosections (5 μm) were cut using a Bright 5040 
(Bright Instrument Company limited, Huntingdon, England) microtome within a Bright 
cryostat with internal temperature kept constant at 25 oC. Sections were cut onto 
uncoated glass microscope slides (VWR International), with each slide containing six 
samples from each participant (three from visit 3 and three from visit 4 [pre-exercise, 
immediately post-exercise and 3-h post-exercise]) to decrease the variation in staining 
intensity between sections. Sections were fixed for one hour in 3.7% formaldehyde 
(made up in dH2O) and subsequently washed 3 times for 30 seconds in dH2O. 
Following this slides were incubated for 5 minutes in 0.5% triton-X100 made up in 1 x 
phosphate-buffered saline (PBS) at room temperature and then washed 3 times for 5 
minutes with wash buffer (1 x PBS). Thereafter, slides were incubated for 2 hours in 
1:25 anti-MHCI (mouse IGM, DSHB A4,840) and 1:100 anti-dystrophin (mouse IgG2b, 
Sigma Aldrich D8168) in 5% normal goat serum (NGS) at room temperature. After 
washing the slides three times for 30 seconds in 1 x PBS, slides were incubated for 30 
minutes in 1:150 goat anti-mouse (GAM) IgM 633 (for MHCI) and 1:200GAM IgG2b 595 
(for dystrophin) in 1 x PBS at room temperature. Incubation was followed by three 5 
minutes washes (1 x PBS), after which the slides were incubated again, this time in 1:50 
bodipy solution in 1 x PBS at room temperature in the dark. A final wash of the slides 
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was then performed twice for 3 minutes in 1 x PBS. Glass coverslips were mounted with 
20 μl mowiol mounting medium (6 g glycerol [Sigma Aldrich, G5150], 2.4 g mowiol 4-88 
[Fluka, 81381] and 0.026 g 1,4-diazobicyclo-[2,2,2]-octane [DABCO; Fluka, 33490] 
dissolved in 18 ml 0.2M Tris-buffer [pH 8.5; Sigma Aldrich, T5030]) to protect the sample 
and preserve the fluorescence signal. Slides were left to dry overnight before 
immunofluorescence visualisation. 
 
(ii) Microscopy: All images were taken using a confocal microscope (Leica DMIRE2, 
Leica Microsystems) with 40x oil immersion objective (1.25 Numerical Aperture). Bodipy 
was excited with a 488 nm line of the argon laser and 510-652 nm emission. To detect 
dystrophin signal, Alexa Fluor 594 fluorophores were excited with the 594 nm line of the 
helium-neon laser and 668-698 nm emission. To detect myosin heavy chain type I 
(MHCI) signal, Alexa Fluor 633 fluorophores were excited with the 633 nm line of the 
helium-neon laser and 698-808 nm emission.  
 
 
(iii) Image quantitation: As will be explained later, data are available for two subjects. For 
both, 3 slide replicates, each with a pre-exercise, immediately post-exercise and 3-h 
post-exercise section underwent staining, imaging and quantification. During the fasted 
trial and on average, 4 fibre images were captured pre-exercise, 5 fibre images were 
captured immediately post-exercise and 5 fibre type images were captured 3-h post-
exercise. During the fed trial and on average, 5 fibre images were captured pre-exercise, 
4 fibre images were captured immediately post-exercise and 4 fibre type images were 
captured 3-h post-exercise. The average number of type I fibres [type II fibres] analysed 
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across the two participants in the fasted trial was 15 [20] (pre-exercise), 24 [27] 
(immediately post-exercise) and 19 [44] (3-h post-exercise). The average number of 
type I fibres [type II fibres] analysed across the two participants in the fed trial was 32 
[43] (pre-exercise), 17 [21] (immediately post-exercise) and 25 [30] (3-h post-exercise). 
 
Bodipy spot stained area per fibre was quantified by setting uniform threshold intensity 
and size values to detect spots within intracellular regions of the dystrophin mask in a 
fibre type specific manner. A HiGauss filter was applied to bodipy images prior to bodipy 
signal detection. Fibre area was exported from the software based on the intracellular 
regions determined with the dystrophin mask. Percent area of bodipy staining of the total 
fibre area was calculated ([bodipy stained area [um2] / area of muscle [um2]*100). Fibre 
area was exported from the software based on the intracellular regions determined with 
the dystrophin mask. The coefficient of variation for repeated measurements of IMTG 
content for this method in our laboratory was 35 ± 33%. 	
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CHAPTER 3   
 
MAXIMAL FAT OXIDATION 
DURING EXERCISE IS 
POSITIVELY ASSOCIATED WITH 
24-HOUR FAT OXIDATION AND 
INSULIN SENSITIVITY IN YOUNG 
HEALTHY MEN 
 
 
 
 
 
 
The work contained within this chapter is published: 
Robinson SL, Hattersley J, Frost GS, Chambers ES, and Wallis GA. Maximal fat oxidation during 
exercise is positively associated with 24-hour fat oxidation and insulin sensitivity in young, healthy men. J 
Appl Physiol 118: 1415-1422, 2015. 
 
Please note that the data presented in Chapters 3 and 4 of this thesis comes from data collected from one 
study. 
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3.1 Abstract 
Disturbances in fat oxidation have been associated with an increased risk of obesity and 
metabolic disorders such as insulin resistance. There is large inter-subject variability in 
the capacity to oxidize fat when physically active although the significance of this for 
metabolic health is unclear. We investigated whether the maximal capacity to oxidize fat 
during exercise is related to 24-hour (h) fat oxidation and insulin sensitivity. Maximal Fat 
Oxidation (MFO; indirect calorimetry during incremental exercise) and insulin sensitivity 
(Quantitative Insulin Sensitivity Check Index, QUICKI) was measured in 53 young, 
healthy men (age 24±7 y; V̇O2max 52±6 ml/kg/min). 24-h Fat Oxidation (24-h FO; indirect 
calorimetry) was assessed in 16 young, healthy men (age 26±8 y; V̇O2max 52±6 
ml/kg/min) during a 36-h stay in a whole-room respiration chamber. MFO (g/min) was 
positively correlated with 24-h FO (g/d) (R=0.65, P=0.003; R=0.46, P=0.041 when 
controlled for V̇O2max [L/min]), 24-h % energy from FO (R=0.58, P=0.009) and insulin 
sensitivity (R=0.33, P=0.007). MFO (g/min) was negatively correlated with 24-h fat 
balance (g/d) (R=-0.51, P=0.021) but not significantly correlated with 24-h RQ (R=-0.29, 
P=0.142). While further investigations are needed, our data showing positive 
associations between maximal fat oxidation and 24-h fat oxidation, and maximal fat 
oxidation and insulin sensitivity, in healthy young men suggests that a high capacity to 
oxidize fat whilst physically active could be advantageous for the maintenance of 
metabolic health.  
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3.2 Introduction  
Exercise intensity is the main determinant of fuel utilization during exercise. With 
increasing exercise intensity there is an obligatory rise in the contribution of 
carbohydrate and a decline in the contribution of fat to energy expenditure (Romijn et al. 
1993; Bergstrom & Brooks, 1999; van Loon et al. 2001).  The absolute rate of fat 
oxidation during exercise typically shows an inverted hyperbola with fat oxidation 
increasing to a maximum at moderate exercise intensities (45-65% maximal oxygen 
consumption [V̇O2max]) and decreasing to eventually become negligible at higher 
exercise intensities (Pérez-Martin et al. 2001; Achten et al. 2002). Interestingly, there is 
substantial inter-subject variability in the relative contribution of fat to energy expenditure 
during exercise (Goedecke et al. 2000) and this large degree of variability is also 
apparent in the maximal rates of fat oxidation (MFO) that have been reported. For 
example, MFO determined during incremental treadmill exercise in 300 healthy men and 
women was 0.46±0.17 g/min (Mean±Standard Deviation [SD]) and varied ~5-fold 
between individuals (range: 0.18-1.01 g/min) (Venables et al. 2005). Part of the inter-
subject variability can be explained by aerobic capacity/training status (Holloszy et al. 
1997), nutritional status (Bergman & Brooks, 1999; Coyle et al. 2001), physical activity 
level (Venables et al. 2005), fat-free mass (FFM) (Venables et al. 2005) and sex-related 
differences (Tarnopolsky et al. 2001). Whilst appreciable efforts have been made to 
understand the determinants of fat oxidation during exercise (Goedecke et al. 2000; 
Venables et al. 2005), the significance of the observed variability in the capacity to 
oxidize fat during exercise for metabolic health requires clarification (Kelley & Simoneau, 
1994; Jeukendrup & Wallis, 2005; Isacco et al. 2013).  
	 99 
Reduced fat oxidation has previously been related to long-term changes in body weight 
or composition. For example, increased daily (i.e., 24-h) respiratory quotient (RQ; 
indicative of low relative fat oxidation) has been associated with an increased risk of 
body mass gain (Zurlo et al. 1990) and regain of body fat mass after diet-induced weight 
loss (Ellis et al. 2010). As a high fat oxidation whilst physically active could make 
important contributions to daily fat oxidation it is not unreasonable to consider a high 
capacity to oxidise fat whilst physically active as advantageous for the maintenance of 
body mass or body composition. Mechanistically, one viewpoint is that a reduced fat 
oxidation (and thus elevated carbohydrate oxidation) during exercise or on a daily basis 
may impact upon long-term body weight or composition through increased ad libitum 
food intake in free-living conditions (Almeras et al. 1994, Pannacciulli et al. 2007). 
However, this is clearly an oversimplification of what is a complex area; with more recent 
work demonstrating that there are multiple signals involved in appetite regulation (for 
review see Blundell et al. 2015). Impairments in fat oxidation at the level of skeletal 
muscle have also been associated with reduced metabolic flexibility and insulin 
resistance (Kelley & Simoneau, 1994) and enhancements in fat oxidation with exercise 
training are related to improvements in insulin sensitivity (Goodpaster et al. 2003; 
Venables & Jeukendrup, 2008). However, the evidence to date linking the capacity for 
fat oxidation during exercise to metabolic health is limited and inconsistent. For example, 
a low MFO was associated with a higher clustering of metabolic syndrome risk factors in 
overweight men (Rosenkilde et al. 2010), yet no association between variability in 
Respiratory Exchange Ratio (RER) during exercise and insulin sensitivity was observed 
in endurance-trained men (Goedecke et al. 2001). Overall, our understanding of the 
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links between the capacity to oxidize fat during exercise and metabolic health remain to 
be comprehensively studied.  
 
As exercise is a primary means to acutely increase fat oxidation and reduced fat 
oxidation has been linked to disorders such as obesity and insulin resistance, further 
understanding the significance of the observed inter-subject variability in the capacity to 
oxidize fat during exercise could provide insights into the role of physical activity in the 
optimization of metabolic health. Thus, the purpose of the present study was to test the 
hypothesis that the capacity for fat oxidation during exercise is related to 24-h fat 
oxidation and insulin sensitivity as markers for long-term metabolic health.  
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3.3 Methods 
 
3.3.1 General design and study participants 2 
A total of 57 young, healthy, recreationally active Caucasian men participated in the 
study. Their characteristics are displayed in Table 3.1. All subjects provided informed 
written consent and a local Research Ethics Committee in the United Kingdom approved 
the study. Each participant visited the laboratory on two occasions. During the first 
(Familiarisation) and second (Exercise Test) visits, which were separated by ~4-7 days, 
participants performed a graded treadmill Exercise Test to voluntary exhaustion with 
indirect calorimetry used to assess the MFO and V̇O2max. Self-reported diet and physical 
activity was recorded via diaries in the four days immediately preceding the second visit. 
A resting, overnight-fasted blood sample was also collected for determination of insulin 
sensitivity on the second visit in 53 participants. 16 participants selected to represent a 
broad MFO range determined during the Exercise Test also took part in a further trial.  
This trial consisted of a 36-h stay in a whole-room respiration chamber to measure 24-h 
energy expenditure and substrate utilization by indirect calorimetry (24-h Assessment). 
Chamber conditions were designed to simulate participant’s habitual energy intake, 
percent macronutrient intake and daily energy expenditure as estimated from the food 
and physical activity diaries.  
 
																																																								2	This study did not address the reproducibility of MFO or daily fat oxidation. However, previous reports demonstrate a coefficient of 
variation (CV) for Fatmax (the exercise intensity which corresponds to MFO) of 9.6% in a group of 10 well-trained individuals (Achten 
& Jeukendrup, 2003) and of 0.8% for 24-h RQ and 6.7% for fat oxidation in a group of 22 healthy obese adults (Toubro, Christensen, 
& Astrup, 1995).	
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Table 3.1 Participant Characteristics 
 24-h Assessment (n=16) Insulin Sensitivity (n=53) 
Age (y) 26±8 (18-42) 24±7 (18-44) 
Height (m) 
1.81±0.05 
(1.72-1.89) 
1.80±0.07 
(1.64-1.96) 
Weight (kg) 
81.0±11.2 
(65.5-101.7) 
78.7±11.3 
(54.7-113.0) 
BMI (kg/m2) 
24.5±2.5 
(21.3-29.7) 
24.2±2.6 
(18.9-29.9) 
Body fat (%) 15±5 (9-30) ND 
V̇O2max (ml/kg/min) 52±6 (39-60) 52±6 (39-62) 
Data are mean±SD (range). ND – not determined. 
 
3.3.2 Experimental procedures 
(i) Familiarisation: This visit was used for consenting, screening and to familiarize 
participants with the Exercise Test. Height (Stadiometer, Seca, UK) and weight (OHaus, 
Champ II scales, USA) were measured to calculate BMI (weight[kg]/height[m]2). A 
treadmill-based Exercise Test, identical to that described in more detail below, was then 
completed on a motorized treadmill (PPS 70sport-I, Woodway, Weil am Rhein, 
Germany) in order to familiarize participants with the exercise testing procedures. 
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Participants were then given two sets of digital weighing scales (Electronic Kitchen 
Scale, SF 400, Zhejiang Province, China and Swees Digital Pocket Weighing Scales, 
Kent, UK), blank diaries and detailed instructions to enable the completion of diet and 
physical activity diaries. Participants were instructed to follow their normal diet and 
activity between the first and second laboratory visit with the exception of the day 
immediately preceding the second visit (see below).  
 
For the 4 days preceding the second laboratory visit, participants were asked to weigh 
and record all consumed food and drink items and document activity patterns accurately 
and in as much detail as possible. The activity diary used was based on Bouchard et al. 
(Bouchard et al. 1993) and required participants to record their level of activity every 15 
minutes, using a code from a 12-point scale provided for the entire 24-h of each of the 
four days. Participants were encouraged to make notes on any sport or exercise 
performed during the 4 days.  
 
(ii) Exercise test: Participants reported to the laboratory between 07:00-08:00 h following 
an overnight fast from 22:00 h the evening before and having abstained from strenuous 
physical activity and alcohol consumption in the preceding 24-h period. Participants 
were asked not to perform any physical activity on the morning of testing, such as brisk 
walking or cycling to the laboratory, and to consume 500 ml water upon waking to 
promote hydration. Diet logs and physical activity diaries were checked and any 
potential cases of under-reporting and/or inaccuracies were clarified, after which body 
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weight was recorded as described above, a resting blood sample was obtained and the 
Exercise Test performed.  
 
The Exercise Test was based on the protocol described previously by Achten and 
colleagues (Achten et al. 2003) with the starting speed and treadmill inclination set to 
3.5 km/h and 1%, respectively. The treadmill speed was increased by 1 km/h every 3 
minutes until the participants Respiratory Exchange Ratio (RER; as is conventionally 
used in studies of exercise metabolism to indicate relative fuel utilization) reached 1.00, 
after which the treadmill gradient was increased by 1% per minute until volitional 
exhaustion. Heart rate was measured continuously throughout exercise using a heart 
rate monitor (Polar FT-2, Finland) and recorded during the final 30 seconds of each 
exercise stage. Breath-by-breath measurements of oxygen consumption (V̇O2) and 
carbon dioxide production (V̇CO2) were obtained during exercise using an online 
automated gas analysis system (Oxycon Pro, Jaeger, Wuerzberg, Germany). The gas 
analysers were calibrated with a 5.07% CO2, 14.79% O2, 80.14% N2 gas mixture (BOC 
Gases, Surrey, UK), and the volume transducer was calibrated with a 3-liter calibration 
syringe (Jaeger, Wuerzberg, Germany). Environmental conditions were documented 
during the conduct of exercise testing and remained constant with humidity at 51±6%; 
and temperature at 22±1 °C.  
 
(iii) Respiration chamber stay (24-h assessment): Participants (n=16 out of the 57 
initially tested) were provided scanned copies of their food and activity diaries recorded 
in the 4-d preceding the second laboratory visit and asked to repeat these during the 
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four consecutive days leading up to the 24-h Assessment visit. Participants arrived at 
the laboratory between 18:00-19:00 h on the evening before the experimental period 
having abstained from alcohol and strenuous physical exercise that day. Upon arrival, 
height and weight were reconfirmed and body composition was assessed using air 
displacement plethysmography (BODPOD; Cosmed, Rome, Italy). Thereafter, 
participants entered and stayed in a dual-respiration whole room metabolic chamber 
system as described previously (Schoffelen et al. 1997) for a period of 36-h. Both 
chambers were occupied simultaneously to prevent feelings of isolation.  Three airtight 
hatches were used for blood collection, the exchange of food and any urine produced. 
The room was ventilated with fresh air at a rate of 7 m3/h during the daytime period, and 
5 m3/h in the evening. Environmental conditions during the 24-h chamber assessment 
were kept stable with humidity at 57±5% and temperature at 24±1 °C and 22±1 °C for 
day and night, respectively. The concentration of O2 and CO2 was measured using two 
separate sets of ABB AO2000 analysers, a paramagnetic O2 analyser (Magnos 206, 
ABB, Germany) and CO2 was measured by using infrared analysers (Uras 26, ABB, 
Germany). Flow was measured with dry bellows meters (G16, Meterfabriek 
Schlumberger, Germany). In-going air was analysed every 15 min and outgoing air once 
every 1 min. During the experiment the gas measurement system was calibrated every 
five minutes using nitrogen (N5.5) and a calibration gas (CO2 8000PPM, 18% O2, 
balance N2 ±1%). Online analysis of V̇O2 and V̇CO2 was calculated using a 
microcomputer (Macintosh, Apple, USA).  
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The first 12-h in the chamber was used to habituate the participant with the room and 
the 24-h Assessment commenced the following morning at 07:00 h and finished at 07:00 
h the following day. A standard day in the room is outlined in Figure 3.1. This researcher 
provided meals and snacks throughout the measurement period which participants were 
asked to consume within 10-15 minutes of provision (Table 3.2; see also Appendix 6 for 
an example of a typical day’s food intake). Total energy and percent macronutrient 
intake was matched with the participants’ average daily intake (based on the 4-day 
weighed food intake analysed previously). Alcohol and caffeine was not provided during 
the 24-h Assessment. To account for alcohol, the calories consumed from alcohol during 
the 4-d measurement period were distributed evenly between carbohydrate, fat and 
protein intake during the 24-h period. The potent effect of caffeine on metabolic rate and 
fuel utilisation (Acheson et al. 1980) means that the lack of caffeine provision (in line 
with each participant’s habitual use) is a methodological limitation. Undoubtedly, it would 
be important for future research to consider the provision of caffeine in their study 
design, especially if the aim is to simulate participant’s habitual diet. 
 
Participants performed a simple and non-exhaustive step activity at three separate time 
points during the 24-h Assessment period. Each exercise period lasted between 10-20 
minutes and was designed to ensure that 24-h energy expenditure reflected that 
calculated from the 4-d self-reported activity diary. Outside the designated exercise, 
eating and sleeping periods, participants were not allowed to sleep or perform any 
additional physical activity other than light activities such as reading, watching television 
or working on a computer. Blood was collected routinely (10 ml per sample) via an 
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indwelling cannula inserted in an antecubital arm vein. Urine samples were collected for 
the entire 24-h measurement period. Participants were asked to empty their bladder 
prior to the measurement period (i.e. at 07:00 h) to ensure urine produced during the 
first night was not included in analyses. No alcohol, tea, coffee or caffeinated beverages 
were allowed but water and non-caffeinated herbal teas were available ad libitum.  
 
	
Figure 3.1 A schematic overview of proceedings during the 36-h stay in the respiration 
chamber. E = exercise, M = meal, S = snack, BP = body composition assessment,  = 
blood draw,             = urine collection. 
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3.3.3 Self-report diet and activity analysis 
Food diaries were analysed using dietary analysis software (Dietplan Version 6.7, 
Forestfield Software, Horsham, UK). Daily energy intake (EI; kcal/d), absolute 
macronutrient intake (g/d) and percentage contribution of macronutrients to daily energy 
intake were established for each participant. Daily energy expenditure was estimated 
using the factorial approach (Manore et al. 2009). Here, each of the 12 codes, which 
had a corresponding metabolic equivalent (MET) value, was assigned a Physical Activity 
Level (PAL; Recommended Daily Allowances, 1989) and a daily PAL was determined by 
multiplying each of the 12 codes by the total amount of time spent at the activity level. 
Where participants had made notes on a specific sport and exercise activity undertaken 
during the 4 days, the Compendium of Physical Activities (Ainsworth et al. 2011) was 
used to calculate the specific PAL value. Daily energy expenditure was then estimated 
by multiplying the daily PAL value by the age and sex specific resting metabolic rate 
(RMR; kcal/d) using height, weight and the World Health Organization (WHO) equation 
(WHO, 1985):  
 
Energy Expenditure (kcal/d; men < 30 years): Daily PAL value * RMR (15.4 * body mass 
[kg]) - (27.0 * height [m]) + 717) 
  
Energy expenditure (kcal/d; men > 30 years): Daily PAL value * RMR (11.3 * body mass 
[kg]) - (16.0 * height [m]) + 901)                    
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3.3.4 Plasma and urine analyses 
Whole blood was collected into EDTA-containing Vacutainers (BD, New Jersey, USA). 
Samples were immediately centrifuged at 3000 revolutions per minute for 15 minutes at 
4°C. Aliquots containing plasma were stored at -80°C until analysed. All collected 
samples were analysed using enzymatic colorimetric assays for glucose (Glucose 
Oxidase kit, Instrumentation Laboratories, Cheshire, UK), non-esterified fatty acids 
(NEFA; NEFA kit, Randox, London, UK), glycerol (GLY kit, Randox, London, UK) and 
lactate (LAC kit, Randox, London, UK) using an ILAB 650 Clinical Chemistry Analyser 
(Instrumentation Laboratory, Warrington, UK). Insulin was analysed by 
radioimmunoassay using a commercially available kit (HI-14K Human Insulin, Millipore, 
Billerica, MA). Collected urine volume was measured using digital weighing scales 
(Model 323, Salter, Kent, UK) and analysed enzymatically for urea (UREA kit, Roche, 
Mannheim, Germany) and creatinine (CREA kit, Roche, Mannheim, Germany) using an 
automated clinical chemistry analyser (Roche Cobas c702 Analyser, Roche, Mannheim, 
Germany). 
 
3.3.5 Calculations 
Insulin sensitivity was calculated using the Quantitative Insulin Sensitivity Check Index 
(QUICKI; as described in Chapter 2, Section 2.5), which has been validated against and 
shown to have a strong positive correlation (R = 0.78) with insulin sensitivity measured 
using the gold standard hyperinsulinaemic euglycemic clamp technique (Katz et al. 
2000). During the exercise test V̇O2 and V̇CO2 were averaged over the last minute of 
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each sub-maximal exercise stage with fat and carbohydrate oxidation were calculated 
according to the equations of Frayn (Frayn et al. 1983), with the assumption that the 
urinary nitrogen excretion rate was negligible. V̇O2max was calculated as the highest 
rolling 60 second average V̇O2 for participants displaying two of the three following 
criteria: an RER >1.1; heart rate within 10 beats of predicted maximum (calculated as 
220-age; Fox et al. 1971) or; an increase of < 2 ml/kg/min in V̇O2 with a further increase 
in workload. V̇O2 peak (highest rolling 30 seconds average) was calculated for 
participants who failed to demonstrate at least two of the above criteria. For each 
participant, two previously characterized (Achten et al. 2002) features were established: 
1) MFO, obtained by visual inspection as originally described (Achten et al. 2002); 2) 
Fatmax, defined as the exercise intensity (%V̇O2max) that elicits MFO.  
 
For the 24-h Assessment V̇O2 and V̇CO2 were initially averaged in 30 minute intervals 
and extrapolated to 24-h values and used to calculate 24-h Respiratory Quotient (RQ = 
V̇CO2 / V̇O2; as the expression of relative fuel utilization conventionally used in 
metabolic chamber studies), 24-h EE (Weir, 1949), 24-h carbohydrate and 24-h fat 
oxidation (Frayn, 1983) with urinary nitrogen correction where appropriate. Urinary 
nitrogen content was estimated by correcting urinary urea and creatinine by 1.11 to 
account for non-measured nitrogen sources (e.g., ammonia, urate) (Bingham et al. 
1988). 24-h protein oxidation (g/d) was calculated by multiplying total N (g/d) by 6.25. 
24-h fat balance was calculated as dietary 24-h fat intake (g/day) – 24-h fat oxidation 
(g/day). The food quotient (FQ) for the chamber diet was calculated as previously 
described (Tourbo et al. 1998). RQ and substrate utilization was also estimated for non-
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sleeping (encompassing 07:00-23:00 h) and sleeping (Sleep; encompassing 01:45-
04:45 h, [Schoffelen & Westerterp, 2008]) periods. As with the 24-h determinations, V̇O2 
and V̇CO2 was averaged in 30-minute intervals and extrapolated to the corresponding 
period duration in order to calculate RQ and substrate utilization (Frayn, 1983). We 
corrected substrate oxidation rates using 24-h urinary nitrogen excretion values rather 
than using excretion values specific to the non-sleeping and sleeping periods and we 
acknowledge this as a methodological limitation.  
 
3.3.6 Statistical analyses 
Data were analysed using SPSS (SPSS Version 21, Chicago, IL). All data were normally 
distributed according to the Shapiro-Wilk test of normality and are presented as 
Mean±SD (and range where appropriate). Statistical significance was accepted at P < 
0.05. Paired samples t-tests were used to compare differences in habitual and chamber 
24-h energy intake (kcal/day), 24-h energy expenditure (kcal/d), 24-h energy balance 
(kcal/d), and plasma hormone and substrate responses over time. Bivariate correlations 
were used to explore relationships between MFO and: 1) 24-h fat oxidation; 2) other 
potential correlates of 24-h fat oxidation (e.g., V̇O2max, blood metabolite/hormone 
responses assessed as 24-h area under the curve [trapezoid method]); and 3) insulin 
sensitivity. Partial correlations were used where applicable to adjust for potential 
relevant confounders.  
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3.4 Results 
Results for the 24-h assessment are presented for 16 participants with the exception of 
the blood data, which due to difficulty in blood collection, is presented for 15 participants. 
Associations between MFO and insulin sensitivity are based on 53 participants.  
 
3.4.1 Diet and energy expenditure 
As can be seen from Table 3.2 and as planned there were no significant differences 
between the participants’ energy and macronutrient intake, 24-h energy expenditure and 
24-h energy balance estimated from 4-day food and physical activity diaries and that 
measured during the 24-h Assessment in the respiration chamber.														
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Table 3.2 Comparison between 4-d self-report and chamber food intake, energy 
expenditure and energy balance. 
 
 
 
3.4.2 MFO and 24-h substrate oxidation 
The MFO for the 16 participants who undertook the 24-h Assessment was 0.59±0.21 
g/min (range 0.30-1.02 g/min). In these participants Fatmax was 56±17 % V̇O2max and 
ranged from 30-78 % V̇O2max. During the 24-h Assessment, 24-h RQ was 0.86±0.03 
(range 0.81-0.90). 24-h fat, carbohydrate and protein oxidation was 81±30 g/d (range 
27-135 g/d), 346±75 g/d (range 153-470 g/d) and 120±54 g/d (range 25-204 g/d), 
respectively. The relative contributions of fat, carbohydrate and protein oxidation to total 
energy expenditure throughout the 24-h Assessment are shown in Figure 3.2 and this 
 4-d 24-h Assessment 
Energy intake (kcal/d) 2779±652 2773±657 
Energy Expenditure (kcal/d) 2705±219 2621±203 
Energy balance (kcal/d) 74±638 153±601 
Carbohydrate (%) 42±10 43±11 
Fat (%) 34±7 36±6 
Protein (%) 20±7 20±7 
Alcohol (%) 4±5 n/a 
FQ 0.84±0.03 0.84±0.03 
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corresponded to 28±10, 53±10 and 19±9 %, respectively. 24-h fat balance was 31±46 
g/d. Sleeping RQ (01:45-04:45 h) was significantly lower than non-sleeping RQ (07:00-
23:00 h) (0.82±0.02 and 0.88±0.03, respectively, P<0.001). As can be seen in Figure 2, 
the relative contributions of each macronutrient to 24-h energy expenditure differed 
between sleeping and non-sleeping (fat 36±10 % and 25±10 %; carbohydrate 28±6 % 
and 59±12 %; protein 29±11 % and 16±8 %; all P<0.001).  
 
	
Figure 3.2 Percentage contribution of carbohydrate, fat and protein to energy 
expenditure for n = 16. E = exercise, M = meal, S = snack. 
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MFO (g/min) was significantly and positively correlated with 24-h fat oxidation (24-h FO, 
g/d), 24-h % energy from fat oxidation (%EnFO) and negatively correlated with 24-h fat 
balance (Figure 3.3) but was not significantly associated with 24-h RQ (R=-0.29, 
P=0.142). V̇O2max (L/min) was positively correlated with MFO (g/min) and 24-h FO (g/d) 
(R=0.72, P=0.001 and R=0.51, P=0.022, respectively). MFO (g/min) remained positively 
correlated with 24-h FO (g/d) when controlled for V̇O2max as a potential confounder 
(L/min) (R=0.46, P=0.041). The findings were similar when MFO expressed relative to 
FFM (mg/kg FFM/min) was correlated with 24-h FO (g/kg FFM/d, R=0.70, P=0.001) and 
24-h %EnFO (R=0.60, P=0.007) and 24-h RQ (R=0.31, P=0.12). V̇O2max (L/min) was 
positively correlated with MFO (mg/kg FFM/min; R=0.58, P=0.009) but not 24-h FO (g/kg 
FFM/d, R=0.35, P=0.093); therefore partial correlations between MFO and 24-h FO (with 
both expressed relative to FFM) controlled for V̇O2max were deemed unnecessary.  
 
 
 
 
 
 
 
 
 
 
 
	 116 
 
 
 	
Figure 3.3 Correlations between MFO (g/min) and (A) 24-h FO (g/d), (B) 24-h FO 
(%EnFO) and (C) 24-h fat balance (g/d). 
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When the data was separated into Sleep (01:45-04:45 h) and non-sleeping (07:00-23:00 
h) periods, MFO (g/min) was significantly negatively correlated with sleeping RQ (R=-
0.51, P=0.022) but was not significantly correlated with non-sleeping RQ (R=-0.24, 
P=0.187). MFO (g/min) was positively correlated with fat oxidation during both the Sleep 
and non-sleeping periods (g: R=0.71, P=0.001 and R=0.58, P=0.01, respectively; 
%EnFO: R=0.59, P=0.008 and R=0.51, P=0.021, respectively). Similar findings 
prevailed when MFO expressed relative to FFM (g/kg FFM/min) was correlated with 
sleeping and non-sleeping FO (g/kg FFM: R=0.73, P=0.001 and R=0.63, P=0.004, 
respectively).  
 
24-h carbohydrate intake (g/d) and 24-h energy balance (kcal/d) were significantly 
negatively correlated with 24-h FO (g/d, R=-0.59, P=0.008 and R=-0.53, P=0.017, 
respectively), 24-h %EnFO (R=-0.62, P=0.003 and R=-0.56, P=0.013, respectively) and 
24-h FO relative to FFM (g/kg FFM/d, R=-0.62, P=0.005 and R=-0.58, P=0.009, 
respectively). 24-h glycerol concentration AUC (38.6±10.6 mmol/L/d) was positively 
correlated with 24-h FO (g/kg FFM/d, R=0.44, P=0.048) and showed a tendency for a 
positive correlation with 24-h FO when expressed otherwise (g/d, R=0.40, P=0.071 or 
%EnFO, R=0.40, P=0.069). 24-h AUC for the other measured plasma metabolite and 
hormone responses did not correlate with any expression 24-h of fat oxidation.  
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3.4.3 Plasma metabolites and hormones 
Plasma metabolite and hormone responses to the different activities performed in the 
respiratory chamber are shown in Table 3. Plasma glycerol concentration increased 
significantly pre- to post-exercise in the fasted state whereas plasma glucose, insulin 
and NEFA showed no change. In response to feeding, plasma insulin and glucose 
concentrations increased, whereas plasma glycerol and NEFA concentrations remained 
similar. Overnight, plasma insulin concentration decreased and plasma glycerol and 
NEFA concentrations both increased, whereas plasma glucose showed no change. 
 
Table 3.3 Plasma hormone and metabolite responses to different activities performed 
within the respiratory chamber. 
 Fasted Exercise 
(07:25-07:55) 
Lunch 
(12:30-13:15) 
Dinner 
(17:00-18:30) 
Overnight 
(21:55-07:25) 
Pre Post Pre Post Pre Post Pre Post 
Insulin 
(µIU/mL) 
15±6 13±6 15±7 
 
59±47 
* 
11±4 
 
77±47 
** 
23±12 
 
13±5 
** 
Glucose 
(mmol/L) 
5.2±0.5 5.4±0.7 5.1±0.9 6.1±1.9 
* 
5.9±1.8 9.0±3.7 
** 
5.3±0.7 5.0±1.5 
 
Glycerol 
(µmol/L) 
30±16 51±24 
** 
16±4 18±7 30±11 29±14 17±10 35±24 
** 
NEFA 
(mmol/L) 
0.32±0.19 0.38±0.17 0.26±0.17 0.34±0.22 
** 
0.47±0.24 0.51±0.24 0.21±0.14 0.36±0.14 
** 
* and ** denote significance change in concentration pre- to post-sample at the P<0.05 
and P<0.01 level, respectively.  
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3.4.4 Insulin sensitivity 
MFO assessed in the larger cohort of participants was 0.60±0.18 g/min (range 0.30-1.02 
g/min) and this corresponded to an exercise intensity of 58±17 % V̇O2max (range 21-83 
% V̇O2max). Resting plasma glucose and insulin concentration was 5.0±0.4 mmol/L and 
11±4 µIU/mL, respectively. Insulin sensitivity (IS) as estimated using the QUICKI was 
0.34±0.02 (range 0.31-0.40; arbitrary units, AU). MFO (g/min) was significantly positively 
correlated with IS (R=0.33, P=0.007). V̇O2max (L/min) was significantly positively 
correlated with MFO (g/min) but not with IS (R=0.72, P=0.001 and R=0.11, P=0.223, 
respectively), therefore partial correlations between MFO and IS controlled for V̇O2max 
were deemed unnecessary. 
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3.5 Discussion 
The purpose of the present study was to investigate the hypothesis that the capacity for 
fat oxidation during exercise is related to daily fat oxidation and insulin sensitivity as 
markers for long-term metabolic health. Accordingly, for the first time we report 
significant and positive relationships between the maximal capacity for fat oxidation 
during exercise (MFO) and 24-h fat oxidation, and between MFO and insulin sensitivity 
in healthy young men.  
 
In seeking to explain the observed association between MFO and 24-h FO we explored 
the influence of a variety of factors on these two variables. We found that V̇O2max was a 
strong correlate of 24-h FO and as V̇O2max was also correlated with MFO it suggests that 
aerobic capacity could be a driver of the association between MFO and 24-h FO. The 
findings of the present study support those of Venables and colleagues (Venables et al. 
2005) who showed V̇O2max to be a significant predictor of MFO assessed in 300 healthy 
men and women and are consistent with the well-established effect of endurance 
exercise training to increase V̇O2max and the capacity to oxidize fat during exercise 
(Kiens et al. 1993; Martin et al. 1993). A parallel with our finding can be drawn from a 
prior report showing V̇O2max to explain the major (76%) proportion of variance in 
adaptation of 24-h fat balance to increased dietary fat intake (Smith et al. 2000), 
suggesting aerobic capacity can exert an important influence over 24-h fat oxidation 
under these conditions.  However, and in contrast to what might be expected, cross-
sectional studies do not report higher 24-h fat oxidation in endurance trained individuals 
as compared to their sedentary counterparts (Lanzi et al. 2014), suggesting a high 
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aerobic capacity may not be a necessary pre-requisite for high daily fat oxidation. In 
support of this, the present study showed that MFO was still significantly and positively 
related to 24-h fat oxidation when controlled for V̇O2max, which suggests an independent 
relationship. Overall, while we reveal a correlation between MFO and 24-h FO the 
present study highlights the need for longitudinal training studies to delineate the relative 
role of changes in maximal aerobic capacity and the capacity to oxidize fat during 
exercise on daily patterns of substrate oxidation.  
 
It could be argued that variables other than V̇O2max may also be contributing to our 
observations relating MFO to 24-h FO. Previous research shows that carbohydrate 
intake and the state of energy balance (Jequier & Schutz, 1983) can influence fuel 
utilization. In the present study carbohydrate intake and energy balance were 
significantly and negatively associated with 24-h FO, although they were not associated 
with MFO (data not shown). The lack of association of carbohydrate intake with MFO is 
consistent with the findings of Goedecke et al. (Goedecke et al. 2000) who found no 
association between dietary carbohydrate intake and inter-subject variability in 
exercising RER over a range of pre-determined workloads. Moreover, Rosenkilde 
(Rosenkilde et al. 2010) found no differences in habitual carbohydrate intake or energy 
balance between two groups of moderately overweight men who differed markedly in 
their MFO during exercise. Thus, while it is well established from intervention studies 
that nutritional status can exert large effects on the balance of fuels oxidized during 
exercise (Bergman & Brooks, 1999; Coyle et al. 2001), we do not believe this to be 
underlying the associations between MFO and 24-h FO in the present study.   
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Regular blood draws were taken throughout the 24-h Assessment in an attempt to 
explore relationships between plasma metabolic responses and 24-h FO. While the 
majority of these were uninformative, including NEFA concentration AUC (correlation 
with 24-h FO: g/d, R=0.22, P=0.220; g/kg FFM/d, R=0.25, P=0.185), glycerol 
concentration AUC was significantly and positively associated with 24-h FO (correlation 
with 24-h FO: g/kg FFM/d, R=0.44, P=0.048). Our glycerol data reflects static 
concentration measurements and we cannot infer whether these glycerol concentrations 
are driven by alterations in lipolytic rate or glycerol clearance. Furthermore, as the 
relationship between MFO and 24-h FO did not alter substantially (R=0.61, P=0.011) 
when glycerol AUC was included as a partial correlate the observation should be treated 
with caution. Nonetheless, previous work suggests a link between lipolytic rate and fat 
oxidation. For example, Horowitz et al. (Horowitz et al. 1997) found that a reduced 
lipolytic rate was associated with a suppression of fat oxidation, whereas Coggan et al. 
(Coggan et al. 2000) observed a higher lipolytic rate in trained compared with untrained 
subjects, and this was associated with a higher fat oxidation during 30 minutes of 
exercise at 75% to 80% maximal oxygen consumption (V̇O2max). More recently, Isacco et 
al. (Isacco et al. 2013) found that women with a preferential body fat distribution (a lower 
abdominal to lower body fat mass ratio) oxidized more fat during a 45-minute cycling 
exercise compared with women who had a less preferential body fat distribution (higher 
abdominal to lower body fat mass ratio) and this was associated with increased glycerol 
concentrations. The use of isotopic tracers of lipid metabolism would be needed to fully 
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investigate the potential involvement of lipolytic rate in the observed association 
between MFO and 24-h FO.  
 
We chose to look at relationships between MFO with 24-h FO, as the latter may be more 
reflective of long-term susceptibility to obesity. For example, previous work links high 
daily RQ, which is indicative of a low relative fat oxidation, with an increased risk of body 
mass gain (Zurlo et al. 1990) and regain of body fat mass after diet-induced weight loss 
(Ellis et al. 2010). While we did not observe a significant association between MFO and 
24-h RQ the correlation was directionally consistent (R=-0.29) with what would be 
predicted. Nonetheless, our data did reveal a significant and negative correlation 
between MFO and sleeping RQ, which could suggest that the relationship becomes 
stronger under conditions where the suppressive effects of insulin on lipid metabolism 
may be less apparent. Indeed, previous studies have demonstrated that as compared to 
non-exercise control conditions fat oxidation in response to acute aerobic exercise was 
higher during the sleeping but not the non-sleeping period (Jequier & Schutz, 1983; 
Hawkins et al. 2012). Collectively, this suggests the sleeping period may be particularly 
sensitive to alterations in lipid metabolism in response to physiological perturbations. 
While we did not see a significant correlation between MFO and 24-h RQ, we reiterate 
that we report positive associations between MFO and 24-h absolute fat oxidation, and 
between MFO and 24-h fat oxidation as a proportion of daily energy expenditure. These 
relationships, which incorporate energy expenditure, are likely more relevant than RQ as 
they will contribute ultimately as determinants of absolute, and relative substrate 
balances, respectively. The negative association between MFO and fat balance 
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observed in the present study reinforces this concept. In additional analysis, we 
explored relationships between MFO and fat oxidation measured during the various 
activities performed in the respiratory chamber (data not shown). This analysis indicated 
that the relationship between MFO and 24-h FO appears to reflect an overall elevated 
oxidation of fat rather than being restricted to a particular time period or to certain 
activities. Thus, MFO could reflect an overall capacity for daily whole body fat oxidation 
and our interpretation of the present data is that MFO could be a marker for long-term 
regulation of body mass or composition, although we accept further work is necessary to 
test this concept.  
 
We also explored relationships between MFO and insulin sensitivity using a surrogate 
marker of insulin sensitivity (QUICKI). In contrast with Goedecke et al. (Goedecke et al. 
2001) who observed no association with exercising RER we found a small to moderate 
correlation between MFO and insulin sensitivity. The exact reason for this discrepancy is 
unclear, but could be explained by methodological differences. For instance, in the 
present study rates of fat oxidation were determined over a wide range of exercise 
intensities providing the resolution to identify the maximal capacity for fat oxidation 
during exercise whereas the study by Goedecke and colleagues assessed RER during 
three pre-determined exercise workloads. Also, exercise RER considers only relative 
fuel utilization whereas MFO, which incorporates metabolic rate, could better reflect 
metabolic capacity and thus be more likely to correlate with insulin sensitivity. However, 
this suggestion is not consistent with the observations of Chu and colleagues who 
recently showed MFO to be positively correlated with insulin resistance (estimated from 
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the homeostatic model assessment of insulin resistance) and unrelated to whole-body 
insulin sensitivity index (determined from oral glucose tolerance testing) (Chu et al. 
2013). However, this was observed in a group of normal and overweight girls, which is 
quite different to the study population tested herein.  
 
The data from the present study, which is suggestive of a link between MFO and insulin 
sensitivity in young, healthy men is consistent with observational studies showing that 
impairments in fat metabolism at the level of skeletal muscle are associated with 
reduced metabolic flexibility and insulin resistance (Kelley & Simoneau, 1994) and 
longitudinal studies showing enhancement in fat oxidation with exercise training is 
associated with improvements in insulin sensitivity (Goodpaster et al. 2003; Venables & 
Jeukendrup, 2008). Furthermore, greater exercise training-induced improvements in 
insulin sensitivity have been observed using exercise training strategies that enhance fat 
oxidation during acute exercise (e.g., targeting training intensity Fatmax or exercising in 
the overnight-fasted state (Venables & Jeukendrup, 2008). From a mechanistic 
standpoint, this association between MFO and insulin sensitivity seems plausible. It has 
been suggested that incomplete metabolism of fatty acids in the β-oxidation pathway 
induces an accumulation of acyl carnitines in the mitochondria and this is associated 
with insulin resistance (Koves et al. 2005). Furthermore, the accumulation of lipid 
metabolites such as ceramide, diacylglycerol and long-chain fatty acyl-CoA has also 
been linked with insulin resistance in skeletal muscle (Shaw et al. 2013). We 
acknowledge that we have not studied insulin sensitivity using direct methods (e.g., 
hyperinsulinaemic euglycemic clamp technique) but our observations could imply that a 
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higher capacity for fat oxidation during physical activity could alleviate lipotoxic stress in 
skeletal muscle and confer improvements in insulin sensitivity.  
 
Finally, we believe there are two further aspects of our study that warrant consideration 
in discussion. Firstly, we purposely chose to feed subjects their habitual diet and to 
replicate activity levels in the metabolic chamber trial in order to reflect variation between 
individuals under conditions that mimicked their daily lives and we were successful in 
achieving this. It would be important in future work to confirm these observations under 
conditions of standardised dietary and physical activity levels.  Secondly, our findings 
linking MFO to 24-h FO advance a potential role for MFO as a determinant of long-term 
regulation of body mass or composition. However, it is notable that obese individuals do 
not always have a lower MFO compared with their lean counterparts (Ara et al. 2011; 
Lanzi et al. 2014), even when matched for cardiorespiratory fitness (Croci et al. 2014). 
Nonetheless, Rosenkilde and colleagues found that even within a relatively 
homogenous group of overweight men those with a lower MFO exhibited a higher 
clustering of metabolic syndrome risk factors than those with a higher MFO (Rosenkilde 
et al. 2014). Therefore, we believe that the inter-subject variability in MFO should be 
considered as a potential marker of risk for metabolic disorders within defined population 
groups (e.g., normal weight, overweight).  
 
In conclusion, we observed a significant and positive association between maximal fat 
oxidation during exercise and 24-h fat oxidation, and maximal fat oxidation during 
exercise and insulin sensitivity in healthy young men. Future work should seek to 
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establish if this is a causal relationship and address in a variety of subject populations 
the long-term implications of the apparent inter-subject variation in maximal fat oxidation 
during exercise and risk for disorders associated with disturbances in fat metabolism, 
such as obesity, insulin resistance and type II diabetes.  
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CHAPTER 4   
 
LIPOLYTIC MARKERS, INSULIN 
AND RESTING FAT OXIDATION 
ARE ASSOCIATED WITH 
MAXIMAL FAT OXIDATION 		
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The work contained within this chapter is published: 
Robinson SL, Chambers ES, Fletcher G, and Wallis GA. Lipolytic markers, insulin and resting fat 
oxidation are associated with maximal fat oxidation. Int J Sports Med in press, 2016.			
Please note that the data presented in Chapters 3 and 4 of this thesis comes from data collected from one 
study. 			
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4.1 Abstract 
The maximal capacity to oxidise fat during exercise (MFO) is associated with 24-h fat 
balance and insulin sensitivity. Understanding the factors that influence MFO could have 
implications for metabolic health. We investigated relationships between selected 
plasma metabolites and hormones, and resting fat oxidation with MFO. Resting fat 
oxidation and MFO was measured in 57 young, healthy men and venous blood was 
collected at rest and during incremental exercise. Plasma glycerol (R=0.39, P=0.033), 
non-esterified fatty acids (NEFA: R=0.27, P=0.030) and insulin (R=-0.36, P=0.007) 
measured at MFO correlated with MFO; only glycerol remained correlated when 
controlled for resting concentrations (R=0.36, P=0.008). The change in glycerol from rest 
to MFO correlated with exercise-induced fat oxidation (R=0.32, P=0.012). V̇O2max was 
correlated with both resting fat oxidation (R=0.44, P=0.001) and MFO (R=0.52, 
P<0.001). Resting fat oxidation also correlated with MFO (R=0.55, P<0.001); this 
relationship remained when controlled for V̇O2max (R=0.41, P=0.001). This study 
reports new relationships between plasma lipolytic markers, insulin and resting fat 
oxidation with MFO and shows the plasma glycerol response to uniquely reflect 
exercise-induced fat oxidation. V̇O2max is important for MFO but the relationship can be 
dissociated, which could have implications for physical activity interventions aimed at 
increasing fat oxidation to optimise metabolic health. 
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4.2 Introduction 
Impairments in fat oxidation are associated with the development of cardio-metabolic 
risk factors. For example, an elevated daily (i.e. 24-h) respiratory quotient (RQ; 
indicative of a low relative fat oxidation) has been shown to be predictive of body mass 
gain (Zurlo et al. 1990) and regain of body fat mass after diet-induced weight loss (Ellis 
et al. 2010). Furthermore, a reduced fat oxidation under resting conditions at the level of 
skeletal muscle is associated with impaired insulin sensitivity and metabolic flexibility 
(Kelly & Simoneau, 1994). We have recently demonstrated that the maximal attainable 
rate of fat oxidation during exercise (maximal fat oxidation, MFO) is associated with 24-h 
fat oxidation, 24-h fat balance and insulin sensitivity as markers of long-term metabolic 
health (Robinson et al. 2015). A greater understanding of the factors that influence MFO 
could therefore provide insights into how to increase fat oxidation and optimise 
metabolic health.  
 
The circulating metabolic and hormonal milieu has been shown to influence fat oxidation 
during fixed intensity exercise. For example, an increase in plasma glucose or insulin 
typically suppresses fat oxidation during exercise, whereas elevations in non-esterified 
fatty acid (NEFA) concentrations increase it (Costill et al. 1977; Vukovich et al. 1993). 
However, the independent and relative influence of these plasma markers on MFO as a 
marker of the maximal capacity for fat oxidation has not been comprehensively studied. 
Rosenkilde and colleagues reported a significant and positive relationship between 
resting NEFA concentration and MFO, although as NEFA concentration was not 
measured during exercise the significance of this observation is unclear (Rosenkilde et 
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al. 2010). Interestingly, Lanzi and colleagues demonstrated markedly higher circulating 
levels of NEFA, glycerol and insulin across a range of exercise intensities in obese as 
compared to lean individuals yet reported no group differences in MFO (Lanzi et al. 
2014). This indicates that the plasma lipolytic and insulin response to exercise may not 
be important in modulating MFO during exercise although the confounding presence of 
obesity could alter expected relationships between these plasma markers and MFO.  
 
Previously, in a large cross-sectional study, indicators of physical fitness (V̇O2max, 
physical activity level), body composition (fat free mass, fat mass) and sex-related 
metabolic differences have been identified as significant and independent determinants 
of MFO during exercise (Venables et al. 2005). Whilst informative, the study did not 
consider the influence of resting substrate oxidation on MFO. Studies of metabolic 
flexibility have shown that dietary nutrient intake and energy balance can affect baseline 
substrate oxidation and subsequent responses to metabolic challenges (Galgani et al. 
2008) and thus it is plausible that baseline fat oxidation could influence the substrate 
oxidation response to a subsequent bout of exercise. Indeed, fasting RER has been 
shown to predict RER during exercise in trained athletes and MFO in overweight men 
(Goedecke et al. 2000; Rosenkilde et al. 2010). However, fasting RER does not provide 
information on rates of substrate oxidation and as such the influence of resting rates of 
fat oxidation on MFO is not known. This is important to describe in order to inform the 
necessity to consider resting fat oxidation rates in future studies using MFO as a marker 
of fat oxidation capacity during exercise.    
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In summary, the evidence to date linking circulating levels of plasma hormones and 
metabolites as potential correlates of MFO is limited and inconsistent and requires 
further clarification. Further, the links between the actual rate of resting fat oxidation and 
MFO has not yet been established. Therefore, the purpose of the present study was to 
investigate the influence of selected plasma metabolites and hormones and resting fat 
oxidation on maximal fat oxidation during exercise.  
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4.3 Methods 
 
4.3.1 Participants 
57 young, healthy, recreationally active Caucasian men were recruited for the study 
(age 24±7 y; height 1.80±0.07 m; weight 78.7±11.3 kg; V̇O2max 52±6 ml/kg/min; Body 
Mass Index [BMI] 24.2±2.6 kg/m2). Each participant provided written informed consent 
and a local Research Ethics Committee in the United Kingdom approved the study. The 
data from 53 of the participants used in this study has been presented elsewhere 
(Robinson et al. 2015), however the principle aims of that study were different to those 
of the current study, therefore allowing us to present novel interpretations of the data 
herein.   
 
4.3.2 General design 
This cross-sectional study involved two laboratory visits each separated by ~4-7 days 
(Figure 4.1).  The first (Familiarization) and second (Main Experimental Trial) visit had 
participants perform a laboratory-based graded treadmill exercise test to volitional 
exhaustion to allow for the determination of MFO and V̇O2max by indirect calorimetry. 
The second visit also involved an assessment of body composition (via dual-energy x-
ray absorptiometry [DXA] or skinfolds), resting fat oxidation and blood sample collection 
at rest and during exercise. Self-reported diet and physical activity were documented 
using diaries in the 4-d immediately preceding the second visit.  
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Figure 4.1 Schematic representation of the study design. 
 
4.3.3 Experimental procedures 
(i) Familiarisation: Please refer to Chapter 3, Section 3.3.2 (i). 
 
(ii) Main experimental trial: Participants arrived at the laboratory at 08:00 h following an 
overnight fast from 22:00 h the evening before and having abstained from alcohol 
consumption and strenuous physical activity in the preceding 24-hour period. 
Participants were asked not to perform any physical activity on the morning of testing, 
such as brisk walking or cycling to the laboratory, and to consume 500 ml water upon 
waking to promote hydration. The researcher checked diet and physical activity diaries 
meticulously and any potential cases of misreporting were discussed and clarified, 
following which body weight was recorded and body composition assessed. For the first 
29 participants, body fat percentage, lean-tissue mass and fat mass were calculated 
using DXA (QDR software, Hologic Inc., Bedford, MA). For the remaining 28 
participants, these features of body composition were determined using 4-site skinfolds 
and the updated sex and race/ethnicity specific equations (Davidson et al. 2011). All 
measurements were taken by an International Society for the Advancement of 
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Kinanthropometry (ISAK) Level 1 Accredited Anthropometrist and followed International 
Standards for Anthropometric Assessment.  
 
An indwelling cannula (20g IV catheter, BD Venflon, Helsingborg, Sweden) was inserted 
into an antecubital arm vein and connected to a 150 cm polyethylene extension line (V-
Green I.V. Extension Line, Vygon, Swindon, UK). This was attached to a 3-way stopcock 
(BD Connecta, Vygon, Swindon, UK) to allow for repeated blood collection during 
treadmill running exercise without the need for changes in running speed or form. The 
cannula was kept patent for the duration of insertion by regular flushing of 0.9 % sodium 
chloride  (B Braun, Melsungen, Germany). Participants then rested for 30 minutes in the 
supine position in a dimly lit, thermo-neutral, quiet room with indirect calorimetry used to 
assess resting energy expenditure and fat oxidation (see below). Participants were 
instructed to refrain from any movement during this period. Upon completion a resting 
blood sample (10 ml) was obtained and ~15 minutes later the exercise test was 
performed. 
 
The procedure for the exercise test is described in Chapter 3, Section 3.3.2 ii. As well, a 
venous blood sample (5 ml) was obtained prior to the start of exercise (with the 
participant standing still on the treadmill) and during the final 30 seconds of each 
exercise stage until RER reached 1.00. A final blood sample (10 ml) was drawn at 
V̇O2max.  
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Breath-by-breath measurements of oxygen consumption (V̇O2) and carbon dioxide 
production (V̇CO2) were collected during rest and exercise using an online automated 
gas analysis system (Oxycon Pro, Jaeger, Wuerzberg, Germany). The gas analysers 
were calibrated with a 5.07 % CO2, 14.79 % O2, 80.14 % N2 gas mixture (BOC Gases, 
Surrey, UK), and the volume transducer was calibrated with a 3-liter calibration syringe 
(Jaeger, Wuerzberg, Germany). Environmental conditions during testing were: humidity 
50±5 %; temperature 22±2 °C.  
 
4.3.4 Self-report diet and activity analysis 	
Please refer to Chapter 3, Section 3.3.3. 	
 
4.3.5 Plasma analyses 
Please refer to Chapter 3, Section 3.3.4 for details regarding the analysis of plasma 
glucose, glycerol, NEFA and insulin concentrations. Leptin (rest only) was analysed by 
radioimmunoassay using a commercially available kit (HL-81K Human Leptin; Millipore, 
Billerica, MA).  
 
4.3.6 Calculations 
Resting energy expenditure and fat oxidation were calculated during a stable 
measurement period (i.e., a deviation in V̇O2 of <10% of the average V̇O2 between 
minutes 20-30; mean±SD recording period was 5±2 minutes) according to the equations 
of Frayn (Frayn, 1983) with a protein correction factor of 0.11 mg/kg/min, as used 
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previously (Flatt et al, 1985; Hall et al. 2010). Carbohydrate and fat oxidation, V̇O2max / 
V̇O2peak, MFO and Fatmax were determined according to the procedures outlined in 
Chapter 3, Section 3.3.5. 
 
4.3.7 Statistical analyses 
Data were analysed using SPSS (SPSS Version 21, Chicago, IL). All data were normally 
distributed according to the Shapiro-Wilk test of normality and are presented as 
Mean±SD (and range where appropriate). A One-Way Repeated Measures ANOVA was 
used to investigate the temporal differences in plasma hormone and metabolite 
concentrations with post hoc paired samples t-tests (using the Bonferroni correction) 
applied where necessary for multiple comparisons. Bivariate correlations were used to 
investigate relationships between MFO and: 1) metabolite/hormone concentrations and 
their response to exercise; and 2) other potential correlates of MFO (e.g., resting fat 
oxidation, V̇O2max, FFM). Partial correlations were used where applicable to adjust for 
potential relevant confounders. A paired samples t-test was employed to compare the 
mean exercise intensities at MFO and LIAB. Statistical significance was accepted at P < 
0.05. 
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4.4 Results 
The data described below represents 57 participants, with the exception of resting fat 
oxidation whereby we report data for 51 participants and blood data where we report 
data for between 45-57 participants due to difficulty withdrawing blood from some 
participants at certain time-points.  
 
4.4.1 Diet and activity 
Self-reported energy intake, energy expenditure and energy balance were 2854±604 
kcal/d, 2808±384 kcal/d and 45±613 kcal/d, respectively. The contribution of 
carbohydrate, fat, protein, fiber and alcohol to daily energy intake was 42±9 % 
(4.00±1.71 g/kg), 34±8 % (1.30±0.52 g/kg), 18±6 % (1.58±0.64 g/kg), 2±3%, and 4±5%, 
respectively.  
 
4.4.2 Resting and exercise substrate oxidation  
Resting energy expenditure was 1.37±0.28 kcal/min (range 0.81-2.03 kcal/min). Fasted 
(resting) RER, fat oxidation (g/min) and (% energy from FO [%EnFO]) was 0.80±0.04 
(range 0.73-0.87), 0.08±0.03 g/min (0.02-0.15 g/min) and 53±16% (range 14-80%), 
respectively. The MFO arising from the exercise test was 0.60±0.18 g/min (range 0.30-
1.02 g/min) or 9.18±2.65 mg/kg FFM/min (range 4.13-15.98 mg/kg FFM/min) and this 
corresponded to an exercise intensity of 58±17 % V̇O2max (range 21-83 % V̇O2max).  
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4.4.3 Plasma metabolite and hormonal responses  
Plasma metabolite responses are presented in Table 4.1. 		
Table 4.1 Plasma metabolite responses from rest to MFO to VO2max. 
 Rest MFO V̇O2max 
Glucose 
(mmol/L) 
5.0±0.4 5.1±0.5 5.8±0.1** ^ 
Glycerol (µmol/L) 40.0±19.8 80.2±53.5* 151.8±85.2** ^ 
NEFA (mmol/L) 0.57±0.19 0.81±0.45* 0.66±0.37 
Lactate (mmol/L) 0.8±0.2 2.1±1.4* 10.2±3.3** ^ 
Values are mean ± SD. * denotes a significant change from rest to MFO, ** from MFO to 
V̇O2max, and ^ from rest to V̇O2max 
 
In response to exercise, plasma glycerol (P=0.001), NEFA (P=0.002) and lactate 
(P=0.011) concentration increased significantly from rest to MFO, whereas glucose did 
not change. The change from MFO to V̇O2max resulted in a significant rise in plasma 
glucose (P<0.001), glycerol (P<0.001) and lactate (P<0.001), however plasma 
concentration of NEFA was unaltered. Plasma glucose (P<0.001), glycerol (P<0.001) 
and lactate (P<0.001) were all significantly higher at V̇O2max than under resting 
conditions. Plasma insulin did not change from rest to MFO (10.9±3.5 µIU/mL and 
8.6±3.2 µIU/mL, respectively; P>0.05) or from MFO to V̇O2max (8.6±3.2 µIU/mL and 
8.3±6.9 µIU/mL, respectively; P>0.05) but was significantly lower at V̇O2max than at rest 
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(10.9±3.5 µIU/mL and 8.3±6.9 µIU/mL, respectively; P=0.026). Resting leptin 
concentration was 3.5±3.6 ng/mL. 
 
4.4.4 Correlational analysis 3 
For clarity, correlations of specific variables with fat oxidation rates are presented with 
oxidation rates expressed in absolute terms (i.e., g/min). Unless explicitly stated, 
expressing fat oxidation relative to lean body mass does not change the outcomes.  
 
(i) Resting fat oxidation: V̇O2max (L/min, R=0.44, P=0.001), FFM (kg; R=0.39, P=0.002) 
and energy expenditure (kcal/d; R=0.34, P=0.009) were significantly and positively 
associated with resting fat oxidation. No measured plasma hormones or metabolites 
were significantly associated with resting fat oxidation, with the exception of resting 
plasma NEFA concentration which was significantly and positively correlated with resting 
fat oxidation expressed relative to lean body mass (R=0.29, P=0.019).  
 
(ii) Maximal Fat Oxidation during exercise: Fasting RER (R=-0.47, P<0.001), resting fat 
oxidation (R=0.55, P<0.001; Figure 4.2), V̇O2max (L/min; R=0.52, P<0.001), body mass 
(kg; R=0.24, P=0.037), FFM (kg; R=0.28, P=0.018) and BMI (kg/m2; R=0.25, P=0.031) 
were all significantly correlated with MFO. Resting fat oxidation (g/min) remained 
positively correlated with MFO when controlled for V̇O2max as a potential confounder 
																																																								3	This researcher accepts that there is potential for the issue that so many correlations run the risk of multiple co-linearity. One way 
around this is to perform multiple regression analysis to look at independent predictors. However, it was felt that the sample size was 
insufficient to perform this form of anaylsis, so it is acknowledged that the weak to moderate, albeit significant, individual correlations 
should be interpreted with caution.	
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(L/min) (R=0.41, P=0.001). Fat mass, energy intake, energy expenditure, energy 
balance and macronutrient intakes were not significantly correlated with MFO (P>0.05). 
  
	
Figure 4.2 Correlation between resting fat oxidation and MFO during exercise. 
 
While resting glycerol concentration was not significantly correlated with MFO, glycerol 
concentration at MFO was significantly and positively associated with MFO (Figure 4.3), 
and this correlation remained when controlled for potential confounding variables (i.e., 
glycerol concentration at rest, R=0.36, P=0.008; V̇O2max, R=0.51, P<0.001). 
Furthermore, the change in glycerol concentration from rest to MFO correlated with the 
change in fat oxidation from rest to MFO (R=0.32, P=0.012). 
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Figure 4.3 Correlations between (A) plasma glycerol concentration at rest and MFO; 
and (B) plasma glycerol concentration at MFO and MFO. 
 
The concentration of NEFA at rest and at MFO was significantly and positively 
associated with MFO (R=0.36, P=0.003 and R=0.27, P=0.030, respectively), however 
the significant relationship between NEFA concentration at MFO and MFO was lost 
when resting NEFA concentration was considered as a potential confounding variable 
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did not correlate with the change in fat oxidation from rest to MFO (R=0.10, P=0.236). 
Glucose and lactate concentration at rest and at MFO were not significantly associated 
with MFO.  
 
Insulin concentration at rest and at MFO was significantly and negatively associated with 
MFO (R=-0.29, P=0.016 and R=-0.36, P=0.007, respectively), and the relationship 
between insulin concentration at MFO and MFO showed a trend for significance when 
resting insulin concentration was included as a partial correlate (R=-0.23, P=0.060).  
The change in insulin concentration from rest to MFO did not correlate with the change 
in fat oxidation from rest to MFO (R=-0.115, P=0.224). Resting plasma leptin 
concentration was not associated with resting fat oxidation or MFO but was significantly 
and positively associated with the following parameters of body composition: body 
weight (kg; R=0.24, P=0.048), BMI (R=0.33, P=0.011), waist circumference (R=0.40, 
P=0.002) and % body fat (R=0.59, P<0.001).  
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4.5 Discussion 
The purpose of the present study was to investigate the influence of selected plasma 
metabolites and hormones and resting fat oxidation on MFO during exercise. 
Accordingly, we report significant relationships between circulating concentrations of 
NEFA, glycerol and insulin measured during exercise and MFO. We also show that 
resting fat oxidation is significantly and positively associated with MFO and provide new 
insights into the role of V̇O2max as a determinant of fat oxidation across a range of 
physiological contexts.  
 
The first main set of observations in the current study was that plasma NEFA or glycerol 
concentrations and plasma insulin concentrations measured during exercise at the point 
of MFO, were positively and negatively associated with MFO, respectively. To the best 
of our knowledge, such associations specific to MFO have not previously been reported. 
The findings are however consistent with what might be predicted based on the 
observations of others. For example, Goedecke and colleagues demonstrated that 
plasma NEFA concentration measured during exercise was a significant determinant of 
the inter-subject variability in RER during low (~41% V̇O2peak) and moderate (~63% 
V̇O2peak) intensity exercise in trained cyclists (Goedecke et al. 2000). Furthermore, as 
compared to untrained individuals, endurance-trained men exhibited elevated plasma 
glycerol concentrations and rates of fat oxidation during 30 minutes of exercise at 75-
80% V̇O2max (Coggan et al. 2007). Finally, Horowitz and co-workers showed that 
elevations in plasma insulin concentration suppress fat oxidation during low (25-45% 
V̇O2max) and moderate (68% V̇O2max) intensity exercise (Horowitz et al. 1997, Horowitz et 
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al. 1999). Collectively, the results of the present study extend support for the integrated 
influence of lipolysis (as reflected by plasma glycerol concentration), the anti-lipolytic 
action of insulin, and plasma NEFA availability as determinants of fat oxidation during 
exercise.   
 
Interestingly, Lanzi and colleagues demonstrated that MFO was similar in lean and 
obese individuals, yet the obese group displayed markedly higher circulating levels of 
NEFA, glycerol and insulin across a range of exercise intensities (Lanzi et al. 2014).  
While it should be noted that the lean group were considerably fitter than the obese 
group (V̇O2peak: 44.9±1.3 versus 53.8±1.7 ml/kg FFM/min), the findings do contrast our 
current observations and would indicate that these plasma responses are not important 
modulators of MFO. In the study of Lanzi and co-workers, fat oxidation rates were higher 
in the obese group at lower exercise intensities (20-30% V̇O2peak) and higher in the lean 
group at higher exercise intensities (65-85% V̇O2peak). Furthermore, studies comparing 
fitness-matched lean and obese subjects have shown higher rates of fat oxidation in 
obesity despite the presence of hyperinsulinemia and similar or elevated plasma NEFA 
concentration during exercise (Horowitz & Klein, 2000; Goodpaster et al. 2002). 
Therefore, the role of circulating levels of NEFA, glycerol, and insulin in determining fat 
oxidation during exercise may be altered as a function of obesity.  
 
We also explored associations between the resting concentrations of glycerol, NEFA, 
insulin and leptin with MFO. In line with Rosenkilde and colleagues (Rosenkilde et al. 
2010) we observed a significant and positive relationship between resting NEFA 
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concentration and MFO. We also identified previously undocumented significant positive 
and inverse correlations between resting concentrations of glycerol and insulin with 
MFO, respectively. Interestingly, the relationships between the concentrations of NEFA 
and insulin during exercise with MFO were lost when controlled for their resting 
concentrations using partial correlations. Moreover, the exercise-induced changes in 
NEFA and insulin were not correlated with the exercise-induced change in fat oxidation 
(i.e., resting to MFO). This suggests that while plasma NEFA and insulin concentrations 
at rest and during exercise are generally correlated with MFO, they may not be the 
prominent drivers of the exercise-induced increase in fat oxidation. While leptin has 
been shown to promote fat oxidation in muscle (Minokoshi et al. 2012), we did not 
observe a significant relationship between resting plasma leptin concentration and 
whole-body fat oxidation. Nevertheless, our data is consistent with previous studies that 
show leptin concentration is positively associated with body mass and body fat (Ostlund 
et al. 2013).  
 
By contrast, the significant and positive relationship between plasma glycerol 
concentration during exercise and MFO remained when controlled for resting glycerol 
concentration and the exercise-induced change in glycerol was significantly and 
positively correlated with the exercise-induced change in fat oxidation. Moro and 
colleagues have recently demonstrated that 33% of the variation in fat oxidation 
observed during 90 minutes exercise at 70% V̇O2max could be explained by the 
subcutaneous abdominal adipose tissue dialysate glycerol concentration (as a marker of 
lipolysis) area under the curve during the exercise period (Moro et al. 2013). 
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Additionally, previous studies have reported that changes in lipolytic rate (i.e., rate of 
appearance of whole-body glycerol) coincide temporarily with changes in fat oxidation 
during exercise (Coggan et al. 2007, Horowitz et al. 1997). In this light, we interpret our 
observations to indicate that plasma glycerol concentrations uniquely reflect the 
metabolic processes underlying the regulation of fat oxidation during exercise. 
Nonetheless, we acknowledge that further work is necessary to fully delineate the 
influence of lipolytic rate and plasma NEFA kinetics as determinants of the inter-subject 
variability in MFO. From a practical standpoint, these findings suggest that previously 
established interventions that help maximise the lipolytic response could assist with 
increasing ones capacity to oxidise fat during exercise, i.e., conducting fasted- as 
oppose to fed-state exercise (de Bock et al. 2005) or strategically manipulating the 
composition of the pre-exercise diet (Thomas, Brotherhood & Brand, 1991; Stevenson et 
al. 2009).  
 
Consistent with the findings of others we report that V̇O2max (Achten & Jeukendrup, 
2002; Venables et al. 2005) and FFM (Venables et al. 2005) are significantly and 
positively correlated with MFO. However, these previous reports did not consider the 
role of resting fat oxidation as a potential correlate of MFO. Indeed, fasting RER has 
been shown to predict both RER during low-moderate exercise intensities in trained 
athletes and MFO in overweight men (Goedecke et al. 2000; Rosenkilde et al. 2010). 
Accordingly, we confirm the observation of Rosenkilde and colleagues (Rosenkilde et al. 
2010) by showing fasting RER was negatively correlated to MFO and extend this to 
demonstrate that the actual rate of resting fat oxidation is significantly and positively 
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correlated with MFO. Our further analysis shows that V̇O2max is positively correlated with 
both resting fat oxidation and MFO. We previously reported significant and positive 
correlations between V̇O2max and 24-hour fat oxidation (Robinson et al. 2015) and 
collectively this implicates V̇O2max as an important determinant of fat oxidation under a 
range of physiological conditions. Interestingly, the significant relationships between 
resting fat oxidation and MFO reported herein and MFO and 24-hour fat oxidation 
reported previously (Robinson et al. 2015) remain when controlled for the influence of 
V̇O2max. This suggests that metabolic factors either directly or indirectly associated with 
V̇O2max such as skeletal muscle fibre type, capillary density and/or muscle oxidative 
capacity are also important determinants of an individual’s overall capacity to oxidize fat.  
 
In conclusion, we report new associations between plasma glycerol, NEFA and insulin 
concentration and resting fat oxidation with MFO and identify the plasma glycerol 
response to exercise to uniquely reflect exercise-induced fat oxidation. In line with 
previous suggestions, our results indicate that resting fat oxidation should be considered 
in studies investigating exercise-induced fat oxidation (Goedecke et al. 2000). That is, it 
would be important for such studies to account for baseline (resting) fat oxidation in 
explaining differences between individuals (e.g., whether differences in MFO are 
exercise specific or reflect more generalised differences in fat oxidation) or in studies 
designed to assess the impact of an intervention, for example on exercise fat oxidation 
(i.e., does an intervention affect exercise fat oxidation per se or fat oxidation more 
generally). We also identify that V̇O2max is related to fat oxidation at rest and during 
exercise, which aligns with our previous work showing that V̇O2max is related to fat 
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oxidation over a 24-h period (Robinson et al. 2015). Nonetheless, resting fat oxidation 
also correlated with exercise fat oxidation and exercise fat oxidation correlated with 24-h 
fat oxidation even when controlled for the influence of V̇O2max. Our finding that V̇O2max 
and fat oxidation could be dissociated implies that improvements in cardio-respiratory 
fitness (i.e., V̇O2max) per se would increase fat oxidation but is not essential for an 
increase in fat oxidation. This is consistent with recent work showing exercise training-
induced improvements in insulin sensitivity to be unrelated to changes in V̇O2max 
(Brennan et al. 2014) and could have implications, perhaps through a focus on 
improving metabolic capacity, for the design of physical activity interventions aimed at 
optimising metabolic health.   
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CHAPTER 5  
 
INFLUENCE OF PRE- AND POST-
EXERCISE FEEDING ON 
SUBSTRATE UTILISATION, 
LIPOLYTIC MARKERS AND INSULIN, 
AND INTRAMUSCULAR 
TRIGLYCERIDE UTILISATION IN 
OBESITY 
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5.1 Abstract 
In the absence of weight loss exercise does not appear to improve insulin sensitivity in 
obese populations, which is surprising given that regular exercise training has been 
shown to augment IMTG turnover and reduce the accretion of insulin-resistance 
inducing lipid metabolites. It could be that the timing of nutrition around exercise 
influences this response. We aimed to investigate the effects of a single exercise bout 
performed either before (Fasted exercise) or after breakfast (Fed exercise) on exercise 
substrate utilisation, lipolytic markers and insulin, and intramuscular triglyceride (IMTG) 
utilisation in obesity. Using a randomized, crossover design, six overweight or obese but 
otherwise healthy men performed 1-h of constant load bicycle exercise (65% V̇O2max) 
followed by 3-h of controlled recovery. On one occasion, exercise was performed after 
an overnight fast (Fasted) and breakfast was provided 30 minutes following exercise, 
and on the other they received a standardised breakfast 90 minutes before exercise 
(Fed). Indirect calorimetry was used during exercise to measure whole body substrate 
utilisation, and venous blood was collected routinely before, during and after exercise to 
assess the plasma hormone and metabolite response (n=6). Fibre type-specific relative 
IMTG content was determined by immunofluorescence staining in needle biopsies from 
the vastus lateralis before, immediately after and 3-h after exercise (n=2). During 
exercise, fat oxidation was significantly higher in Fasted vs. Fed (Fasted, 0.64±0.13 
g/min; Fed, 0.41±0.09 g/min, P<0.01). The concentration of circulating plasma glycerol 
(25-30 min: Fasted 67±30 μmol/l, Fed 28±9 μmol/l, P=0.01; 55-60 minute: Fasted 
122±61 μmol/l, Fed 45±20 μmol/l; P=0.02) and NEFA (25-30 min: Fasted 0.39±0.35 
mmol/l, Fed 0.12±0.08 mmol/l; P=0.047; 55-60 minute: Fasted 0.61±0.56 mmol/l, Fed 
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0.15±0.10 mmol/l; P=0.04) were significantly higher during exercise in the Fasted- vs. 
Fed-state. The influence of exercise, and the timing of nutrition around exercise, in 
modulating IMTG degradation could not be firmly established based upon the low 
sample size and divergent responses reported. This study shows that an acute bout of 
aerobic exercise performed in the Fasted- as compared with Fed-state augments 
exercise fat oxidation, as well as the circulating concentration of plasma glycerol and 
NEFA during exercise in obesity. Further work is required to establish the efficacy of 
exercise, and the timing of nutrition around exercise, on IMTG utilisation in obesity. 
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5.2 Introduction 
The increasing prevalence of obesity is undoubtedly a major public health concern, 
largely because obesity is closely associated with a cluster of clinical symptoms of which 
includes insulin resistance; a precursor to cardiovascular disease and type II diabetes 
(Haffner & Miettinen, 1997). Weight loss via caloric restriction and increasing levels of 
physical activity are two primary strategies used in the treatment of obesity. Weight loss 
can improve insulin sensitivity in obesity (Golay et al. 1985; Webber et al. 1994), but 
maintaining weight loss often proves to be difficult, with most individuals re-gaining body 
mass within 3-5 years (Weiss et al. 2007). Regular physical activity can aid weight 
maintenance following weight loss (Wing & Hill, 2001) and it can also enhance aerobic 
capacity, which is a key determinant of exercise and daily fat oxidation (Chapter 3, 
Robinson et al. 2015; Chapter 4, Robinson et al. 2016).  
 
Chapter 3 of this thesis, coupled with the work of others, demonstrates that enhancing 
exercise and/or 24-h fat oxidation could be beneficial for improving insulin sensitivity 
(Robinson et al. 2015) and optimising metabolic health (Zurlo et al. 1990; Ellis et al. 
2010; Rosenkilde et al.2010; Isacco et al 2014; Robinson et al. 2015) and thus it seems 
logical to expect that regular physical activity should be a mainstay strategy for those 
seeking to optimise metabolic health. 
 
Indeed, the skeletal muscle of highly trained individuals typically exhibits high peripheral 
insulin sensitivity. This is because regular exercise training ensures high oxidative 
capacity and constant stimulation of intramuscular triglyceride (IMTG) turnover, which 
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lessens the accumulation of insulin resistance-inducing lipid metabolites in skeletal 
muscle such as ceramides, diacylglycerols and fatty acyl CoA (Shaw, 2010). The 
positive relationships between (i) exercise training status and (ii) exercise fat oxidation, 
with insulin sensitivity, affords the suggestion that obese sedentary individuals who are 
insulin resistant might benefit from performing regular physical activity in an attempt to 
stimulate IMTG turnover and reduce the deleterious effects of excess lipid on 
intracellular insulin signalling pathways. Yet surprisingly, carefully controlled longitudinal 
exercise training studies demonstrate that exercise training in the absence of weight 
loss has no or at best modest impact on peripheral insulin resistance in obesity (Ross et 
al. 2000; Ross et al. 2004). 
 
Interestingly, previous work conducted in lean, healthy individuals suggests the timing of 
recent nutrition around exercise could be important in mediating IMTG utilisation during 
exercise. For instance, De Bock and colleagues (De Bock et al. 2005) demonstrated that 
2-h of constant load cycling (75% V̇O2max) performed in the overnight fasted state 
induced a significantly higher fat oxidation rate during exercise, which was paralleled 
with a substantial reduction in type I fibre IMTG content pre- to post-exercise (18±2% to 
6±2%, respectively; P=0.007). In contrast, IMTG breakdown was completely prevented 
when exercise was performed in the fed state i.e., following breakfast (P>0.05).  
 
There is also evidence to suggest that overnight fasted exercise could help optimise 
metabolic adaptation to training in lean individuals, which could induce long-term 
benefits for improved insulin sensitivity. For instance, Civitarese and colleagues 
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(Civitarese et al. 2005) demonstrated in healthy, lean men that an acute bout of fasted 
aerobic exercise was significantly more potent than fed exercise at augmenting mRNA 
expression in muscle of genes that are pivotal players in FA transport and oxidation 
such as CD36, CPT 1, uncoupling protein 3, and 5’-AMP-activated protein kinase-a. 
Encouragingly, studies performed in lean individuals comparing the effects of chronic 
exercise training performed in the fasted- vs. fed-state demonstrate a similar pattern of 
response (Van Proeyen et al. 2010; Van Proeyen et al. 2011). 
 
The influence of fasted vs. fed exercise on IMTG utilisation and muscle oxidative 
adaptation has not yet been studied in obesity, however there is indirect evidence from a 
stable isotope tracer study which suggests that IMTG can be used as a substrate source 
during fasted exercise in this population (Goodpaster et al. 2002). In this study, relative 
to their lean counterparts, obese individuals exhibited a greater reliance on fat oxidation 
towards energy expenditure during 60-minutes of aerobic exercise performed in the 
overnight fasted (post-absorptive) state (i.e., before breakfast), with the contribution of 
non-plasma fatty acid oxidation (likely from IMTG) being ~50% higher. Considered 
collectively, it could be speculated that the timing of recent nutrition around exercise is a 
critical factor in explaining the failure of aerobic exercise training to induce favourable 
effects on peripheral insulin sensitivity in longitudinal studies on obese populations.  
 
The emerging question is whether chronic exercise performed in the fasted state is 
superior to exercise performed in the fed state at promoting oxidative adaptation and 
IMTG turnover, reducing the accretion of lipid metabolites in muscle and, therefore, 
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improving insulin sensitivity in obesity. This could have important implications regarding 
nutritional strategies to improve insulin sensitivity through aerobic exercise training in 
these populations. Accordingly, it is first necessary to demonstrate improvements in the 
metabolic responses to an acute exercise bout, which ultimately is likely to underpin 
long-term metabolic health benefits. 
 
The current study aimed to explore the influence of fasted- versus fed-state exercise on 
(1) exercise substrate utilisation, (2) the plasma hormone and metabolite response 
during and around exercise and (3) IMTG utilisation in obesity. It was hypothesised that 
a single bout of aerobic exercise performed in the fasted- versus fed-state would (1) 
induce a greater reliance on fat and lesser reliance on carbohydrate towards exercise 
energy expenditure, (2) enhance the availability of circulating lipolytic makers (namely, 
plasma glycerol and NEFA) and reduce the availability of insulin during exercise 
(metabolites and hormones previously identified as important correlates of exercise fat 
oxidation; Chapter 4, Robinson et al. 2016), and (3) enhance IMTG degradation. 
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5.3 Methods 
 
5.3.1 Participants  
A total of six sedentary, overweight men (white European, BMI 25-29.9 kg/m2 or Asian, 
BMI 23-27.4 kg/m2) with a high waist circumference (white European ≥ 94 cm [37 
inches], Asian > 90 cm [35 inches])  or Class I obese men (white European men, BMI 
30-34.9 kg/m2 or Asian BMI 27.5-35 kg/m2) (n=6; 5 white European men, 1 Asian man) 
were recruited for the study based on body composition criteria that placed them at risk 
for cardiovascular disease and type II diabetes (NICE, 2014). Their characteristics are 
shown in Table 5.1. They gave written informed consent to participate in the study, 
which was approved by the National Research Ethics Committee West Midlands The 
Black Country (Ref: 15/WM/0128).  
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Table 5.1 Participant Characteristics 
 Men, n=6 
Age (y) 32±12 
Height (m) 1.80±0.04 
Weight (kg) 103±12 
BMI (kg/m2) 32±4 
Waist/hip circumference (cm) 113±11/ 113±7 
Blood pressure 
(systolic/diastolic; mm Hg) 
130±6/79±6 
Body fat (%) 33±6 
V̇O2max (ml/kg/min) 29±4 
Resting metabolic rate (kcal/d) 1744±322 
Estimated energy expenditure 
(kcal/d) 
2670±492 
	
	
5.3.2 General design 
This study involved four laboratory visits. On the first (Screening), participants had their 
Body Mass Index (BMI) determined and waist and hip circumference measured, 
following which they had their resting blood pressure checked and a 12-lead 
electrocardiogram (ECG) was conducted.  
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The second visit (Pre-Study Evaluation) was used to determine the participant’s body 
composition (via Dual-Energy X-Ray Absorptiometry [DXA]), resting metabolic rate 
(using a ventilated hood), maximal aerobic capacity (V̇O2max; using a short incremental 
cycling exercise test performed to exhaustion) and to confirm work intensity for the main 
experimental trials.  
 
The third and fourth visits (Main Experimental Trials) were separated by a minimum of 
seven days and conducted in a randomized order. These trials were preceded by a 2-
day standardized weight-maintaining diet based on individual energy requirements. On 
one occasion a standardized breakfast was consumed, followed one hour later by the 
collection of a skeletal muscle biopsy sample and then a further 30 minutes by the 
performance of a 60-minute steady-state moderate intensity cycling exercise bout. 
Immediately, and at 3-h after exercise further skeletal muscle biopsy samples were 
collected. Expired breath collected using indirect calorimetry was recorded at intervals 
during exercise testing to quantify whole body fat oxidation during each trial. On the 
other occasion, participants underwent the same procedures but the standardized 
breakfast was consumed 30 minutes following cessation of exercise.  
 
5.3.3 Experimental procedures 
(i) Visit 1 - Screening: The purpose of this visit was to obtain consent and screen 
participants. The participants arrived at the laboratory in the morning (08:00 h). On 
arrival, measures of height (Stadiometer, Seca, UK) and body weight (OHaus Champ II 
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Scales, USA) were taken to determine Body Mass Index (BMI; weight [kg]/height2 [m]). 
Waist and hip circumference to the nearest mm and resting blood pressure (Omron M6, 
The Netherlands) were also determined (those with a resting blood pressure ≥140/90 
mmHg  were not included in the study). If participants successfully completed the 
Screening Form and met the eligibility requirements with respect to BMI/waist 
circumference/blood pressure they were asked to undertake a 12-lead 
electrocardiogram (ECG) examination in order to detect any potential cardiac issues 
(Oxycon Pro, Jaeger, Wuerzberg, Germany).  
 
(ii) Visit 2 - Pre-study evaluation4 : Participants reported to the laboratory between 
07:00-17:00 h at least one week before the Main Experimental Trials. Participants were 
weighed in light clothing following which body composition was determined using DXA 
(QDR software, Hologic Inc., Bedford, MA). Thereafter, participants rested for 30 
minutes in the supine position in a dimly lit, thermo-neutral, quiet room with a ventilated 
hood system (GEM; GEM Nutrition, Cheshire, UK) and indirect calorimetry used to 
assess resting energy expenditure (see below). Participants were instructed to refrain 
from any movement during this period. Approximately 15 minutes later an incremental 
exercise test on an electronically braked cycle ergometer (Lode Sport Excalibur, 
Groningen, The Netherlands) was performed to determine the participants level of 
aerobic fitness (V̇O2max). For this, participants started cycling at 35 W and the work rate 
was increased 35 W every 3 min until volitional exhaustion. Heart rate was measured 																																																								4	It is acknowledged as a limitation of the present study that activity and food intake was not controlled on the day preceding the 
measurement of resting energy expenditure.	
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continuously during exercise using a heart rate monitor (Polar FT-2, Finland) and 
recorded during the final 30 seconds of each exercise stage. Breath-by-breath 
measurements of oxygen consumption (V̇O2) and carbon dioxide production (V̇CO2) 
were collected during exercise using an online automated gas analysis system (Oxycon 
Pro, Jaeger, Wuerzberg, Germany). The gas analysers were calibrated with a 5.07 % 
CO2, 14.79 % O2, 80.14 % N2 gas mixture (BOC Gases, Surrey, UK), and the volume 
transducer was calibrated with a 3-liter calibration syringe (Jaeger, Wuerzberg, 
Germany). Environmental conditions during testing were: humidity 56±4 %; temperature 
21±2 °C. After an ~30 minute rest period participants undertook a familiarisation 
exercise bout that had them perform a ‘practice’ cycling exercise bout (30 minutes at a 
sub-maximal steady-state intensity [65% V̇O2max]) to accustom them with the exercise 
procedures to be employed during Visits 3 and 4.  
 
(iii) Visits 3 and 4 - Main experimental trials (Figure 5.1): These visits were separated by 
at least 7 days and each was preceded for two days by a standardized weight 
maintaining diet (50% carbohydrate, 35% fat, 15% protein) based on estimated 
individual energy requirements (see below). Participants arrived in the morning (~08:15 
h) following an overnight abstinence from food and drink (from 10pm, except water) and 
having performed no strenuous physical activity and abstained from alcohol and caffeine 
consumption for the 2 days before. On the morning of these visits participants were 
asked to consume ~1 pint of tap water upon waking to ensure they were adequately 
hydrated on arrival at the laboratory. Participants had a cannula placed in a forearm vein 
to allow for a baseline and then repeated blood sampling during the experimental 
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session. On one occasion (15 minutes after arrival) a standardised breakfast was 
consumed within 15 minutes (25% daily energy intake; 65%, 20%, 15% energy from 
carbohydrate, fat and protein, respectively), followed one hour later by the collection of a 
skeletal muscle percutaneous needle muscle biopsy sample (B1) (biopsy procedure and 
analysis described below). Participants then performed a 60-minute steady-state 
moderate intensity (65% V̇O2max) cycling exercise bout, as this has previously been 
shown to induce IMTG degradation in lean individuals (Watt et al. 2002; Shepherd et al. 
2012). Immediately (B2), and at 3-h after exercise (B3) further skeletal muscle biopsy 
samples were collected. On the other occasion, participants underwent the same 
procedures but the standardised breakfast was consumed 30 minutes following 
cessation of exercise. Expired breath collected using indirect calorimetry was recorded 
twice during exercise to determine rates of oxygen consumption (V̇O2) and carbon 
dioxide production (V̇CO2) to quantify whole body fat oxidation. Heart rate was 
monitored continuously during exercise and recorded every 10 minutes (Polar FT-2, 
Finland), alongside self-rated perceived exertion using the standard Borg scale (Borg, 
1970). Environmental conditions were documented during the conduct of exercise 
testing. They were kept stable and did not differ between the two trials with humidity at 
51±3 % and 52±4 %; temperature 22±0 °C and 22±1 °C for fasted and fed conditions, 
respectively.  
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Figure 5.1 A schematic representation of the Main Experimental Trials. EB = collection 
of expired breath. * = blood collection. 
 
5.3.4 Blood sampling and analysis 
Venous blood was sampled from an antecubital vein and collected into either EDTA- or 
serum containing Vacutainers (BD, New Jersey, USA) and immediately centrifuged at 
3,500 revolutions per minute for 15 minutes at 4°C. Aliquots containing plasma were 
stored at -80°C until analysed. Sample analysis was performed using enzymatic 
colorimetric assays for glucose (Glucose Oxidase, Instrumentation Laboratories, 
Cheshire, UK), glycerol (GLY, Randox, London, UK), NEFA (NEFA, Randox, London, 
UK) and triglyceride (TG kit, Instrumentation Laboratory, Warrington, UK) using an ILAB 
650 Clinical Chemistry Analyser (Instrumentation Laboratory, Warrington, UK). Plasma 
insulin was analysed using a human insulin Enzyme Linked-Immuno-Sorbent Assay 
(ELISA) kit (Invitrogen, Paisley, UK) and a Biotek ELx800 analyser (Biotek Instruments, 
Vermont, USA). 
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5.3.5 Muscle  
(i) Muscle sampling: In this study all six participants received six muscle biopsies (three 
during Visit 3 and three during Visit 4). For each, participants rested in the supine 
position and a muscle biopsy was obtained from the vastus lateralis using the 
percutaneous needle biopsy technique (Bergstrom, 1975), adapted to include suction. 
Prior to this, antiseptic (Videne, Ecolab, UK) was applied to the skin ~20 cm proximal to 
the patella, following which skin and muscle fascia was anaesthetized using 1% 
Lidocaine (Braun, Melsungen, Germany). When the area was numb to the touch a 4-6 
mm incision was made through the skin and muscle fascia using a surgical scalpel 
(Swann-Morton, Sheffield, UK). A 6G biopsy needle was then inserted ~2-6 cm into the 
incision and a piece of muscle guillotined. A sample of ~100 mg was collected and freed 
from any visible non-muscle material, following which a portion was mounted in 
embedding Tissue Tek OCT (Sigma Aldrich, Dorset, UK) and frozen in liquid nitrogen-
cooled isopentane (Sigma Aldrich, Dorset, UK) and transferred to an aluminium cryotube 
(Caltag Medsystems, PA6003) for later immunofluorescence microscopy analysis. All 
samples were stored at -70oC for later analysis. 
 
Unfortunately, due to freezer failure, muscle samples from 4 of the 6 participants were of 
insufficient quality to undergo immunofluorescence analysis. Muscle from these 
participants appeared to have thawed and re-frozen during its period of storage in the -
70 freezer. Upon opening the aluminium tube, the muscle and Tissue Tek mounting 
medium was moulded to the shape of the tube (Figure 5.2). Accordingly, it was not 
possible to detect any myosin heavy chain type I (MHCI; used to determine fibre type) or 
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dystrophin signal (a plasma membrane marker) once these muscles were stained 
appropriately (Figure 5.3; staining protocol described below). It is suspected this was 
because the thaw and re-freeze damaged the muscle architecture and / or the proteins 
such that the antibodies were unable to bind appropriately. Therefore all muscle data is 
presented on two participants.  
 
 
	
 
Figure 5.2 Example images showing muscle and Tissue-Tek mounting in a sample that 
had thawed and re-frozen (of insufficient quality to undergo analysis; A) and muscle that 
had not thawed and re-frozen (of sufficient quality to undergo analysis; B). As can be 
seen, Tissue-Tek in (A) is moulded differently on top of the cork than in (B). During the 
period of removal from the freezer, the Tissue Tek in (A) thawed and subsequently 
expanded towards and over the edge of the cork, whereas in (B) the Tissue-Tek 
retained its shape that was apparent upon initial freezer storage. 
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Figure 5.3 Representative images comparing muscle samples that were unable (A) and 
able (B) to undergo immunofluorescence analysis. As can be seen, the muscle 
architecture in image A is clearly distorted with several of the fibres appearing to have 
disjoined. There is also an absence of MHC1 staining preventing the identification of 
fibre type. Yellow bars represent 50 μm. 
 
(ii) Sample preparation and staining: Cryosections (5 μm) were cut using a Bright 5040 
(Bright Instrument Company limited, Huntingdon, England) microtome within a Bright 
cryostat with internal temperature kept constant at -25 oC. Sections were cut onto 
uncoated glass microscope slides (VWR International), with each slide containing six 
samples from each participant (three from visit 3 and three from visit 4 [pre-exercise, 
immediately post-exercise and 3-h post-exercise]) to decrease the variation in staining 
intensity between triplicate sections. Sections were fixed for one hour in 3.7% 
Bodipy MHCI 
A A 
B B 
	 181 
formaldehyde (made up in dH2O) and subsequently washed 3 times for 30 seconds in 
dH2O. Following this slides were incubated for 5 minutes in 0.5% triton-X100 made up in 
1 x phosphate-buffered saline (PBS) at room temperature and then washed 3 times for 5 
minutes with wash buffer (1 x PBS). Thereafter, slides were incubated for 2 hours in 
1:25 anti-MHCI (mouse IGM, DSHB A4,840) and 1:100 anti-dystrophin (mouse IgG2b, 
Sigma Aldrich D8168) in 5% normal goat serum (NGS) at room temperature. After 
washing the slides three times for 5 minutes in 1 x PBS, slides were incubated for 30 
minutes in 1:150 goat anti-mouse (GAM) IgM conjugated to AlexFluor 633 (for MHCI) 
and 1:200 GAM IgG2b 594 (for dystrophin) in 1 x PBS at room temperature. Incubation 
was followed by three 5 minutes washes (1 x PBS), after which the slides were 
incubated again, this time in 1:50 bodipy solution in 1 x PBS at room temperature in the 
dark. A final wash of the slides was then performed twice for 3 minutes in 1 x PBS. 
Glass coverslips were mounted with 20 μl mowiol mounting medium (6 g glycerol 
(Sigma Aldrich, G5150), 2.4 g mowiol 4-88 (Fluka, 81381) and 0.026 g 1,4-diazobicyclo-
[2,2,2]-octane (DABCO) (Fluka, 33490) dissolved in 18 ml 0.2M Tris-buffer (pH 8.5) 
(Sigma Aldrich, T5030) to protect the sample and preserve the fluorescence signal. 
Slides were left to dry overnight before immunofluorescence visualisation.  
 
(iii) Microscopy: All images were taken using a confocal microscope (Leica DMIRE2, 
Leica Microsystems) with 40x oil immersion objective (1.25 Numerical Aperture). Bodipy 
was excited with a 488 nm line of the argon laser and 510-652 nm emission. To detect 
dystrophin signal, Alexa Fluor 594 fluorophores were excited with the 594 nm line of the 
helium-neon laser and 668-698 nm emission. To detect MHCI signal, Alexa Fluor 633 
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fluorophores were excited with the 633 nm line of the helium-neon laser and 698-808 
nm emission.  
 
(iv) Image quantitation: For both subjects, 3 slide replicates, each with a pre-exercise 
(B1), immediately post-exercise (B2) and 3-h post-exercise section for both trials 
underwent staining, imaging and quantification.  
 
For the fasted trial, the average number of type I fibres [type II fibres] analysed across 
the two participants was 15 [20] (pre-exercise), 24 [27] (immediately post-exercise) and 
19 [44] (3-h post-exercise). For the fed trial, the average number of type I fibres [type II 
fibres] analysed across the two participants was 32 [43] (pre-exercise), 17 [21] 
(immediately post-exercise) and 25 [30] (3-h post-exercise). 
 
Bodipy spot stained area per fibre (for assessment of IMTG) was quantified by setting 
uniform threshold intensity and size values to detect spots within intracellular regions of 
the dystrophin mask in a fibre type specific manner. A HiGauss filter was applied to 
bodipy images prior to bodipy signal detection. Fibre area was exported from the 
software based on the intracellular regions determined with the dystrophin mask. 
Percent area of bodipy staining of the total fibre area was calculated ([bodipy stained 
area [um2] / area of muscle [um2]*100).  
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5.3.6 Calculations  
Insulin sensitivity was calculated using the Quantitative Insulin Sensitivity Check Index 
(QUICKI; Katz et al. 2000). For each of the six participants, baseline plasma glucose 
and insulin concentrations were averaged over the two trials, following which this 
average was inputted into the equation (as described in Chapter 2, Section 2.5). Upon 
reflection, this researcher accepts that a more accurate indice of insulin sensitivity would 
have been derived from an Oral Glucose Tolerance Test, which should have been 
performed during the Screening Visit.  
 
Resting metabolic rate (RMR) was calculated during a stable measurement period (i.e., 
a deviation in V̇O2 of <10% of the average V̇O2 between minutes 20-30; mean±SD 
recording period was 6±4 minutes) and using the equation of Weir (1949). Daily energy 
expenditure (DEE) was then estimated by multiplying RMR by a population specific 
activity factor (1.53; WHO, 2001).  
 
RMR = 3.9*V̇O2 + 1.1*V̇CO2 
DEE = RMR*1.53 
 
During the incremental exercise test V̇O2 was considered as maximal when two of the 
following three criteria were met; an RER >1.1, heart rate within 10 beats of predicted 
maximum (calculated as 220-age; Fox, Naughton & Haskell, 1971), or an increase of < 
2ml/kg/min in V̇O2 with a further increase in workload. V̇O2max was calculated as the 
highest rolling 60 second average V̇O2. 
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For the Main Experimental Trials, carbohydrate and fat oxidation were quantified 
according to the equations of Frayn (1983), with the assumption that the urinary nitrogen 
excretion rate was negligible. 
 
Carbohydrate oxidation (g/min) = 4.55*V̇CO2 – 3.21* V̇O2 
Fat oxidation (g/min) = 1.67* V̇O2 – 1.67* V̇CO2 
 
5.3.7 Statistical analyses 
Data were analysed using SPSS software (version 21; Chicago, IL). All data were 
normally distributed according to the Shapiro-Wilk test of normality and are presented as 
means±SD unless explicitly stated (and ranges where appropriate). Statistical 
significance was positioned at P<0.05. Incremental areas under the curve (iAUC) for 
glucose, glycerol, insulin, NEFA and TG were calculated for each trial using the 
trapezoid method. Paired-sample t-tests were used to compare differences in heart rate, 
RPE, V̇O2 uptake, V̇O2max, CO2 production, RER, fat oxidation (g/min and % energy from 
fat oxidation [%EnFO]), carbohydrate oxidation (g/min and % energy from carbohydrate 
oxidation ([% EnCO]) and iAUC for plasma insulin and metabolites between trials. A two-
way analysis of variance (condition and time) was used to assess metabolic differences 
between conditions. Where a significant interaction effect was observed, a post-hoc 
Bonferroni pairwise comparison was performed to locate the variance. Due to low 
sample size muscle data was not analysed statistically but is instead described 
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5.4 Results 
 
5.4.1 Pulmonary gas exchange and substrate oxidation during exercise (Table 
5.2).  
There were no significant differences in heart rate or V̇O2 during exercise between 
Fasted and Fed conditions, respectively. However, V̇CO2was significantly higher and, 
accordingly, exercise RER was significantly lower during Fasted exercise as compared 
with Fed. A parallel with this, the calculated fat oxidation rate and %EnFO was 
significantly higher, whereas the carbohydrate oxidation rate and & %EnCO was 
significantly lower in Fasted relative to Fed. Subjective rating of RPE was significantly 
lower in the Fasted condition. 
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Table 5.2 Pulmonary gas exchange and substrate oxidation rates during exercise 
(values are mean±SD). 
 Fasted Exercise Fed Exercise P Value 
Heart rate, bpm 126±12 127±16 P>0.05 
RPE 12±2 
(12 = between ‘light [11]’ 
and ‘fairly hard [13]’ 
13±2 
(13 = ‘fairly hard) 
P=0.04 
V̇O2, ml/min  
(%V̇O2max) 
1990±176 (65±1) 2017±159 (65±2) P>0.05 
V̇CO2, ml/min 1786±129 1889±178 P=0.02 
RER 0.90±0.02 0.94±0.02 P=0.01 
Fat oxidation, g/min 
(%EnFO) 
0.64±0.13 (31±5) 0.41±0.09 (21±5) P<0.01 
(P<0.01) 
Carbohydrate 
oxidation, g/min 
(%EnCO) 
3.45±0.14 (69±5) 4.22±0.58 (79±5) P=0.01 
(P<0.01) 
 
 
5.4.2 Metabolic and hormonal response to feeding and exercise (Figure 5.4).  
There were no significant differences in plasma glucose, glycerol, NEFA and triglyceride 
concentrations at Baseline between Fasted and Fed conditions (P>0.05). Plasma insulin 
was significantly higher in the Fasted trial at Baseline (P=0.03), however this is unlikely 
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to be physiologically relevant as the difference in plasma insulin concentration between 
Fasted and Fed conditions was minor (27.8±9.1 µIU/mL and 22.9±11.2 µIU/mL, 
respectively; Figure 5.4 C).  
 
(i) Plasma glucose concentration (Figure 5.4 A): Glucose differed significantly between 
conditions during the post-exercise period i.e., at 230 minutes (a parallel with ingestion 
of the post-exercise meal provided in the Fasted condition) and at 290 minutes. No 
significant differences in glucose concentration were observed between conditions at 
any other time points (note: a trend towards a significantly higher glucose availability 
was observed at 75 min in Fed [P=0.055]). In the Fasted condition, glucose 
concentration was stable before and during exercise but increased markedly following 
ingestion of the post-exercise meal. Glucose returned close to its baseline value at 350 
min. In the Fed condition, glucose concentration increased following ingestion of the pre-
exercise meal but returned towards baseline values immediately before exercise where 
it remained stable until the end of the assessment period. iAUC for glucose was 
significantly higher in Fasted vs. Fed (2490±481 mmol/L x min and 2201±436 mmol/L x 
min, respectively; P=0.03).  
 
(ii) Plasma glycerol concentration (Figure 5.4 B): Glycerol was significantly higher prior 
to and during exercise in Fasted, whilst it was higher at all time points during the post-
exercise period in Fed. In both conditions, glycerol concentration decreased marginally 
between the baseline and pre-exercise measurement, but increased during exercise, 
with this increase being greater in Fasted than Fed. In the Fasted condition, the post-
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exercise meal reduced glycerol concentration. In contrast, glycerol concentration in the 
Fed condition significantly decreased during the first 65 minutes post-exercise, but 
increased thereafter. Glycerol iAUC did not significantly differ between conditions 
(Fasted 15,036±4,682 μmol/l x min; Fed 12,359±4,018 μmol/l x min).  
 
(iii) Plasma insulin concentration (Figure 5.4 C): Insulin was significantly higher at 
baseline and during the post-exercise period in Fasted as compared with Fed, however 
no significant differences were observed between conditions at any other time point. In 
Fasted, insulin remained stable throughout the pre-exercise and exercise period, but 
showed a marked increase following the post-exercise meal. Insulin remained high 
throughout the post-exercise period. In Fed, the pre-exercise meal increased insulin 
concentration, which thereafter declined over the remaining course of stay, except 
during the first thirty minutes of exercise when it increased from immediately pre-
exercise. There was a trend for iAUC to be higher in the Fasted as compared with Fed 
condition (29,511±27,939 µIU/mL x min and 20,681±19,931 µIU/mL x min, respectively; 
P=0.051).   
 
(iv) Plasma NEFA concentration (Figure 5.4 D): NEFA availability was significantly 
higher in Fasted than Fed immediately before and during the exercise bout, however no 
significant differences were observed at any other time point between conditions (note: a 
trend towards significantly higher NEFA availability in Fed was observed at 350 min 
[P=0.053]). In the Fasted condition, NEFA concentration remained stable prior to-
exercise, however 30 minutes into exercise it was lower than pre-exercise levels, but 
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increased above pre-exercise levels at the end of exercise. The post-exercise meal 
induced a significant decline in NEFA concentration throughout the post-exercise period. 
In the Fed condition, the pre-exercise meal caused a significant reduction in NEFA 
availability throughout exercise; during which it remained stable. Only after exercise did 
NEFA concentration show a significant rise back towards, and then above, its baseline 
value. A trend towards a significantly higher NEFA iAUC was observed in Fasted vs. 
Fed (151±95 and 112±51, respectively; P=0.063).  
 
(v) Plasma triglyceride concentration (Figure 5.4 E): Triglyceride concentration did not 
differ significantly at any time point between conditions. iAUC for triglyceride showed a 
trend towards being higher in Fasted vs. Fed (689±460 mmol/L x min and 682±303 
mmol/L x min, respectively; P=0.050).  
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Figure 5.4 Circulating plasma glucose (A), glycerol (B), insulin (C), NEFA (D), and 
triglyceride (E) concentration over the 350-minute stay. Double headed arrows represent 
the exercise period. * Significant difference between Fasted and Fed trials (P<0.05). † 
Significant difference at Baseline between conditions (P<0.05).Values are Mean±SEM. 
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5.4.3 QUICKI 
Insulin sensitivity estimated using the QUICKI was 0.29±0.02 (range 0.27-0.32). Of note, 
this score, obtained in an overweight / obese population of men, is lower than that found 
in Chapter 3 (0.34±0.02; range 0.31-0.40), which employed a cohort of healthy, lean 
men and similar to that previously reported in diabetic subjects (0.30±0.01; Katz et al. 
2010). This implies that this study employed a population with potentially compromised 
insulin sensitivity.  
 
5.4.4 IMTG lipid content 
As mentioned previously, muscle data is provided for two participants. Accordingly, it is 
acknowledged that the sample size is insufficient to make strong conclusions. 
Descriptions are provided for both participants separately in light of the divergent 
responses reported between individuals. 
 
(i) Participant 1 (Figure 5.5): Pre-exercise IMTG content was higher in type I fibres 
compared with type II fibres in both Fasted and Fed conditions (type I Fasted 13%, type 
I Fed 5%; type I Fed 5%, type 2 Fed 2%).  
 
Cycling at 65% V̇O2max for 60 minutes induced a reduction in IMTG content in type I 
fibres between B1 and B2 in Fasted (-56%), however there was an increase in Fed 
(+42%). In both conditions there was a reduction in IMTG content between B2 and B3, 
however this reduction was greater in Fasted (-68%) than Fed (-22%). Overall, i.e., 
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between B1 and B3, there was a reduction in IMTG content in both conditions, with this 
being greater in Fasted (-86%) as compared with Fed (-18%).  
 
In type II fibres, there was a reduction in IMTG content between B1 and B2 in Fasted (-
36%), but an increase in Fed (+29%). In both conditions, IMTG content decreased 
between B2 and B3, as well as between B1 and B3, however the magnitude of this 
decrease was greater in Fasted than in Fed (B2 and B3: Fasted -79%, Fed 35%; B1 and 
B3: Fasted 86%, Fed 15%).  
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Figure 5.5 Comparison of exercise in the Fasted- vs. Fed-state on IMTG lipid content. 
Data are presented as means±SEM (n=1; participant 1). 
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Participant 2 (Figure 5.6): Pre-exercise IMTG content was higher in type I fibres 
compared to type II fibres in both Fasted and fed conditions (type I Fasted 10%, type II 
Fasted 3%; type I Fed 9%, type 2 Fed 2%). 
 
In both conditions, cycling at 65% V̇O2max for 60 minutes induced a reduction in IMTG 
content in type I fibres between B1 and B2, however this reduction was greater in fed (-
51%) than in fasted (-32%). In both conditions there was an increase in IMTG content 
between B2 and B3, however this increase was greater in fasted (+75%) than fed 
(+16%). Overall i.e., between B1 and B3, there was an increase in IMTG content in 
fasted (+19%) and a reduction in fed (-43%).  
 
In type II fibres, there was a greater reduction in IMTG content between B1 and B2 in 
fed (-41%) than in fasted (-9%). In both conditions, between B2 and B3 there was an 
increase in IMTG content, with this rise being slightly greater in fasted relative to fed 
(+25% and +21%, respectively). IMTG content increased between B1 and B3 in fasted 
(+25%) but was reduced in fed (-29%).  
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Figure 5.6 Comparison of exercise in the Fasted- vs. Fed-state on IMTG lipid content. 
Data are presented as means±SEM (n=1; participant 2). 
 
 
 
0.00
2.00
4.00
6.00
8.00
10.00
12.00
14.00
16.00
B1 B2 B3
IM
TG
 li
pi
d 
co
nt
en
t
(%
 a
re
a 
lip
id
 s
ta
in
in
g)
Fasted 
Type I Type II
0.00
2.00
4.00
6.00
8.00
10.00
12.00
14.00
16.00
18.00
B1 B2 B3
LD
 a
re
a/
fib
re
 a
re
a 
(%
)
Fed 
Type I Type II
	 197 
5.5 Discussion 
The aim of the current study was to investigate the influence of Fasted- versus Fed-state 
exercise on (1) exercise substrate utilisation, (2) the plasma hormone and metabolite 
response during and around exercise and (3) IMTG utilisation, in an obese group of men 
identified as at risk for cardiovascular disease and type II diabetes on the basis of select 
anthropometrical measurements (NICE, 2014). 
 
5.5.1 Whole body substrate utilisation during exercise 
By using indirect calorimetry we were able to quantify the influence of feeding on whole 
body substrate utilisation during exercise. From this, we found that exercise fat oxidation 
was ~35% higher and subsequently carbohydrate oxidation was ~17% lower during 
exercise performed in the Fasted- as compared with Fed-state. This finding is consistent 
with previous reports using healthy (de Bock et al. 2005) and obese (Derave et al. 2007) 
men and accordingly it is acknowledged that this is not an entirely novel finding. 
Nevertheless, this data further demonstrates the potency of fasted as compared with fed 
exercise in augmenting exercise fat oxidation, which is an effect that could have 
important implications. For instance, it is becoming progressively apparent that 
increasing exercise fat oxidation could help to optimise metabolic health. For example, in 
Chapter 3 of this thesis it was demonstrated, using healthy lean men, that the Maximal 
rate of Fat Oxidation during exercise is significantly and positively associated with insulin 
sensitivity (Robinson et al. 2015). What is more, work in overweight men shows that a 
lower MFO is associated with a higher clustering of metabolic syndrome risk factors, 
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when compared with those who exhibit a higher MFO, whereas Isacco and colleagues 
(Isacco et al. 2014) have shown that a lower MFO is associated with a more 
unfavourable body fat mass distribution in post-menopausal women.  
 
Chapter 3 of this thesis also revealed a significant and positive relationship between 
MFO and 24-h fat oxidation (Robinson et al. 2015), with the latter being previously linked 
with body mass gain (Zurlo et al. 1990) and body mass re-gain after diet-induced weight 
loss (Ellis et al. 2010). Interestingly, recent work conducted in young, non-obese men 
has shown under energy-balanced conditions increased 24-hour fat oxidation following 1 
hour of aerobic exercise performed in the overnight fasted state, with this response 
being completely blunted when exercise was performed postprandial (Iwayama et al. 
2015). Considered collectively, these findings (Iwayama et al. 2015; Robinson et al. 
2015) suggest that the increased fat oxidation observed during Fasted vs. Fed exercise 
in this study may extend to 24-h, and that Fasted- as compared with Fed-exercise could 
be a more viable strategy to improve metabolic health in an at risk population. 
Nevertheless, it is accepted as a limitation of the present study that, due to reasons of 
equipment availability, substrate utilisation was not assessed around the exercise 
period. Thus we must concede that the influence of Fasted versus Fed exercise on post-
exercise substrate utilisation could not be established. This is important information to 
know, given that the influence of exercise on substrate metabolism is not confined to the 
period of physical activity itself, and the impact of exercise on lipid metabolism can 
persist hours into recovery (Kuo et al. 2005; Henderson et al. 2007). The insights gained 
by Iwayama and colleagues (Iwayama et al. 2015) suggest that Fasted exercise could 
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be superior to Fed exercise at augmenting daily fat utilisation (independent of energy 
balance), at least in young, non-obese men. The next logical step would be to establish 
whether this effect persists in obesity and, if so, to then perform carefully controlled 
longitudinal studies investigating the influence of regular aerobic exercise training 
performed in either the fasted- or fed-state on exercise and daily fat oxidation, whilst 
also considering potential subsequent effects on metabolic health.  
 
5.5.2 Plasma hormone and metabolite response to exercise and feeding 
The greater contribution of fat towards exercise energy expenditure observed in the 
Fasted condition was paralleled with a greater circulating concentration of plasma 
glycerol and NEFA during exercise, compared with Fed. This corroborates with our 
recent report showing that the plasma lipolytic and insulin response to exercise is a key 
regulator of exercise fat oxidation in lean, healthy men (Chapter 4; Robinson et al. 
2016). Our finding also aligns with De Bock and colleagues (De Bock et al. 2005) who 
reported markedly higher NEFA and glycerol concentrations throughout fasted exercise 
compared with fed. Interestingly, no significant differences were observed in plasma 
insulin concentration during exercise between conditions, which is surprising given the 
anti-lipolytic nature of insulin (and previous observed negative associations between 
maximal fat oxidation during exercise and circulating insulin concentration; Chapter 3, 
Robinson et al. 2016). However, it is notable that insulin was higher at all time points 
during the exercise bout in Fed and it is likely that greater statistical power would have 
yielded significant differences between conditions.   
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As well as during exercise, we explored the plasma hormone and metabolite response 
before and after exercise. From this we observed a higher glucose iAUC for the overall 
intervention (time 0-350 min) when exercise was performed fasted. Although we did not 
assess the glycaemic response to breakfast across conditions, we did observe a greater 
rise in glucose following ingestion of breakfast in Fasted vs. Fed. Indeed, others have 
demonstrated a greater glycaemic response to a standardised breakfast when exercise 
was performed in the Fasted as compared with Fed state (Derave et al. 2007) and type 
II diabetes (Larsen et al. 1997; Poirer et al. 2001). Derave and colleagues speculated 
that the blunted response in Fed may be attributed to an exercise-induced transient 
suppression of the meal-induced elevation in glucose, which is subsequently used as a 
substrate to fuel muscle contraction. Interestingly, the present study shows this may not 
be the entire case, as although glucose decreased during exercise in Fed, it declined to 
a much greater extent during the period between the meal and the onset of exercise 
(minutes 75 to 110). This could be due to a synergistic effect of muscle contraction 
coupled with a concomitant elevation in insulin reduced hepatic glucose production 
following the ingestion of breakfast before exercise. The marked increase in glucose 
concentration following breakfast in the Fasted trial is likely explained by adaptations in 
splanchnic tissues following exercise (Rose et al. 2001). Specifically, prior exercise has 
been shown to reduce hepatic glucose uptake and increase intestinal glucose 
absorption and we believe it is these alterations that are likely the primary contributing 
factors towards the overall higher iAUC for glucose observed in Fasted.  
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Finally, it should be noted that the measurement period following exercise was likely too 
short to entirely capture the various plasma hormone and metabolite responses to 
exercise. This is particularly pertinent to plasma triglyceride concentrations, which have 
been shown to take several hours to rise and recover (Davitt et al. 2013). As such, we 
acknowledge this as a limitation of the present study and would ask future research to 
be cognisant of this when designing similar research herein.  
 
5.5.3 Influence of exercise and the timing of feeding on IMTG utilisation  
One hypothesis for this study was to investigate the influence of an acute bout of 
exercise performed in either the Fasted or Fed state on IMTG utilisation in obesity. 
Unfortunately due to reasons previously documented, muscle from only two individuals 
was of sufficient quality to undergo analysis. Accordingly, we acknowledge that the 
strength of the interpretations made is greatly limited by the low sample size, and we ask 
readers to be cognisant of this herein.  
 
Consistent with previous reports, and supporting the accuracy of the assay used in this 
study, the data demonstrates that IMTG content is up to 4-fold higher in type I compared 
with type II fibres (Steffensen et al. 2002; De Bock et al. 2005). Although limited by a low 
sample size, the data presented suggests that both type I and type II fibre IMTG can be 
utilised during acute exercise in obesity. With regards to type I fibre degradation, our 
finding aligns with previous reports showing a reduction in type I fibre IMTG content 
during acute fasted exercise in trained lean individuals (van Loon et al. 2003; de Bock et 
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al. 2005) and untrained lean individuals (Shepherd et al. 2012). It also lends support to 
the work of Goodpaster and colleagues (Goodpaster et al. 2002) who provided indirect 
evidence which suggested that IMTG could contribute to exercise fat oxidation in 
obesity, at least when exercise is performed in the overnight fasted state. We extend this 
suggestion by demonstrating type I fibre IMTG degradation following fasted but also fed 
exercise. Interestingly, our finding contradicts those of Ipavec-Levasseur and colleagues 
(Ipavec-Levasseur et al. 2015) who reported no IMTG degradation in obesity following 
60 minutes of steady-state cycling exercise, and with Nellemann and colleagues who 
observed no alteration in IMTG content after 90 minutes of cycling at 50% V̇O2max using 
8 overweight but otherwise healthy, untrained men (Nelleman et al. 2014).  
 
Discrepancies observed between studies could be due to differences in study 
methodology. For example, Ipavec-Levasseur and colleagues assessed IMTG content 
using the non-invasive magnetic resonance spectroscopy (MRS) technique, which 
despite being shown to have good test-retest reliability (Larson-Meyer et al. 2006) is not 
without its limitations. Firstly, from the perspective of its technique there can be difficulty 
in arranging the muscle volume of importance to minimise the involvement of 
vasculature and subcutaneous adipose tissue, and to ensure orientation of the muscle 
fibres along the magnetic field. The presence of extramuscular lipids could cross-
contaminate the IMTG signal and confound the measurement, whereas histochemical 
determination of IMTGs (as used in this study) allows direct quantification of lipid within 
muscle fibres. Furthermore, one MRS scan takes at minimum 15 minutes, meaning that 
post-exercise measurement of IMTG may have been influenced by post-exercise IMTG 
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utilisation during the period of preparation. Biopsy samples in this study were taken 
immediately (i.e., within a few minutes) post-exercise to mitigate this potential issue. 
Lastly, Ipavec-Levasseur and colleagues chose to analyse the soleus muscle group, 
which has less involvement during cycling exercise than the quadriceps muscle (as 
analysed in this study). In the study by Nellemann and colleagues, the lack of IMTG 
degradation might be because they used a mixed muscle enzyme assay and therefore 
the presence of extra-muscular triglyceride may have cross-contaminated the IMTG 
signal and confounded the IMTG measurement (Watt et al. 2002). One strength of the 
present study is that individual muscle fibers were dissected from the muscle sample 
and then analysed, which permitted direct quantification of lipid within muscle fibres. 
Nevertheless, we would emphasise that our finding of a reduction in type I IMTG content 
following an acute bout of endurance exercise in obesity is preliminary and it would 
undoubtedly be of virtue to further investigate this response using a larger population 
sample so that a firmer conclusion can be established.  
 
The observed exercise-induced degradation of type II fibre IMTGs in obesity is 
consistent with Shepherd and colleagues (Shepherd et al. 2012) who reported a 
reduction in type II fibres (mean±SD reduction was 37±5%) following 60 minutes of 
resistance exercise in sedentary men. However, our finding contrasts with others who 
observed no significant reduction in type II fibre IMTG content during prolonged 
moderate-intensity cycling exercise using young, active men (De Bock et al. 2005) and 
endurance-trained men (van Loon et al. 2003). Of note, these three studies utilised oil 
red O (ORO) staining to image IMTG whereas the current study used bodipy, which has 
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been suggested to be the preferred dye of choice due to its narrower emission spectra 
and lack of influence on light transmission in comparison with ORO (Prats et al. 2013). 
Even so, it is clear that further work is needed to clarify the influence of exercise, as well 
as the timing of nutrition around exercise, on type II fibre IMTG degradation in obesity 
and it is to be reiterated that the low sample size with respect to muscle analysis in this 
study greatly limits the strength of our interpretations.  
 
Indeed, the low sample size and divergent responses reported with respect to muscle 
analysis meant that the influence of the timing of nutrition around exercise on IMTG 
utilisation could not be clearly established. Nevertheless, insights from indirect 
calorimetry and blood measurements permit some speculation. For instance, our finding 
of a significantly higher exercise fat oxidation and circulating concentration of glycerol 
and NEFA during exercise in Fasted than Fed is consistent with De Bock and colleagues 
(De Bock et al. 2005). Interestingly, these changes in the metabolic milieu during 
exercise were paralleled with an elevated degradation of type I fibre IMTG. Accordingly, 
it could be that the lower exercise-induced fat oxidation in Fed vs. Fasted in the present 
study is due to a suppression of adipose and muscle tissue lipolysis, coupled with 
increased glucose utilisation through greater availability in the presence of increased 
insulin in the Fed state (Kiens, 2006). This suggestion is supported by the observed 
decline in glucose in Fed but not Fasted throughout exercise (Figure 5.4 A). Whilst we 
cannot elucidate the influence of feeding on modulating potential alterations in IMTG 
degradation during exercise, it is hoped that these initial insights and speculations will 
encourage future research to explore the influence using a larger sample size.   
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5.5.4 Practical considerations 	
In this study, each participant successfully performed 60 minutes of steady-state (65% 
V̇O2max) cycling exercise on two separate occasions. This duration of exercise was 
selected because it has previously been shown to induce IMTG degradation in lean 
individuals (Watt et al. 2002; Shepherd et al. 2012) and is recommended by the Institute 
of Medicine (IOM 2002) and the International Association for Obesity (Saris et al. 2003) 
to mitigate unhealthy body mass gain or regain after a period of weight loss in obesity. 
However, this researcher would like to point out that there was a large inter-subject 
response regarding the ease at which each participant completed the exercise sessions. 
Specifically, the mean±SD (range) RPE for the Fasted and Fed session was 12±2 (10-
16; 10 = between ‘very light [9]’ and ‘light [11]’, 16 = between ‘hard [15]’ and ‘very hard 
[17]’) and 13±2 (10-15), respectively. This demonstrates that some subjects found the 
exercise bout considerably more difficult than did others, which could impact upon the 
adherence of this type of exercise in overweight and obese populations (both over the 
short- and long-term).  
 
Interestingly, subjective RPE was (on average) significantly lower during the Fasted as 
compared with Fed condition. Specifically, 50% of participants (3 out of 6) reported a 
lower RPE during the Fasted bout whilst the other 50% reported no difference between 
conditions. Whilst speculative, this effect could be because feeding in close proximity to 
exercise caused some degree of GI distress during exercise. It is noteworthy that the 
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sample size in this study was low and therefore these findings can by no means be 
generalised to the entire population. While some people may prefer to exercise in the 
Fasted as compared with Fed state, others may prefer vice-versa and so recommending 
Fasted exercise to those who find it more difficult to perform could be an additional 
‘barrier’ to exercise. Also interesting is that Fasted as compared with Fed exercise 
increased exercise fat utilisation, which could have potential implications for daily fat 
utilisation and fat balance (Iawayama et al. 2015). As such, performing exercise in the 
Fasted state could be a means of increasing the efficiency of exercise training, which 
would translate into greater clinical benefits with equal effort by the individual; an effect 
that could increase exercise adherence (Hansen, Strijcker & Calders, 2016).   
 
In light of the above it would be important when designing and implementing exercise 
interventions aimed at improving ones metabolic health status that clinicians and 
practitioner’s consider the viability of the exercise load and the nutritional state by which 
one commences exercise on a case-by-case basis, particularly if the aim is to prescribe 
an exercise regime that is enjoyable and, importantly, sustainable. 
 
In conclusion, this study shows that an acute bout of aerobic exercise performed in the 
Fasted- as compared with Fed-state augments exercise fat oxidation, as well as the 
circulating concentration of plasma glycerol and NEFA during exercise in obesity. The 
data is suggestive of IMTG utilisation during aerobic exercise in this population, however 
the low sample size with respect to muscle analysis greatly limits any interpretation. The 
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influence of the timing of nutrition around exercise could not be established and is 
something future research should seek to explore.  	 	
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CHAPTER 6   
 
GENERAL DISCUSSION 
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6.1 Summary of key findings 
Prior to this thesis the links between the inter-subject variability in the capacity to oxidise 
fat (MFO) during exercise and metabolic health were only partially understood. 
Accordingly, the first aim of this thesis was to offer better resolution on the links between 
MFO and metabolic risk by determining the relationship between MFO and daily (i.e., 
24-hour) fat oxidation, and MFO and insulin sensitivity, as surrogate markers for long-
term metabolic health in healthy young men (Chapter 3). The first novel finding from this 
investigation was that there was a significant and positive association between MFO and 
24-h fat oxidation (expressed as both g/min and %EnFO) and a significant and negative 
correlation between MFO and daily fat balance (g/d). A second original finding was that 
there was a significant and positive association between MFO and insulin sensitivity as 
determined using a surrogate marker (QUICKI). Considered collectively, these findings 
build upon the existing body of literature showing that one’s capacity to oxidise fat during 
exercise or whilst physically active could have important implications for metabolic 
health. 
 
The new findings presented in Chapter 3 extend the need for a more comprehensive 
understanding of the factors that influence the inter-subject variability in MFO during 
exercise. This information is important as it could be used in the design of physical 
activity strategies to optimize fat oxidation and improve metabolic health. Prior to this 
thesis, the evidence linking plasma hormone and metabolite concentrations as 
correlates of MFO were limited and inconsistent, whereas the links between resting fat 
oxidation rate had not been established. Therefore, a second aim of this thesis was to 
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investigate the influence of selected plasma hormones and metabolites and resting fat 
oxidation on MFO during exercise. The study presented in Chapter 4 revealed novel 
relationships between circulating concentrations of NEFA, glycerol and insulin measured 
during exercise and MFO. Of particular note, the plasma glycerol response to exercise 
could uniquely reflect exercise-induced fat oxidation (or the metabolic processes 
underlying the regulation of fat oxidation during exercise). This study also demonstrated, 
for the first time, that resting fat oxidation was significantly and positively associated with 
MFO.  
 
A better understanding of the factors that influence the capacity to oxidise fat during 
exercise could help to inform novel strategies to increase fat oxidation during exercise 
and subsequently exert a favourable influence on one’s metabolic health. At the start of 
this PhD project it was not known whether the timing of recent nutrition with respect to 
exercise is important in explaining the inability of aerobic exercise training per se to 
improve peripheral insulin sensitivity in obese populations. Accordingly, Chapter 5 was 
designed to investigate the influence of meal timing i.e., eating before or after an acute 
exercise bout, on fuel utilisation, the plasma hormone and metabolic response, and 
IMTG use during exercise in overweight and obese men. This study demonstrated that 
fasted, as compared with fed, exercise significantly increases exercise fat oxidation and 
supresses carbohydrate oxidation; a response that was paralleled with a greater 
circulating concentration of plasma glycerol and NEFA during exercise in fasted vs. fed. 
Data also suggests type I and type II fibre IMTG degradation in obesity, however the 
power of this finding and the influence of feeding in modulating this response is limited 
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by the low sample size (n=2) and divergent responses reported. Nevertheless, it is 
hoped that the insights provided from this study will prompt future research to explore 
the overall response to the timing of nutrition around exercise in a larger sample, as this 
could have important implications from the perspective of optimising metabolic health. 
 
  
6.2 Maximal fat oxidation during exercise is positively associated with 24-hour 
fat oxidation and insulin sensitivity in young, healthy men.  
This first study was designed to explore the relationship between MFO and 24-h fat 
oxidation, as the latter could be reflective of long-term susceptibility to perturbations in 
body mass (Zurlo et al. 1990) and/or composition (Ellis et al. 2010). The study reports, 
for the first time, significant and positive relationships between MFO (g/min) and 24-hour 
fat oxidation (expressed as g/d and %EnFO) and a significant and negative relationship 
between MFO and 24-h fat balance. It therefore builds upon the existing body of 
literature and lends support to previous suggestions that a high capacity for fat oxidation 
during exercise could be advantageous for metabolic health (Rosenkilde et al. 2010; 
Isacco et al. 2013). 
 
Such findings linking MFO to 24-h FO advance a potential role for MFO as a marker of 
long-term body mass and/or composition. However, this researcher acknowledges that 
there are a number of important considerations that must first be brought to attention 
before any definitive conclusions can be made. Firstly, from the perspective of study 
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design it should be noted that the cohort demographics of the participants used in this 
study (i.e., young, healthy men) limit extrapolation to the general population. Whilst there 
is good evidence showing that the inter-subject variability in MFO is apparent across a 
range of populations i.e., obese (Croci et al. 2014: MFO 0.38 ± 0.19 g/min), sedentary 
overweight (Rosenkilde et al. 2010: mean±SD MFO in low-RER group 0.33±0.10 g/min, 
high-RER group 0.17±0.03 g/min), normal weight and healthy (Robinson et al. 2015: 
MFO 0.59±0.21 g/min), highly-trained individuals (Achten & Jeukendrup, 2003a: 
0.52±0.19 g/min) and children (Chu et al. 2014) we restricted this study to a very specific 
population (young, healthy, recreationally active men) and it is not yet known whether 
the links between MFO and 24-h fat oxidation extend to other populations such as 
children, teenagers, women etc. Following up this type of work in other populations, 
particularly those at risk for disorders associated with disturbances in fat metabolism 
such as obesity, insulin resistance and type II diabetes, would be an important way 
forward in this area and this is something that future research should seek to explore. It 
is also important to re-emphasise (in light of the point made in the Discussion of Chapter 
3) that it would be important in future work to confirm these observations under 
conditions of standardized dietary and physical activity levels. 
 
The presumption that MFO could be a useful marker for the long-term regulation of body 
mass and/or composition is based on the correlational data presented (Chapter 3) and 
an important question raised from this study is whether MFO is associated with long-
term changes in body mass and/or composition. Indeed, these findings could help to 
provide new insights into why there are responders and non-responders to exercise for 
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weight loss. For example, whilst this is clearly a complex issue, there is some evidence 
that a reduced fat oxidation (or alternatively, a high carbohydrate oxidation) during 
exercise drives higher ad libitum food intake in free-living conditions (Almeras et al. 
1994). However, these authors measured exercise substrate utilisation using RQ and 
did not monitor short- and/or long-term changes in participants’ body mass or 
composition. Accordingly, they were unable to formulate a potential link between 
exercise fat oxidation, ad libitum food intake, and body mass and/or composition. To this 
researchers knowledge, the metabolic link to the compensatory changes in diet or 
activity that can occur in individuals who do not respond to exercise for weight loss has 
not been comprehensively studied and is at present a grey area.  
 
Although it is beyond the scope of this thesis, it would be interesting to follow-up with the 
subjects studied in Chapter 3 (~every 5 years) to determine whether the absolute 
contribution of fat towards exercise energy expenditure is related to long-term changes 
in body mass and/or composition. This information could help offer a metabolic link 
explaining whether a lower contribution of fat towards exercise energy expenditure 
predicts changes in body mass and/or composition. If MFO is predictive of long-term 
changes in body mass and/or composition then a better appreciation of the mechanisms 
that underpin this association, as well as establishing viable nutrition intervention and/or 
exercise training strategies aimed at optimising MFO, would be important. 
 
The data presented in Chapter 3 suggests that the measurement of MFO during 
exercise could have value in exercise prescription. For example, exercise training at the 
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intensity that elicits MFO (Fatmax) has been shown to be superior to moderate intensity 
interval training at increasing MFO during exercise and insulin sensitivity (Venables & 
Jeukendrup, 2008). Therefore, training at Fatmax could be recommended in order to 
optimise the rate of fat oxidation during exercise, which could confer improvements in 
ones metabolic health status. However, it is notable that for some individuals their MFO 
could occur at a very low exercise intensity (Fatmax for 19% [11 out of 57] of the 
participants employed in Chapter 4 occurred at an exercise intensity <35% V̇O2maxx) 
meaning that in the absence of extremely prolonged exercise the absolute energy 
expenditure would likely be insufficient if their goal was to create an exercise induced 
energy deficit. Accordingly, this researcher believes that it is important the individual’s 
goals are accounted for before exercise and/or training strategies are recommended 
based upon an individual’s MFO.   
 
A second novel finding from this study was the observed significant and positive 
relationship between MFO and insulin sensitivity (QUICKI), which affords the suggestion 
that a higher fat oxidation during physical activity could confer improvements in insulin 
sensitivity. From a mechanistic perspective, a higher fat oxidation during exercise could 
help to alleviate lipotoxic stress in skeletal muscle by reducing the accumulation of 
insulin resistance-inducing lipid metabolites such as ceramide, DAG and LCFA-CoA 
(Shaw et al. 2010). However, this is merely a speculation at present. The novel findings 
presented in Chapter 3 pave way for future research to investigate the role of changes in 
MFO on insulin sensitivity and, if a relationship exists, to explore the mechanistic basis 
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for this by using skeletal muscle sampling to delineate the influence of markers of 
lipotoxic stress on this response.  
 
In an attempt to explain the association between MFO and 24-h FO, we explored the 
influence of a variety of factors on these variables. The data presented in Chapter 3 
showed clearly that aerobic fitness (V̇O2max) was the primary driver of both MFO and 24-
h fat oxidation, which is consistent with others who employed a more heterogeneous 
cohort (Venables et al. 2005). This finding would suggest that promoting both physical 
activity and physical fitness are important strategies to increase one’s capacity to oxidise 
fat during exercise.  
 
Whilst is it clear that aerobic capacity is an important driver of MFO during exercise, it is 
interesting that cross-sectional studies demonstrate no relationship between aerobic 
training status and 24-h fat oxidation, which is reinforced by our additional analysis that 
showed the relationship between MFO and 24-hour fat oxidation remained when 
controlled for V̇O2max as a potential confounding variable and suggests an independent 
relationship. Indeed, to date this work, and the work of others, have been mainly cross-
sectional in nature. From a physiological perspective there is a need to perform carefully 
controlled longitudinal training studies of exercise training to establish if some of the 
relationships observed in Chapter 3, such as the links between MFO and V̇O2max, MFO 
and 24-h FO, and MFO and insulin sensitivity are indeed causal, as well as the 
investigation of underlying mechanisms and their significance for their long-term control 
of body weight, composition and metabolic health. The use of longitudinal training 
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studies could be used to delineate the relative role of changes in maximal aerobic 
capacity and the capacity to oxidize fat during exercise on daily patterns of substrate 
oxidation. This would help inform whether physical activity interventions designed to 
increase MFO should focus on improving one’s V̇O2max or instead concentrate on 
enhancing metabolic factors either directly or indirectly associated with V̇O2max (e.g., 
skeletal muscle fibre type, capillary density and/or oxidative capacity).  
 
 
 
6.3 Plasma lipolytic markers, insulin and resting fat oxidation are associated 
with maximal fat oxidation during exercise 
Appreciable efforts have been made by multiple research teams to uncover the factors 
that influence the inter-subject variability in fat oxidation during exercise (Goedecke et 
al. 2000; Venables et al. 2005; Rosenkilde et al. 2010; Isacco et al. 2014), however prior 
to this thesis a large proportion of this variation was unexplained and, in particular, the 
influence of selected plasma hormones and metabolites had not been established. This 
is important information to know, as it could help to inform the most favourable hormonal 
and metabolic milieu to optimise exercise fat oxidation, with implications thus for 
strategies to manipulate this milieu with overall potential benefits for metabolic health. 
Accordingly, the purpose of Chapter 4 was to investigate the relationships between 
various regulators and indices of fat oxidation during the transition through maximal fat 
oxidation with incremental exercise.  
 
	 224 
This chapter provides new insights into previously unidentified factors that influence 
MFO during exercise. Firstly, the study revealed significant relationships between 
plasma NEFA (positive relationship), glycerol (positive relationship) and insulin (negative 
relationship) concentrations at MFO with MFO. These relationships extend support for 
the integrated influence of lipolysis (as reflected by plasma glycerol concentration), the 
anti-lipolytic action of insulin and plasma NEFA availability as factors that influence one’s 
capacity to oxidise fat during exercise. In line with this, resting concentrations of NEFA 
and insulin were also significantly positively and negatively correlated with MFO, 
respectively. Interestingly, the significant associations between concentrations of NEFA 
and insulin at MFO with MFO were lost when their resting concentrations were included 
as a partial correlate. Moreover, the exercise-induced changes in NEFA and insulin were 
not correlated with the exercise-induced change in fat oxidation (i.e., resting to MFO). 
This suggests that NEFA and insulin are generally associated with MFO, but they are 
likely not the prominent drivers of the exercise-induced increase in fat oxidation.  
 
The significant and positive relationship between plasma glycerol concentration during 
exercise and MFO remained when controlled for resting glycerol concentration and the 
exercise-induced change in glycerol was significantly and positively correlated with the 
exercise-induced change in fat oxidation. Coupled with previous work that demonstrates 
associations between lipolytic rate (i.e., rate of appearance of whole-body glycerol) with 
changes in fat oxidation, this novel finding suggests that plasma glycerol concentrations 
uniquely reflect the metabolic processes underlying the regulation of fat oxidation during 
exercise.  However, as stated above plasma NEFA concentration did not correlate with 
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MFO when resting NEFA concentration was considered as a potential confounding 
variable. This makes it tempting to presume that a higher MFO is associated with a 
greater utilisation of IMTG, as opposed to a higher utilisation of adipose tissue derived 
fatty acids. This seems plausible given that glycerol released following IMTG 
degradation is not re-utilised within muscle, but is instead released into the circulation. 
However, it could also be due to greater re-esterification of NEFA in adipose tissue, as 
the source of glycerol for triglyceride synthesis in fat tissue is glucose (Holloszy & Kohrt, 
1996).  
 
Nevertheless, previous work shows that the absolute contribution of other fat sources 
(i.e., IMTG) to energy expenditure during exercise increases from 40% Wmax to 55% 
Wmax (0.29 ± 0.05 to 0.39 ± 0.03, respectively), whereas the contribution of free fatty 
acids remains similar (0.39 ± 0.04 to 0.41 ± 0.04, respectively; van Loon et al. 2001). 
Whilst speculative, this suggestion lends support to the findings in Chapter 3, which 
identified a higher MFO was associated with greater insulin sensitivity. As mentioned 
above, insulin resistance appears to be associated with increased accumulation of lipid 
metabolites known to interfere with insulin signalling pathways i.e. ceramide, 
diacylglycerol and LCFA CoA. If an elevated MFO induces a higher turnover of IMTG, 
this could help alleviate lipotoxic stress and augment insulin sensitivity. To this end, 
further investigation is necessary to fully delineate the influence of lipolytic rate and 
plasma NEFA kinetics as determinants of the inter-subject variability in MFO and 
determine the exact location of the fuel source.  
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Another interesting observation from this study is that there was significant and positive 
association between resting fat oxidation and MFO during exercise. This was found to 
be the case when resting fat oxidation was expressed both in relative (i.e., RER) and 
absolute (i.e., g/min) terms. This latter relationship is novel and builds upon the existing 
research in this area by offering a more resolute comparison between resting fat 
oxidation and MFO. This could be important information to know, particularly in relation 
to the role of accounting for resting (or ‘baseline’) fat oxidation in future studies i.e., in 
explaining differences between individuals (e.g., whether differences in MFO are 
exercise specific or reflect more generalized differences in fat oxidation) or in studies 
designed to assess the impact of an intervention on exercise fat oxidation (i.e., does an 
intervention affect exercise fat oxidation per se or more so general fat oxidation).  
 
In additional analysis (the results of which are not presented in the experimental 
chapters of this thesis), this researcher explored the relationship between resting fat 
oxidation (g/min) and 24-h fat oxidation (g/d) for the 16 people who took part in both 
experiments presented in Chapters 3 and 4 (Figure 6.1). Whilst no significant 
relationship was observed (R=0.34 P=0.098), the correlation was directionally consistent 
with what might be anticipated and it is reasonable to assume that greater statistical 
power might have yielded a statistically significant difference. Future work may wish to 
explore the relationship between resting fat oxidation (g/min) with both MFO and 24-h fat 
oxidation across a range of populations. Knowing this could add value to the 
measurement of resting fat oxidation in research and/or clinical settings for predicting 
metabolic risk and/or risk of unfavourable perturbations in body composition. Indeed, the 
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links between MFO and resting fat oxidation (identified in Chapter 4 of this thesis) 
coupled with the links between MFO and 24-h fat oxidation and insulin sensitivity as 
surrogate markers of metabolic health (identified in Chapter 5 of this thesis) are 
suggestive of a role for resting fat oxidation as a useful tool for predicting metabolic risk. 
Reinforcing this supposition are two studies, which demonstrate a high RQ at rest is 
related to increases in fat mass (Shook et al. 2015) and exercise-induced changes in 
RQ from rest predict exercise-induced fat loss (Barewell et al. 2009). From the 
perspective of application, the measurement of resting fat oxidation is likely to be more 
easily applicable in the real world setting than measures of substrate utilisation during 
exercise or over a day (i.e., 24-h), in that it takes less time to conduct, places minor 
burden on the individual, and can be performed by a wider range of individuals 
(including those who are unable to perform treadmill exercise to exhaustion such as the 
elderly or disabled).  
 
Consistent with the findings presented in Chapter 3, this study reported a significant and 
positive relationship between V̇O2max and MFO, but also between V̇O2max and resting fat 
oxidation. As Chapter 3 also demonstrated a positive relationship between V̇O2max and 
24-h fat oxidation, these findings collectively imply that V̇O2max is an important 
determinant of fat oxidation under a range of physiological conditions (Figure 6.1). 
Nevertheless, these parameters remained significantly and positively correlated with 
MFO when controlled for V̇O2max as a potentially confounding variable, which adds 
further weight to above mentioned suggestion that other metabolic factors, either directly 
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or indirectly associated with V̇O2max, are also important drivers of an individual’s capacity 
to oxidise fat.  
 
	
Figure 6.1 The relationship between resting fat oxidation (FO), MFO and 24-h FO and 
the influence of cardiorespiratory fitness (V̇O2max) on these parameters. Parentheses 
denote correlation and significance when V̇O2max is controlled for as a potential 
confounding variable.  
 
The primary purpose of the study presented in Chapter 4 was to provide greater 
resolution on the factors contributing to the inter-subject variability in MFO during 
exercise. However, it is noteworthy that the full spectrum of potential influencers was not 
explored. For example, it is well established from intervention studies that nutritional 
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status can exert a large influence on the balance of substrates utilised during exercise, 
yet the contribution of habitual diet to the inter-subject variability was not explored in this 
study. Nevertheless, during the preparation of this thesis our research team performed a 
large-scale cross-sectional study (150 men, 155 women; age 25±6 yrs.; BMI 23±2 
kg/m2; V̇O2max 50±8 ml/kg/min [data are mean ± SD]) that aimed to identify if habitual 
dietary intake independently predicts MFO in healthy men and women (Fletcher et al. 
manuscript in review). Briefly, we have demonstrated that habitual dietary intake makes 
a small (2.6%) but significant contribution to the observed inter-subject variation in MFO. 
Specifically, dietary intake of fat and/or carbohydrate can make significant and 
independent contributions to the individual variability in MFO. As well as habitual diet, it 
is known that other factors such as skeletal muscle fiber type (Wade et al. 1990; 
Goedecke et al. 2000) and genetic predisposition (Zurlo et al. 1990; Tourbo et al. 1998; 
Wu et al. 2015) can influence the contribution of fat towards energy expenditure. 
However, their contribution to explaining the observed inter-subject variability in MFO 
during exercise is currently unknown and is something that future research should seek 
to explore. 
 
A limitation of the studies presented in Chapters 3 and 4 of this thesis (in addition to 
those already presented in the respective Chapters) is that a 24-h recall was not used to 
validate self-reported dietary intake and physical activity. Whilst this is something that 
future work in this area should consider, this researcher would like to point out that he 
performed internal validation of the self-report energy intake and expenditure measures 
and observed excellent consistency with energy balance calculated using the methods 
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described in this manuscript (4-d food and physical activity diaries) and objectively 
measured energy balance using whole-room calorimetry (r=0.943, p<0.001, n=16; 
unpublished observations based on data from Chapter 3; Robinson et al. 2016). As 
such, this researcher feels confident with the data presented in this thesis.    
 
 
6.4 Influence of pre- or post-exercise feeding on substrate utilisation, lipolytic 
markers and insulin, and intramuscular triglyceride utilisation in obesity. 
A recurring message throughout this thesis is that increasing one’s capacity to oxidise 
fat (MFO) whilst physically active could be beneficial for long-term metabolic health 
(Rosenkilde et al. 2010; Isacco et al. 2013; Robinson et al. 2015 [Chapter 3]). 
Accordingly, Chapter 4 provided further resolution on the key factors that influence MFO 
during exercise, in an attempt to inform strategies (e.g., dietary and/or training) aimed at 
optimising exercise fat oxidation, which ultimately could confer improvements in 
metabolic health. The next logical step for this thesis was to utilise these findings from a 
translational perspective and, as such, Chapter 5 provided a feeding strategy that 
attempted to offer the necessary modulation to test the significance of increasing 
exercise fat oxidation in a population at risk for cardiovascular disease and type II 
diabetes.  
 
A key finding from this investigation, and one that is consistent with others (de Bock et 
al. 2005; Derave et al. 2007), was that fasted exercise induced a significantly greater 
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reliance on fat and lesser reliance on carbohydrate towards exercise energy 
expenditure, as compared with fed exercise. As anticipated based upon the data 
presented in Chapter 4 of this thesis (Robinson et al. 2016), circulating concentrations of 
plasma glycerol and NEFA were significantly higher in fasted than fed, with insulin being 
higher, albeit not significantly (probably due to a lack of statistical power), at both 
measurement time-points during exercise in the fed condition. These findings 
demonstrate that we were successful in creating a hormonal and metabolic milieu that 
favours greater fat utilisation during exercise in obesity. 
 
Unfortunately, the low sample size and divergent responses reported with respect to 
muscle analysis meant the influence of these differences on IMTG degradation could not 
be established. Whilst the data suggests exercise-induced type I and type II IMTG 
degradation in obesity, this finding must be observed with caution in light of the low 
sample size and divergent responses reported. Indeed, other research has failed to 
show exercise-induced degradation of IMTGs in obese (Nellemann et al. 2014) and 
overweight populations (Larson-Meyer et al. 2006). Differences in study methodology, 
including between-study differences of the techniques used to measure IMTG content, 
could potentially explain these discrepancies. As such, it is this researcher’s belief that 
future work should strive to adopt a similar experimental set-up (i.e., similar exercise 
intensity, duration and type) such that a fair comparison can be made between studies 
and that the set-up is one that is practically applicable to the population at hand. For 
instance, in Chapter 5 we purposely chose to exercise participants for 1-h at a steady-
state (65% V̇O2max) as this has previously been shown to induce IMTG degradation in 
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lean individuals (Shepherd et al. 2012; Watt et al. 2002). A study design that 
incorporates longer duration exercise (e.g. 1.5-3-h) may offer more resolution on the 
potential differences in fibre-specific IMTG use between conditions (i.e., fasted vs. fed), 
as this has been show to lead to greater reductions in IMTG content in lean individuals 
(Watt et al. 2002). However, it is unlikely that such a prolonged exercise bout is clinically 
translatable, whereas 60 minutes of exercise as used in this study is recommended by 
the Institute of Medicine (IOM 2002) and the International Association for Obesity (Saris 
et al. 2003) to mitigate unhealthy body mass gain or regain after a period of weight loss 
in obesity. The identification of strategies that augment IMTG turnover, and 
subsequently reduce the accretion of such metabolites, in this population is undoubtedly 
important. The next logical step would be to assess this response using a large and 
more diverse population sample and explore the influence of recent nutrition with 
respect to exercise in mediating alterations in IMTG content following an acute bout of 
aerobic exercise.  
 
Interestingly, recent work by Ross and co-workers suggests there could still be merit to 
fasted exercise even if meal timing around exercise has negligible influence on IMTG 
content. These researchers demonstrated that reduced fat mass, particularly from 
visceral adipose tissue, is linked with improvements in insulin sensitivity (Brennan et al. 
2014). Undoubtedly, fat balance (fat intake [+ synthesis] – oxidation) is the master 
regulator of fat loss and therefore increasing fat oxidation during exercise or whilst 
physically active could be a more influential means of creating a negative fat balance. In 
this respect, it is acknowledged as a limitation of the study presented in Chapter 5 that 
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(due to reasons of equipment availability) substrate utilisation around the exercise bout 
i.e., before and after exercise, was not assessed, and this is something future research 
should strive to determine such that a more complete picture of substrate utilisation 
during and around the exercise bout can be obtained. Nevertheless, the influence of 
fasted- versus fed-exercise on daily fat utilisation was recently addressed by Iwayama 
and colleagues (Iwayama et al. 2016) who demonstrated that, under energy-balanced 
conditions, 60 minutes of fasted exercise (50% V̇O2max) was superior to fed exercise at 
increasing daily fat utilisation; an effect that was independent of energy balance and 
could be due to transient carbohydrate deficits (Iwayama et al. 2015). As such, it is 
anticipated that the Fasted-exercise performed in Chapter 5 induced a greater reliance 
on fat oxidation during the entire period of stay, however it is accepted that this is merely 
speculation. It would be interesting to follow-up the work by Iwayama and colleagues by 
determining the contribution of fat sources (i.e., IMTG, subcutaneous and visceral 
adipose tissue derived FAs) in mediating the observed effect and to assess the long-
term influence of Fasted- versus Fed-exercise on body fat mass and metabolic health, 
as well as its viability across and within a range of populations.  
 
 
6.5 Final conclusions and practical application 
The work contained within this thesis has developed new insights in the understanding 
of the role of the maximal capacity for fat oxidation (MFO) during exercise as a marker of 
metabolic health. In this respect, evidence demonstrating that 24-h fat oxidation and 
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insulin sensitivity is significantly and positively associated with MFO in young, healthy 
men is reported for the first time. From a translational perspective, this would suggest 
that to improve an individual’s metabolic health status it would be favourable to target a 
physical activity / exercise intervention that is aimed at increasing one’s capacity to 
oxidise fat during exercise (MFO). Though, this researcher would like to reiterate that 
further work is required to confirm these associations across a range of populations, 
including (and importantly) those at risk for adverse metabolic health outcomes (i.e., 
overweight / obese and/or insulin resistant individuals).  
 
This thesis also offers new and supporting knowledge concerning the regulators and 
indices of fat oxidation across a range of physiological contexts i.e., at rest, during 
incremental exercise and over 24-h. This information could be useful in the design of 
physical activity interventions aimed towards increasing fat oxidation and improving 
metabolic health. Specifically, and consistent with others (Venables et al. 2005), the 
findings presented within Chapters 3 and 4 of this thesis demonstrate that V̇O2max is an 
important determinant of MFO during exercise. However, the data also shows that the 
relationship between V̇O2max and MFO, V̇O2max and resting fat oxidation, and V̇O2max and 
24-h fat oxidation, can be dissociated. Accordingly, from a practical standpoint it would 
be important that clinicians / practitioners who are seeking to increase an individual’s 
overall capacity to oxidise fat focus the design of their physical activity / exercise 
interventions towards increasing one’s aerobic capacity (V̇O2max), but also metabolic 
factors either directly or indirectly associated with V̇O2max such as skeletal muscle fiber 
type, capillary density and/ or muscle oxidative capacity.  
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There is no definitive evidence showing that one form of exercise is superior to another 
at increasing an individual’s capacity to oxidise fat during exercise and there are various 
forms of exercise that can increase V̇O2max and above-mentioned metabolic factors.  
 
Therefore, it is this researchers belief that in order to increase ones capacity to oxidise 
fat during exercise (with potential favorable implications for metabolic health) focus 
should be placed on designing a physical activity / exercise regime that is practically 
suitable and sustainable by the individual - with its viability considered on a case-by-
case basis. Indeed, this should also be the focus if a reduction in body fat is sought after 
and in this respect this researcher would like to reiterate that fat oxidation and fat loss 
are not synonymous, and ultimately it is the state of energy balance that will determine 
alterations in body composition. The recommendation for an individual to exercise in 
their optimal ‘fat burning’ zone (±10% Fatmax) may not be entirely appropriate, especially 
if this zone occurs at a low exercise intensity meaning that the overall energy 
expenditure incurred by exercise is likely to be insufficient to create an appropriate 
exercise-induced energy deficit. It may also not be applicable given that expensive 
technical equipment and skilled personnel are required to appropriately assess an 
individual’s MFO and Fatmax. There is a low level of access to these tests for the general 
public as their availability is often (but not always) limited to a University laboratory 
setting, and so prescribing this type of exercise prescription could prove to be very 
difficult.  
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Chapter 4 also identified weak-to-moderate, albeit significant, relationships between 
plasma lipolytic markers, insulin and resting overnight-fasted fat oxidation with MFO and 
showed the plasma glycerol response to uniquely reflect exercise-induced fat oxidation.  
Accordingly, the next logical step for this thesis was to utilise these findings from a 
translational perspective and, as such, Chapter 5 provided a feeding strategy that 
attempted to offer the necessary modulation to test the significance of increasing 
exercise fat oxidation in a population at risk for cardiovascular disease and type II 
diabetes. Unfortunately, for reasons previously documented (Section 5.3.5), the 
influence of meal timing on IMTG degradation could not be established. However, the 
data shows clearly that fasted, as compared with fed, exercise augments exercise fat 
oxidation. Accordingly, recommending individuals perform select exercise sessions in 
the fasted-state will likely increase exercise fat oxidation, which could confer 
improvements in metabolic health and encourage a reduction in body fat mass 
(Iwayama et al. 2015). Though this recommendation should not come at the cost of 
reducing one’s likelihood of performing exercise itself; which could occur if an individual 
does not enjoy or have the appropriate knowledge to perform fasted exercise.  
 
It is expected that the work contained within this thesis will encourage future research to 
(i) advance the potential role of MFO as a marker of metabolic disease risk across a 
wide range of populations, (ii) to further identify the factors that underpin the large inter-
subject differences in MFO during exercise, and (iii) to explore the influence of recent 
nutrition with respect to exercise on fat and IMTG utilisation in obesity, with potential 
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implications for the design of strategies (training and / or nutrition) aimed towards 
optimising metabolic health in obesity.   
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Appendix 1  Informed consent form: chapters 3 and 4 
 
 
Informed Consent Form 
 
Determining the capacity for fat oxidation during physical activity  
 
Location(s): 
 Human Performance Laboratory, School of Sport, Exercise & Rehabilitation Sciences, University of 
Birmingham 
       Humans Metabolism Research Unit (HMRU), University Hospital, Coventry 
 
Investigators: 
 Dr Gareth Wallis, Dr John Hattersley, Dr Victoria Burns, Scott Robinson 
 
Contact details: 
Scott Robinson, School of Sport, Exercise & Rehabilitation Sciences, The University of Birmingham,  
Edgbaston, Birmingham, B15 2TT.  Tel: . E-mail:             
 
Dr Gareth Wallis, School of Sport, Exercise & Rehabilitation Sciences, The University of Birmingham,  
Edgbaston, Birmingham, B15 2TT  Tel: . E-mail:         
 
 
Name: 
 
Address: 
 
D.O.B: 
 
I have read the Participant Information Sheet related to this study discussed the 
investigation with ……………………. who has explained the procedures to my 
satisfaction. I am willing to undergo the following procedures or assessments (please 
initial); 
 
General Health Questionnaire  
Height and Weight Measurement  
Treadmill Exercise Testing  
Blood collection  
 Respiration Chamber Stay  
(if eligible for Visit 3)  
 
 
I am willing to undergo the investigation but understand that I am free to withdraw at 
any time. 
 
Signed………………………………... 
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Witness……………………………….. 
 
Date………………………………….. 
 
 
 
 
 
 
Appendix 2  General health and screening questionnaire: chapters 3 and 4 
 
The University of Birmingham 
School of Sport and Exercise Sciences 
 
General Health and Screening Questionnaire 
 
Screening No: 
 
 
Name:  .................................................................................... 
Address: .................................................................................... 
  .................................................................................... 
  .................................................................................... 
Phone/Email: .................................................................................... 
 
Name of the responsible investigator for the study: 
 
  ................................................................................... 
 
Please answer the following questions.  If you have any doubts or difficulty with the questions, 
please ask the investigator for guidance.  Your answers will be kept strictly confidential. 
 
1.  
You are....... 
 
 
Male 
 
Female 
2. What is your exact date of birth?   
 
 Day........... Month...........Year..19........ 
 
So your age is........................... Years 
 
  
3.  
When did you last see your doctor?     In the: 
Last week............ Last month.......... Last six months............ 
Year................. More than a year........... 
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4. Are you currently taking any medication? YES NO 
5. Has your doctor ever advised you not to take vigorous 
exercise? 
YES NO 
6. Has your doctor ever said you have “heart trouble”? YES NO 
7. Has your doctor ever said you have high blood pressure? YES NO 
8. Have you ever taken medication for blood pressure or your 
heart? 
YES NO 
9. Do you feel pain in your chest when you undertake physical 
activity? 
YES NO 
 
10. In the last month have you had pains in your chest when not 
doing any physical activity? 
YES NO 
11. Has your doctor (or anyone else) said that you have raised 
blood cholesterol? 
YES NO 
12. Have you had a cold or feverish illness in the last month? YES NO 
13. Do you ever lose balance because of dizziness, or do you 
ever lose consciousness? 
YES NO 
14.  
a) Do you suffer from back pain 
b)  if so, does it ever prevent you from exercising? 
 
YES 
YES 
 
NO 
NO 
 
15. Do you suffer from asthma? YES NO 
16. Do you have any joint or bone problems which may be made 
worse by exercise? 
YES NO 
17. Has your doctor ever said you have diabetes? YES NO 
18. Have you ever had viral hepatitis? YES NO 
19. 
 
 
Do you know of any reason, not mentioned above, why you 
should not exercise? 
YES NO 
20. Are you completely sedentary in your lifestyle? YES NO 
21.  Are you an exercise-trained athlete? YES NO 
22. Are you accustomed to vigorous exericse (~1 h/week) YES NO 
I have completed the questionnaire to the best of my knowledge and any questions I had have 
been answered to my full satisfaction 
 
Signed:.............................................................  
Date:..................................................................... 
            
Research team use only: 
 
Height (m) =     Weight (kg) =    BMI (kg/m2 =  
 
Visit 1 eligibility check  
 
Criteria Tick = eligible, cross = 
ineligible 
Comment from consenting and 
screening investigator 
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Consent form signed   
Sex (male)   
Age (18-49 years)   
Health questionnaire 
(NO for Q4-21, YES 
for Q22) 
  
BMI (18.5-30 kg/m2)   
This participant is eligible / ineligible (circle as appropriate) to participate in this study 
 
Signed:     (Scott Robinson, PI)  Date:   
 
 
 
 
 
Appendix 3  Graded exercise Test Data Sheet: Chapters 3 and 4 
 
 
Graded Exercise Test: 
 
Date:   Subject Identification Number:           
 
Time Speed 
(km/h) 
Gradient 
(% 
incline) 
VE 
L/Min 
VO2 
ml/min 
VCO2 
ml/min 
VO2 
ml/kg/min 
RER RPE HR 
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
 
 
	 	
NOTES: 
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Appendix 4  24-h Food Diary: Chapters 3 and 4 
 
 
Twenty-Four Hour Food Diary 
 
PLEASE READ THROUGH THESE PAGES BEFORE STARTING YOUR DIARY 
 
 
We would like you to keep this diary of everything you eat and drink over 4 consecutive 
days. 
Please include all food consumed at home and outside the home e.g. work, college or 
restaurants.  It is very important that you do not change what you normally eat and drink 
just because you are keeping this record.  Please eat as you normally would do. 
 
Day and Date 
Please circle the study day (1,2,3,4) and write the date at the top of the page each time 
you start a new day of recording. 
 
Time Slots 
Please note the time of each eating occasion into the space provided. 
 
What did you eat? 
Please describe the foods you eat in as much detail as possible. Be as specific as you 
can.  The example day shows the level of detail needed such as –  
Cooking methods: (fried, grilled, baked, micro-waved etc). 
Any additions (sugar/sweeteners, sauces, pepper, salt, mustard, etc). 
Type and amount of fat / oil used for cooking, e.g. teaspoon peanut oil, 15g butter. 
What brands, e.g. Kellogg’s corn flakes, places food bought, fresh, frozen, tinned, raw. 
What variety – e.g. semi skimmed milk, low fat pro-biotic yogurt, reduced salt, reduced 
sugar?     
Whether soft drinks were low calorie (diet) or decaffeinated? 
Were fruit juices UHT, pasteurised or freshly squeezed, made from concentrate 
Products such as cheese, fish and meat were they smoked or not 
Meats – what part of the animal? Chicken breast? Legs? Wings? back bacon, streaky 
bacon, extra lean beef mince, value beef mince.  
 
E.g. a cheese sandwich is really 3 foods – Bread, Margarine and Cheese.  What type / 
amount of bread? Type / amount of spread? Type / amount of cheese?  
 
Remember to record all snacks and drinks throughout the day. 
 
Portion sizes 
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Please use the kitchen weighing scales provided to weigh every item of food / drink 
consumed – Remember to Zero after each item of food, and check it’s in grams.  Eat the 
amount you would normally eat – don’t use the scales to determine when to stop! 
When weighing is not possible, food quantities can be described using: 
• household measures, e.g. one teaspoon (tsp) of sugar, two thick slices of bread, 4 
tablespoons (tbsp) of peas, ½ cup of gravy, large portion of takeaway chips.  Be careful 
when describing amounts in spoons that you are referring to the correct spoon size. 
• use weights from labels, e.g. 4oz steak, 420g tin of baked beans, 125g pot of Yoghurt 
– but only if everything is eaten – did you eat the fat /skin / bones? 
•  number of items, e.g. 4 fish fingers, 1 Rich Tea biscuit, 1 king size mars bar 
With foods such as fruit, remember to record the weight of the skin/core/stone in the 
weight leftover column 
 
For drinks, quantity can be described using: 
• weight (grams), the size of glass, cup etc (e.g. large glass) or the volume (e.g. 300ml, 
1 pint). 
• volumes from labels (e.g. 330ml can of fizzy drink, 500ml strawberry Innocent 
smoothie). 
 
We would like to know the amount that was actually eaten which means taking into 
account leftovers. You can do this in two ways: 
1. Record what was served and note what was not eaten e.g. 30g of peas, only 12g 
eaten; 1 Weetabix, ate ½ 
2. Only record the amount actually eaten i.e. 18g of peas; ½ Weetabix 
 
Homemade dishes 
If you have eaten any homemade dishes e.g. chicken casserole, please record the 
name of the recipe, ingredients with amounts (including water or other fluids)  for the 
whole recipe, the number of people the recipe serves, and the cooking methods used. 
Write this down in the recipe section at the end of the diary.  Record how much of the 
whole recipe you have eaten in the portion size column. 
 
Take-aways and eating out 
If you have eaten a take-aways or eaten dishes not prepared at home such as at a 
restaurant or a friend’s house, please record as much detail about the ingredients as 
you can e.g. vegetable curry containing chickpeas, aubergine, onion and tomato.  
Please also record the name of the restaurant, takeaway, and the name of the meal, 
e.g. Domino’s pizza, 16inch meat feast, thin base. 
 
Brand name 
Please note the brand name (if known).  Most packed foods will list a brand name, e.g. 
Bird’s eye, Hovis, or Supermarket own brands.  For ready-made meals or for less well 
known brands, please keep the packet’s nutritional information in the bag provided. 
 
Supplements / Medications 
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Please also provide information about any supplements you took.  Please record the 
brand name, full name of supplement, strength and the amount taken should be 
recorded, e.g.  Maximuscle cyclone powder – 40g (2 scoops), Holland and Barret Cod 
Liver Oil and Glucosamine Capsules (500mg) – 1 capsule. 
If you take any new medicines or stop taking ones we know about please record it here. 
 
Was it a typical day? 
After each day of recording please tell us whether this was a typical day or whether 
there were any reasons why you ate and drank more or less than usual.  E.g. Drank 4 
pints of Guinness as it was St Patricks day, day 2 ate very little as not feeling well. 
 
When to fill in the diary 
Please record your eating as you go, not from memory at the end of the day. Use 
written notes if you forget to take your diary with you and fill out your diary ASAP.  Each 
diary day covers a 24hr period, so please include any food or drinks that you may have 
had during the night.  Remember to include foods and drinks between meals (snacks) 
including water. 
 
Overleaf you can see an example day that have been filled in. These examples show 
you how we would like you to record your food and drink, and how to record a 
homemade dish. 
 
Please document what you ate & drank in as much detail as possible, Remember 
If it has passed your lips record it!  J 
 
It only takes a few minutes for each eating occasion! 
 
We thank you for your efforts in filling out this diary. 
Recipes / Takeaways 
Write in recipes of ingredients of homemade dishes or take-aways 
  
 
Name of Dish    Fairy Cakes                                 Serves: makes 20 cakes 
Ingredients – Description, Brand,  Amounts 
Tate & Lyle caster sugar 175g 
Anchor butter, unsalted 175g 
ASDA, free range eggs 3 eggs, 172g (no shell) 
ASDA Self raising flour 175g 
Co-op Baking powder 1 teaspoon 
Silver Spoon Icing Sugar 140g  
Water  10ml  
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Description of cooking method 
 
Mix all ingredients (1-5)  together, then separate into 20 equal portions in cup-cases, 
cook in oven for 15mins 
 
Mix ingredients 6 and 7, pour on top of individual cakes after they are cooked and 
cooled. 
 
 
 
Name of Dish  Big Joe’s 16” Meat Feast pizza          Serves: 2 equal portions 
Ingredients Amounts 
Deep pan pizza base 16 inch, weight unknown 
Tomato Sauce based 1 ladle 
Green peppers Half green bell pepper 
Spicy salami ~ 12 large slices 
Pepperoni ~ 20 small slices 
Tandoori chicken pieces ~ half chicken breast 
Beef meatballs  6 small meatballs  
Onion Half 
  
  
  
  
 
 
 
 
 
 
Time Item / Description Brand / 
variety 
Preparation Amount Left-
overs 
07.00 Coco pops Asda  82g  
 Raisins Tesco value  27g  
 Skimmed Milk Asda  322g  
 Pure Orange Juice, 
not from concentrate 
Tropicana – 
with the bits 
 1 large Glass 
- 457g 
 
      
09.15 Crunchy Granola 
Oats and Honey 
Nature Valley  1 bar – 42g  
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flavour Cereal Bar 
 Mug of strong tea Tetley 1 bag 
Water 
Sugar  
Semi 
skimmed milk 
 
220g 
1 teaspoon 
27g 
 
      
10.30 Apple Golden 
Delicious 
Raw 120g 17g core 
 Pear Conference Raw 101g 10g core 
      
12.00 Humus Sandwich Home made    
 Bread (Tesco the 
finest) 
Tesco, 
sliced, 
multigrain 
 2 slices   
 Tomato On the vine  84g  
 Lettuce Iceberg  35g  
 Chicken Sandwich  Previously 
roasted 
leftover 
chicken 
breast meat, 
no skin 
105g  
 Butter Anchor  Thin layer  
 Cucumber Market  47g  
 Water Tap  1 pint  
 Mug of strong tea – 
Same as above 
Same as 
above 
   
14.30 Can of Coca-Cola 
zero 
Coca-Cola  1 can 330ml  
15.45 Grande Latte Starbucks Extra shot of 
coffee + 
vanilla syrup 
Grande size  
15:45 Chocolate Brownie Starbucks  154g  
16.30 Water Tap  1 pint  
18.30 Pizza - meat feast Big Joe’s – 
see recipe 
Takeaway Half of 16 inch   
18.45 Diet Lemonade Aldi  1.5pints  
20.00 Beer normal strength Carlsberg 
(5%) 
 1 pint  
20.20 Beer normal strength Carlsberg 
(5%) 
 1 pint  
20.45 Beer normal strength Carlsberg 
(5%) 
 1 pint  
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21.20 Beer normal strength Carlsberg 
(5%) 
 1 pint  
22.00 Red-bull, normal (not diet)  1 glass  
 Vodka Smirnoff  Double 
measure 
 
22.30 Toast (Tesco the 
finest) 
Tesco, 
sliced, 
multigrain 
toast 2 slice  
 Baked beans – 
reduced sugar.  
Tesco Microwave 420g  
 Chilli Sauce Nandos extra 
hot peri peri 
sauce 
 3 desert spoons  
22.45 Water Tap water  1 pint  
      
Notes This day I drank more alcohol than normal as it was a colleagues birthday 
Date __/__/__ 
 
Time Item / Description Brand / 
variety 
Preparation Amount Left-
overs 
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Notes  
 
 
Date __/__/__ 
 
Time Item / Description Brand / 
variety 
Preparation Amount Left-
overs 
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Notes  
 
 
Date __/__/__ 
 
Time Item / Description Brand / 
variety 
Preparation Amount Left-
overs 
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Notes  
 
 
Date __/__/__ 
 
Time Item / Description Brand / 
variety 
Preparation Amount Left-
overs 
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Write in recipes of ingredients of homemade dishes or take-aways 
  	
Name of Dish                                                                                  Serves:  
Ingredients – Description, Brand,  Amounts 
  
  
  
  
  
  
  
  
  
  
  
  
Description of cooking method 
 
 
 
 
 
 
 
 
 
 
     
 
 
 
 
     
 
 
 
 
     
Notes  
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Name of Dish                                                                                  Serves:  
Ingredients – Description, Brand,  Amounts 
  
  
  
  
  
  
  
  
  
  
  
  
Description of cooking method 
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Appendix 5  24-h Physical Activity Diary: Chapters 3 and 4 
 
Twenty-Four Hour Activity Diary 
 
We would like to find out about your normal physical activity levels.  
 
Please fill in this diary continuously throughout the day, starting from when you get out of bed in the 
morning to when you go back to bed at night. The diary is split into the hours of the day, and then four 
fifteen-minute periods for that hour. In each box, write the code number (see below) which corresponds to 
the activity which you have carried out during this fifteen minute period. Please fill in all the boxes.  
 
Make any notes you feel appropriate during the hours or at the bottom. 
 
The first page is an example which has been done for you. 
 
Please do not wait until the end of the day to fill this out – fill out as you go! 
 
 
Code Number Description and Activity examples 
1. Sleeping  Sleeping, resting in bed, or lying down. 
2. Lying down (not sleeping)  Resting in bed, lying down (still awake) 
3. Sitting  Sitting, eating, watching TV, reading, listening to 
music, writing, sewing, talking on phone etc. 
4. Standing or Driving  Standing fairly still for example in a Que, or 
showering, driving a car 
5. Light activity / standing with light 
activities  
Standing tasks – dish washing, cooking, 
vacuuming, ironing, playing a musical instrument, 
dressing, yoga, slow walk <2.5mph 
6. Light movements / light manual work  Walking at a moderate pace (2.8 – 3.5mph), 
playing with children (moving), brushing/cleaning, 
gardening, washing windows. 
7. Leisure & sports in a recreational 
environment low intensity   
Golf, bowling, darts, very gentle cycling, juggling, 
non-competitive volleyball, table tennis, tai chi, 
archery, yoga 
8. Manual work at a moderate intensity  Digging, sawing, mowing lawn, walking 3mph 
whilst carrying 10kg, cycling ~10mph 
9. Leisure & sports in a recreational 
environment low to moderate 
intensity  
Cycling >10mph, Heavy Resistance (weight) 
training, hard exercise class, ballet, basketball, 
volleyball, wrestling, Tennis (doubles), general 
dancing 
10. Leisure & sports in a recreational 
environment moderate intensity  
Hockey, fencing, cricket, badminton (competitive), 
squash, tennis (singles), gym cross-trainer, rock 
climibing, circuit class, intense aerobics, rowing, 
recreational football, lacrosse, running 5mph 
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11.   
 
Date __/__/__ 
Time 0 - 15 
mins 
16 - 30 
mins 
31 - 45 
mins 
46 - 60 
mins 
Activity / 
Intensity Notes 
00:00-
01.00 
1 1 1 1  
01:00-
02:00 
1 1 1 1  
02:00-
03:00 
1 1 1 1  
03:00-
04:00 
1 1 1 1  
04:00-
0500 
1 1 1 1  
05:00-
06:00 
1 1 1 1  
06:00-
0700 
1 1 1 1  
07:00-
08:00 
1 1 1 1  
08:00-
09:00 
1 1 2 2  
09:00-
10:00 
1 1 1 2  
10:00-
11:00 
2 2 2 2  
11:00-
12:00 
3 3 2 2 Working from home and 
listen to radio 
12:00-
13:00 
3 2 2 2  
13:00-
14:00 
5 5 2 2 Walk to lectures 
14:00-
15:00 
2 2 4 2  
15:00-
16:00 
2 2 2 2 Lectures 
16:00-
17:00 
5 2 2 2  
17:00-
18:00 
5 2 2 2 Walking home and 
reading course work 
18:00-
19:00 
2 2 2 4  
19:00-
20:00 
5 5 2 4 Deep House clean! 
20:00-
21:00 
10 10 10 10 Hockey training 
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21:00-
22:00 
4 4 2 3  
22:00-
23:00 
3 2 2 1  
23:00-
24:00 
1 1 1 1  
Date __/__/__ 
Time 0 - 15 
mins 
16 - 30 
mins 
31 - 45 
mins 
46 - 60 
mins 
Activity / 
Intensity Notes 
00:00-
01.00 
     
01:00-
02:00 
     
02:00-
03:00 
     
03:00-
04:00 
     
04:00-
0500 
     
05:00-
06:00 
     
06:00-
0700 
     
07:00-
08:00 
     
08:00-
09:00 
     
09:00-
10:00 
     
10:00-
11:00 
     
11:00-
12:00 
     
12:00-
13:00 
     
13:00-
14:00 
     
14:00-
15:00 
     
15:00-
16:00 
     
16:00-
17:00 
     
17:00-
18:00 
     
18:00-
19:00 
     
19:00-
20:00 
     
20:00-
21:00 
     
21:00-      
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22:00 
22:00-
23:00 
     
23:00-
24:00 
     
Date __/__/__ 
Time 0 - 15 
mins 
16 - 30 
mins 
31 - 45 
mins 
46 - 60 
mins 
Activity / 
Intensity Notes 
00:00-
01.00 
     
01:00-
02:00 
     
02:00-
03:00 
     
03:00-
04:00 
     
04:00-
0500 
     
05:00-
06:00 
     
06:00-
0700 
     
07:00-
08:00 
     
08:00-
09:00 
     
09:00-
10:00 
     
10:00-
11:00 
     
11:00-
12:00 
     
12:00-
13:00 
     
13:00-
14:00 
     
14:00-
15:00 
     
15:00-
16:00 
     
16:00-
17:00 
     
17:00-
18:00 
     
18:00-
19:00 
     
19:00-
20:00 
     
20:00-
21:00 
     
21:00-
22:00 
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22:00-
23:00 
     
23:00-
24:00 
     
Date __/__/__ 
Time 0 - 15 
mins 
16 - 30 
mins 
31 - 45 
mins 
46 - 60 
mins 
Activity / 
Intensity Notes 
00:00-
01.00 
     
01:00-
02:00 
     
02:00-
03:00 
     
03:00-
04:00 
     
04:00-
0500 
     
05:00-
06:00 
     
06:00-
0700 
     
07:00-
08:00 
     
08:00-
09:00 
     
09:00-
10:00 
     
10:00-
11:00 
     
11:00-
12:00 
     
12:00-
13:00 
     
13:00-
14:00 
     
14:00-
15:00 
     
15:00-
16:00 
     
16:00-
17:00 
     
17:00-
18:00 
     
18:00-
19:00 
     
19:00-
20:00 
     
20:00-
21:00 
     
21:00-
22:00 
     
22:00-      
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23:00 
23:00-
24:00 
     
Date __/__/__ 
Time 0 - 15 
mins 
16 - 30 
mins 
31 - 45 
mins 
46 - 60 
mins 
Activity / 
Intensity Notes 
00:00-
01.00 
     
01:00-
02:00 
     
02:00-
03:00 
     
03:00-
04:00 
     
04:00-
0500 
     
05:00-
06:00 
     
06:00-
0700 
     
07:00-
08:00 
     
08:00-
09:00 
     
09:00-
10:00 
     
10:00-
11:00 
     
11:00-
12:00 
     
12:00-
13:00 
     
13:00-
14:00 
     
14:00-
15:00 
     
15:00-
16:00 
     
16:00-
17:00 
     
17:00-
18:00 
     
18:00-
19:00 
     
19:00-
20:00 
     
20:00-
21:00 
     
21:00-
22:00 
     
22:00-
23:00 
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23:00-
24:00 
     
 
 
Appendix 6  An example of a day’s food intake whilst in the respiratory chamber, 
including timings of meal and snack provision: Chapter 3. 	
Meal component (time of intake) Portion (g) 
Meal 1 – Breakfast (07:45-08:00) 
    wholemeal toast  
    margarine 
 
120 
20 
Snack (10:15-10:30) 
    digestive biscuit 
    chargrilled chicken slices 
 
15 
160 
Meal 2 – Lunch (12:15-12:30) 
    soup 
    brazil nuts 
    ciabatta roll 
 
400 
30 
90 
Meal 3 – Dinner (17:15-17:30) 
    baked potato 
    baked beans 
    chargrilled chicken slices 
    sports drink 
 
400 
200 
120 
125 
Snack (20:00-20:15) 
    digestive biscuit 
 
30 
Energy and macronutrient intake 
    energy (kcal) 
    carbohydrate (g) 
    fat (g) 
    protein (g) 
 
2207 
273 
67 
124 
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Appendix 7  Written Consent Form: Chapter 5 
 
   	 	 	 	 	 	 	 	
CONSENT FORM 
Title of Project: Influence of pre- or post-exercised food intake on muscle metabolism in 
obesity 
Name of Researchers: Mr Scott Robinson, Dr Gareth Wallis, Dr Konstantinos 
Manolopoulos 	
              Please initial all boxes  
1. I confirm that I have read and understand the information sheet dated 
24/JAN/2015 (Version 1) for the above study.  I have had the opportunity to 
consider the information, ask questions and have had these answered 
satisfactorily. 	
2. I understand that my participation is voluntary and that I am free to withdraw 
at any time without giving any reason, without my medical care or legal rights 
being affected.		
3. I understand that relevant sections of my data collected during the study, 
may be looked at by individuals from the University of Birmingham.  I give 
permission for these individuals to have access to my records.		
4. I agree to take part in the above study.	 	 	 			 	 	 	 	 	 	 	 	 	 	 	
Name of Participant		 Date    Signature																										 		 	 	 	 	 	 	 	 	 	 	 	 	
Address of Participant 
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Contact number of Participant Email of Participant 		 	 	 	 	 	 	 	 	 	 	 	
Name of Person  Date    Signature  
taking consent	
 
 
 
 
Appendix 8  General Health Questionnaire: Chapter 5 
	
GENERAL HEALTH QUESTIONNAIRE 
Title of Project: Influence of pre- or post-exercised food intake on muscle metabolism in 
obesity 
Please answer the following questions.  If you have any doubts or difficulty with the questions, 
please ask the investigator for guidance.  Your answers will be kept strictly confidential. 
 
1. You are a....... 
 
Man Woman 
2. What is your exact date of birth?   
 Day........... Month...........Year..19........ 
So your age is........................... Years 
  
3. How would you describe your ethnicity? ……….. 
Please refer to ethnicity codes and enter a code. 
  
4. When did you last see your doctor?     In the: 
Last week............ Last month.......... Last six months............ 
Year................. More than a year........... 
  
5. Are you currently taking any prescription or non-prescription 
medication? 
YES NO 
6. Has your doctor ever advised you not to perform vigorous 
exercise? 
YES NO 
7. Has your doctor ever said you have “heart trouble”? YES NO 
8. Has your doctor ever said you have high blood pressure? YES NO 
9. Have you ever taken medication for blood pressure or your 
heart? 
 
YES 
 
NO 
10. Do you feel pain in your chest when you undertake physical 
activity? 
YES NO 
 
11. In the last month have you had pains in your chest when not 
doing any physical activity? 
YES NO 
12. Has your doctor (or anyone else) said that you have raised 
blood cholesterol? 
YES NO 
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13. Have you had a cold or feverish illness in the last month? YES NO 
14. Do you ever lose balance because of dizziness, or do you 
ever lose consciousness? 
 
YES 
 
NO 
15. a) Do you suffer from back pain 
b) If so, does it ever prevent you from exercising? 
YES 
YES 
NO 
NO 
16. Do you suffer from asthma? YES NO 
17. Do you have any joint or bone problems that may be made 
worse by exercise? 
YES NO 
18. Has your doctor ever said you have diabetes? YES NO 
19. Have you ever had viral hepatitis? YES NO 
20.  Are you currently participating in another clinical study? YES NO 
21. Do you have any bleeding disorders?  YES NO 
22.  Are you aware of any known allergies to local anesthetic 
(such as lidocaine)? 
YES NO 
23. Are you a current or recent smoker (last 30 days) YES NO 
24.  Do you have a past history of substance abuse or 
engagement in uncommon eating practices (e.g., sustained 
periods of fasting)? 
YES NO 
25. Have you previously (within 5 years of the present study) had 
4 or more muscle biopsies obtained from the thigh 
quadriceps region? 
YES NO 
26. Have you previously donated blood (last 12 weeks)? YES NO 
27.  If you are a woman, are you pregnant? YES NO 
29.  If you are woman, are you breastfeeding? YES NO 
28.  Have you gained/lost ≥2kg’s body mass in the past 3 
months? 
YES NO 
29. Do you know of any reason, not mentioned above, why you 
should not exercise? 
YES NO 
30 Do you perform regular physical activity? YES NO 
 	
Ethnicity codes  
 
1. White – British 
2. White – Irish 
3. Other – White background 
4. Black or Black British-Caribbean 
5. Black or Black British-African 
6. Other black background 
7. Asian or Asian British Indian 
8. Asian or Asian British Pakistani 
9. Asian or Asian British-Bangladeshi 
10. Chinese 
11. Other Asian background 
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12. Mixed – White and Black Caribbean 
13. Mixed – White and Black African 
14. Mixed – White and Asian 
15. Other mixed background 
16. Other ethnic background 
17. Other – please specify  
      ……………………………………………………… 
 					
Appendix 9  Screening Form: Chapter 5 
SCREENING FORM (completed by investigator) 
Title of Project: Influence of pre- or post-exercised food intake on muscle metabolism in 
obesity 
Consent Form signed?       Yes □ No □ 
 
From General Health Questionnaire, is participant eligible to continue? To be eligible participants 
will have indicate ‘No’ to questions 5-30        
               Yes □ No □ 
If No, inform participant they are not eligible. If Yes, continue with Screening Procedures 
 
Demographic Details: 
1. Sex  M/W (Circle) 
2. Ethnicity Code      
3. DOB  ___/____/___ 
4. Age  ____________  
5. Body Weight ________________(kg) 
6. Height _________________(m) 
7. BMI ___________________  BMI = %&''	(*+)-./+-0	 % 1 
8. Waist Circumference (measured midway between top of the iliac crest and lowest 
rib) _________________ (cm) 
9. Hip circumference (measured at the widest part of the buttocks, perpendicular to 
the trunk) 
_________________ (cm) 
10. Blood Pressure _________________mmHg 
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11. ECG administered Yes □         No □  
(This should now be sent to Dr Konstantinos Manolopolous) 
Eligibility Check 
 
Criteria Tick = eligible, cross = 
ineligible 
Comment from consenting and 
screening investigator 
Consent form signed   
Age (18-49 years)   
Health questionnaire 
(NO for Q5-30) 
  
At risk for cardio-
metabolic disease 
(anthropometric 
criteria) 
  
Resting blood 
pressure (<140/90 
mmHg) 
  
ECG outcome   
 
This participant is eligible / ineligible (circle as appropriate) to participate in this study 
                   
Name of Person conducting eligibility check      Date             Signature 
 
 		
 
